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Abstract
The influenza A M2 protein and, in particular, the proposed
transmembrane domain, has been implicated in viral infectivity at
two stages in the replicative cycle: viral uncoating and assembly.
An identical function has been proposed for the protein at both
points of interest, that is, that M2 acts as a proton channel. In
order to work, this hypothesis assumes that M2 possesses a
transmembrane domain, presumably in an a-helical conformation,
that this domain orientates in a prescribed manner across the bilayer
and that, indeed, M2 is able to translocate protons across the
aforementioned bilayer. This thesis examines these assumptions
experimentally using a synthetic, 25 amino acid peptide representing
the proposed transmembrane domain of M2.
The work described herein may be divided into three main
areas, each employing a separate biophysical technique. Circular
dichroism was employed to assign an a-helical secondary structure
to the M2 peptide. Neutron diffraction orientated this region
precisely in the bilayer. Electrophysiological techniques observed
directly, for the first time in viruses, proton translocation. The
effects of amantadine, the only drug prescribed for use against
influenza A infections, in each of these structural and functional
investigations have also been recorded, providing revealing insights
into the drug's efficacy.
M2 has structural analogues in other enveloped viruses and
work such as that reported in this thesis may reveal a common
pathway of viral infectivity for groups of enveloped viruses,
therefore allowing the possibility of broad-spectrum drug therapies.
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CHAPTER 1 INTRODUCTION TO INFLUENZA
3
1. Introduction to influenza
1.1 Historical background
The epidemic is seldom mentioned, and most have apparently
forgotten it. This is not surprising. The human mind always tries
to expunge the intolerable from memory, just as it tries to conceal it
while current.
H. L. Mencken
This is how Mencken (Sacks, 1985) described the great Spanish
influenza pandemic of 1918-1919, the most devastating outbreak of
disease since the Black Death of the Middle Ages. Just as the
world was trying to recover from the carnage of the Great War the
influenza virus struck. In a few short months approximately twenty-
one million people worldwide died. Double the number of Britains
slain in the war were killed by influenza, half a million Americans
died, isolated villages in Alaska were destroyed down to the last
person, and, in India alone, five million fatalities occurred. In
terms of numbers of dead, it was the greatest visitation ever
experienced by the human race.
Pestilences of many sorts have brought death and misery to
mankind throughout history. Over the last one hundred years most
of these plagues have been brought under control; the black death,
cholera, yellow fever, typhus and smallpox no longer rage
unchecked every few years. But influenza continues to flourish and
to cause pandemics that periodically sweep around the world without
restraint. In 1977, (before the identification of acquired immune
disease [AIDS]) Beveridge described influenza as 'the last of the
great plagues' (Beveridge, 1977).
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The name 'influenza' was originally coined in an Italian
document of 1504 and is a corruption of the Latin/Italian word
influentia - 'a flowing from the stars of ethereal fluid affecting the
character and destiny of man.' Thus the causative agent was
thought to be astral in origin. However, the disease had
masqueraded under various names before this; one of the first
recorded epidemics being reported in classical times, 412 B.C., by
Hippocrates and Livy. Quite a number of epidemics that were
beyond reasonable doubt influenza were described in the Middle
Ages. Definite pandemics took place in 1510 and 1580, and
between these two dates, it was documented that, in 1562, Mary,
Queen of Scots, 'fell acquainted' with influenza upon her arrival in
Edinburgh from France. Indeed, the historical record clearly
demonstrates that pandemics have occurred at intervals since ancient
times. More recently, influenza deaths in Britain during the
pandemic of 1847 exceeded those of the great cholera plague of
1832. In 1889-1890 the world suffered the Asian influenza
pandemic. This influenza strain appears to have been highly
virulent. In Europe the incidence was reported to be 40-50% and a
total of around 1% of the population died. The 1918-1919
pandemic, as mentioned, was by far the most devastating in modern
times but serious influenza outbreaks have still continued into the
virological era. In 1968, the Hong Kong virus was first reported in
China. During the following winter it became pandemic and the
mortality in the U.S.A. was estimated at around eighty thousand,
and, in the U.K., an estimated thirty thousand died in an eight week
period alone. The winters of 1971, 1972 and 1975 all displayed
increased influenza rates and associated deaths, indicating that
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influenza viruses were highly active (Harris et al., 1985). In 1989,
an epidemic in the U.K. killed about twenty-five thousand people
(O'Neill, 1991). And, most recently, in England and Wales the
number of deaths attributed to influenza and pneumonia recorded for
the winter of 1990 was ten thousand (Curwen et al., 1990).
The influenza virus has also been implicated in other illnesses
(Section 1.2). Schizophrenia, encephalitis lethargica and certain
leukemias have been postulated to have, at least to a degree, an
influenza aetiological input.
Such historical studies of influenza lead to the conclusion that
epidemics on a global scale will continue to occur until more
effective measures of combating the disease are devised and
implemented. Charles Cockburn, head of the viral section of the
World Health Organisation, wrote in 1973, "The influenza virus
behaves just as it seems to have done for five hundred or a
thousand years, and we are no more capable of stopping epidemics
or pandemics than our ancestors were." Influenza pandemics could
t
well become increasingly serious and there is no known reason why
there should not be another catastrophic one like that of 1918 or
even worse; the disease known as fowl plague, caused by an
influenza virus, results in one hundred percent mortality in chickens.
1.2 The disease, its prevention and treatment
The onset of illness is usually rather abrupt and early symptoms
such as headache, shivers and a dry cough occur 48 hours or more
after the acquisition of infection. In most cases, a sudden rise in
temperature from 37 °C to 40 °C is accompanied by intensification of
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the headache, weakness and pain in the joints. Sleep is disturbed, a
cough develops and the nose becomes obstructed but without
production of a profuse discharge. With influenza B infections,
nasal discharge does occur, and this, along with frequent sneezing
causes a resemblance to the common cold. But with influenza A, a
stuffy, blocked nose and dry throat are more often reported. The
degree of prostration is very variable and is related both to age and
the severity of the fever. The duration of the latter may average
between one and five days. The dry cough is followed by limited
expectoration and the voice may become hoarse. The involvement
of the lower respiratory tract may be indicated by patches of rales
over the lungs. Chest or cardiac complications may now occur and
it is at this stage that sudden or unexpected deaths can result,
particularly in the aged and the very young. Convalescence in those
without previous illness is usually rapid once the fever has subsided
but lassitude, depression and a painful cough may persist for several
days.
Although these are the most readily recognisable symptoms of
influenza A infection, the virus has also been implicated in other
serious illnesses. Respiratory complications include primary (viral)
pneumonia and secondary (bacterial) pneumonia. The latter may
occur particularly in patients with a history of chronic lung disease
(Scadding, 1937), the former has a high mortality rate (Hers et al.,
1958) and is thought to have been involved in the severity of the
1918 outbreak. Cardiac complications have also been described with
reports of inflammatory myocarditis in previously healthy patients
(Hers et al., 1958; Martin et al., 1959). Neurological problems
may arise (Dubowitz, 1958) involving influenzal encephalitis.
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Intriguingly, the neurological pandemic of viral encephalitis
lethargica, that swept the world in 1918-1919, overlapped with the
worldwide influenza outbreak. It is probable, but not certain, that
the influenza pandemic in some manner paved the way for the
encephalitis, and that the influenza virus potentiated the effects of
the encephalitis virus, or lowered resistance to it in a catastrophic
way (Sacks, 1985). Recent studies have also included linking
schizophrenia with influenza (O'Callaghan et al., 1991). In
summary, it is postulated that in the first trimester, a pregnant
woman exposed to influenza infection develops antibodies (Ab) to
this virus. The foetal blood/brain barrier is not fully developed and
maternal Ab can therefore travel through the placenta to the foetal
brain. Here the Ab somehow recognises as antigen (Ag) an area of
hippocampus implicated in schizophrenia. Subsequent tissue damage
occurs (Prof R.M. Murray, Dept of Psychological Medicine,
Institute of Psychology, Kings College Hospital, London, U.K.;
personal communication).
Vaccine and drug therapy development against influenza has not
been very successful. This is due to the unique properties of the
virus itself. There are differences in epidemiological behaviour and
host range between influenza types; studies have shown that
influenza C virus may resemble A in its ability to infect animals as
well as humans (Guo et al., 1983), whilst for influenza B no
consistent evidence is available which suggests the existence of
extra-human reservoirs of infection. Host range may indeed have
effects on viral structure. Influenza viruses are unique among the
respiratory tract viruses in that they undergo significant antigenic
change. Both of the surface antigens (Section 1.3) of the influenza
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A vims undergo two types of antigenic variation: drift and shift.
Antigenic drift involves minor antigenic changes in the
haemagglutinin (HA) and/or neuraminadase (NA), while shift
involves major changes in these molecules. Antigenic drift is due to
point mutations in the gene leading to an accumulation of amino
acid changes (Both et al., 1983). The term 'shift' is applied to the
emergence of a new influenza A vims possessing HA or NA
antigens so different from those of previously prevalent vimses that
it is designated as a new subtype. The change probably results
from recombination between a human and an animal strain, both
influenza A vimses. Host range may be seen to be of cmcial
importance (Webster, 1971). Influenza vims is therefore constantly
changing, so rendering obsolete whichever current vaccine is in use.
Each major shift has found a large proportion of the world
population immunologically defenceless against the newly emerged
virus. The World Health Organisation (WHO) operates an extensive
network of laboratories around the world which remain continuously
alert to the emergence of novel viral strains. These are then made
available to commercial vaccine producers in order to update
existing vaccines.
The conventional vaccine is an egg-grown, formalin- or fi-
propiolactone-inactivated product incorporating the equivalent of 15-
25 fig of HA of each of the latest prevalent strains of influenza
types A and B (Potter, 1982). This polyvalent vaccine is injected
intramuscularly in autumn or in winter during epidemics.
Production costs are reduced and yields increased in vaccine
manufacture by use of a genetic reassortment technique where the
new strains of vims are mixed with an established laboratory 'master
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strain' known for its high yield in eggs (Kilbourne, 1969). The
vaccine is predominantly used with groups liable to the excess
mortality mentioned above; namely, old people, people with
respiratory, cardiac or renal disease, diabetes, anaemia or
immunodeficiency. Side effects are not uncommon but their
occurrance may be reduced by using disrupted (split-virus) vaccines,
in which the envelope of the inactivated virion has been chemically
disrupted. A particularly serious problem, the Guillain-Barre
syndrome, was encountered in one of every one hundred thousand
Americans vaccinated against 'swine flu' (H1N1) during a mass
campaign in 1976-77 (Schonberger et al., 1979), but no such
association has been reported with any subsequent influenza vaccine.
However, it is remarkable that despite decades of trials on all
licensed vaccines the degree of protection which can be expected
remains in doubt. More recent developments include the use of
HA/NA virosomes, vaccinia virus incorporating the HA gene and
even production of small antigenic peptides based on conserved sites
on HA cummon to many strains of influenza (Mims and White,
1988).
Numerous studies of the drug amantadine (1-amino adamantane
hydrochloride) (see Figure 3.4) since the pioneer work of Davies et
al., have continued to give relatively consistent results. Amantadine
and its derivatives (eg. rimantadine) have been shown to be specific
inhibitors of influenza A viruses both in vivo and in vitro and are
effective in the prophylaxis and treatment of human infections
(review by Tominack and Hayden, 1987). Although initially
licensed in 1966 for use against H2N2 viruses and subsequently in
1976 for use against all human influenza A subtypes, it is still only
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used on a very limited scale. However, rimantadine, which is as
effective as amantadine and appears to cause fewer adverse
reactions, is more widely used in the former U.S.S.R. (Zlychnikor
et al., 1981). Even though it is ineffective against influenza B
infections, amantadine remains one of the few truly antiviral drugs
available to the clinician. (For a full account of the mode of action
of amantadine see Section 1.4).
1.3 The structure of the virion
Since the 1940's, when only a few viruses had been
recognised, hundreds of viruses have been discovered and
characterised, largely as a result of the exploitation of cell culture
techniques. Taxonomic criteria for classifying viruses only began to
be established in the 1960's and, presently, viruses of vertebrates
are classified into about 20 families (Matthews, 1982). The
influenza viruses are grouped under the myxoviridae. As the term
myxo (from the Greek myxa', meaning mucus) attests, these viruses
have an affinity for mucopolysaccharides and glycoproteins (in
particular, sialic acid-containing receptors on cell surfaces).
Influenza viruses A, B and C are further classified as being
orthomyxoviridae due to the segmented nature of their genomes.
Influenza A and B are morphologically identical, pleomorphic,
enveloped viruses and are approximately 80-130 nm in diameter
(Figure 1.1). Although they often appear roughly spherical in





Figure 1.1 The structure of influenza A. Each gene segment points
to its respective gene product. NB. Segment 5 codes for NP
(represented by brown circle) and segments 1, 2 and 3 code for
proteins which make up the PP (represented by Mack cube), both of





The lipid envelope, which is derived from the host cell in
which the virus has replicated, is studded with two morphologically
distinguishable glycoprotein spikes in a proportion of approximately
4:1, namely the HA and the NA.
HA was the first membrane protein to have its three-
dimensional structure resolved by X-ray crystallography (Wilson et
al. ,1981). It is a trimer with molecular weight approximately
225 000. Cell attachment abilities reside within this molecule.
Each monomer, HAq, consists of two subunits, HA] and HA2,
linked by disulphide bonds. The amino terminus of HA2 includes a
highly conserved sequence associated with membrane fusion. HA is
therefore responsible both for attachment to host cells via sialic acid
receptors and for membrane fusion between the resultant endosome
(see below) and the virus membrane (White et al., 1982).
NA is a tetramer of total molecular weight 240 000. This
enzyme catalyses the cleavage of the linkage between terminal sialic
acid groups and adjacent sugar residues (Gottschalk, 1957). In
general, the role of NA may be to facilitate the mobility of the
virus both to and from the site of infection by enabling the virus to
evade the protective mucoid layer of the host cell.
Both spikes are thought to penetrate through the lipid bilayer
via anchors of hydrophobic amino acids and may make contact with
the underlying electron-dense layer of matrix (Ml) protein. Ml is
the most abundant protein in the virion (35% of total) and forms a
layer one or a few molecules thick which probably contributes in a
major way to the structural integrity of the virion as well as being
involved in viral assembly at the plasma membrane before budding.
Enclosed within this matrix shell are the nucleoprotein (NP) and the
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polymerase proteins (PB1, PB2 and PA) which are all closely
associated with the single-stranded RNA. The NP appears to be
involved in packing of the RNA. The three polymerase proteins
constitute an RNA transcriptase enzyme (Kawakami and Ishitama,
1983) responsible for initiating RNA transcription in the infected
cell. The virus genome consists of eight molecular species of
single-stranded, negative-sense RNA of different coding potentials
(Inglis et al., 1976) which are replicated independently and are
contained within ribonucleoprotein (RNP) structures.
Influenza B also codes for a glycoprotein similar, and in
addition to, NA. This has been termed NB, and, as it does not
appear to be incorporated into virions, its role in infection is not
clear (Shaw and Choppin, 1984). Little is known of the molecular
biology of influenza C; it has seven RNA segments and no separate
HA and NA (instead it possesses a protein, HE [haemagglutinin-
esterase], which bears both receptor recognition and cleavage
activities).
In addition to the proteins described above, influenza A also
codes for two nonstructural proteins, NS1 and NS2, whose functions
are unknown, and a final protein M2. NS1 and NS2 are encoded
in RNA segment 8 and are found to accumulate in large amounts in
the nuclei of infected cells. Neither of the NS gene products are
found in virions. It has been postulated that they may be involved
in shutting-off host cell protein synthesis (Wolstenholme et al.,
1980). M2 is the subject of this thesis and will be discussed fully
in the next section.
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The cycle of infection of influenza A (Kingsbury, 1990)
commences with initial attachment to host cell sialic acid moieties
via HA (Figure 1.2) (Plate 1.1). The virus is internalised by
receptor-mediated endocytosis and, in the endosome formed, is
exposed to acidic conditions by the action of cellular proton pumps.
At a pH specific for each influenza strain (usually between 5.5 and
6.0), the HA undergoes a conformational change whereby a fusion
region is exposed. Fusion between the viral and the endosomal
membranes takes place and the Ml dissociates resulting in release of
the genetic components into the cell. Transcription occurs in the
nucleus and is initiated by the viral-coded RNA polymerase
complex. The negative-strand RNA is transcribed into positive-
strand RNA (mRNA) by the polymerase and this is then translated
into influenza proteins, or, it is further transcribed into negative
RNA to supply the genetic components for future viruses. The
nucleocapsid is assembled in the nucleus and the envelope is
assembled on the infected cell surface. New virions are formed
from nucleocapsid and envelope and bud-off from the host cell
surface (Plate 1.2).
1.4 Influenza A M2 protein and its proposed role in the replication
of the virus
In 1980, it was observed that, in addition to the open reading
frame coding for Ml, RNA segment 7 also included a second open
reading frame that possibly encoded another protein (Winter and
Fields, 1980). This protein was designated M2 and was subsequently
identified in several infected cell types as a polypeptide of
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approximate molecular weight 15 000. M2 was reported to be a
nonstructural protein found only in infected cells and not in virions
(Lamb and Chopin, 1981). In addition, examination of the
predicted protein sequence of M2 suggested that it contained a
region of amino acids (residues 25 to 43) that was sufficiently
hydrophobic to interact with membranes (Lamb et al., 1981). In
1985, Lamb et al. confirmed this and reported that influenza virus
M2 was an integral membrane protein expressed on the infected cell
surface. Ml is translated from a mRNA that is colinear with RNA
segment 7, whereas M2 is translated from a spliced mRNA - the
initiation codon and subsequent nine amino terminal amino acids of
Ml and M2 are common to both, as they are encoded before the 5'
splice junction. The remaining 88 amino acids of M2, encoded
after the 3' splice junction, are translated from the second open
reading frame. Such early work also revealed a high degree of
amino acid conservation within the external NH2-terminal residues,
from avian through to human viruses, indicating that M2 has
properties which are important to the biology of the viral infection
in host animals.
Recent work has now identified M2 in virions using
monoclonal Abs and, furthermore, has shown that such Abs bind to
the extracellular NH2-terminal domain and restrict the replication of
influenza; a quantitative assay indicated 14 to 68 molecules of M2
per virion in the preparations used (Zebedee and Lamb, 1988).
Other authors have reported electron microscopic evidence
supporting the association of M2 protein with the influenza virion
(Jackson et al., 1991).
Subsequent research involving M2 has been inspired by the
16
 
Plate 1.1 E.M. of influenza A virus (note the HA spikes). This
plate was produced by applying the material to a 400 mesh copper
grid (covered in carbon-coated Formvar) and stained with
phosphotungstic acid (2% for two minutes). The size bar represents
100 nm.
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Plate 1.2 E.M. of budding viruses (single/groups of virus) from a
fragment of cellular membrane (note the complete fringe of HA
molecules). Preparatory procedure as for Plate 1.1. Bar indicates
100 nm.
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action of amantadine upon the influenza virus. The replication of
many intluenza strains is inhibited by this drug and its related
compounds, however, resistant viruses readily arise in vivo in
chickens, mice and humans (Belshe et al., 1988). Nucleotide
sequence analyses have shown that in every case a mutation in the
M2 protein is responsible for resistance (Hay et al., 1985). The
substitutions which confer resistance occur only in the hydrophobic,
putative membrane-spanning region of the molecule, specifically at
residues 27, 30, 31 and 34. Interestingly, if the 'membrane-
spanning' domain adopts an a-helical structure then all the
substitutions fall on one face of the helix near the luminal side of
the membrane (Hay, 1989). The occurrence and predominance of
certain substitutions are strain dependent and whether this reflects
features of M2 itself or the properties of other virus components is
not known. Genetic evidence therefore points to the postulated
transmembrane domain of the M2 protein as the prime target of
amantadine.
However, amantadine is not virucidal and it does not hinder
viral absorption or penetration. Its effects have been shown to
occur at two possible stages. The first occurs early during infection
at the uncoating stage and the second occurs late in the cycle and
prevents proper virus maturation (Hay et al., 1986).
In cell culture, susceptibility to the early action of these drugs
is a feature common to most human viruses; only certain equine and
avian strains (H5 and H7) that infect, for example, chick embryo
cells and MDCK cells, have so far been shown to succumb to the
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late effect. However, the clearest indication as to the mechanism of
drug action and the function of the M2 protein has come from
studies of this latter phenomenon.
Inhibition occurs at the final stage in virus assembly by
blocking the release of virus particles without interfering with bud
formation (Ruigrok et al., 1991). This appears to be the direct
consequence of a specific alteration in the HA structure during its
transport to the surface of drug-treated, infected cells. Addition of
drug after the initial infection period does not significantly affect the
synthesis of other virus components or the amount of HA
synthesised, its posttranslational modification including glycosylation,
acylation, and proteolytic cleavage, or its transport to the plasma
membrane. However, the conformation of the molecule exposed on
the cell surface is indistinguishable from that acquired following
exposure of mature HA to a pH below about 5.5, as shown by
several criteria, in particular, susceptibility to proteolytic digestion
and reducing agents and recognition by monoclonal antibodies
specific for the low pH form of HA (Sugrue et al., 1990). Pulse-
chase experiments have shown that the sensitive stage occurs some
20 minutes after synthesis of HA and coincides with the proteolytic
cleavage of HAq to HA] and HA2 (the mature, fuseogenic form of
the HA molecule). This points to a compartment late in the
transport pathway, such as the trans-Golgi or post-Golgi vesicles.
The coincidence with protelytic cleavage is not particularly
surprising in view of the nature of the phenomenon, since only the
cleaved form of HA can undergo the irreversible conformational
change upon exposure to low pH (Wiley and Skehel, 1987).
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The fact that alterations in the primary sequence of M2 alone
can abolish the effect of amantadine (the amantadine-resistant
mutants) argues against a direct effect on HA and points to
interference with an interaction between HA and M2 - either a
direct structural interaction or some indirect interrelationship between
the two proteins. Evidence favours the latter, and there are
indications that the acidity of the cellular compartment relative to
the pH at which the HA conformational transition occurs is
important. Certain influenza viruses are insensitive to the action of
amantadine in MDCK cells (which are epithelial) but are susceptible
in chick embryo fibroblasts; whereas mutants possessing HAs that
undergo the conformational transition at higher pH values of 6.0 to
6.4 (wild type, pH 5.6) are sensitive in both cell types. Of interest
in this regard are reports of differences in the acidities of the
cisternae and vesicles of the Golgi complex of different cells and, in
particular, the lower pH in corresponding compartments of
fibroblasts as compared to epithelial cells (Anderson and Orci,
1988). The Rostock virus HA, which undergoes the conformational
change at pH 6.0, is affected by amantadine in MDCK cells and
chick embryo fibroblasts whereas the Weybridge virus HA, which
undergoes the conformational change at pH 5.6, is only affected by
amantadine in chick cells. This may be because fibroblasts have a
lower pH in their intracellular compartments than do epithelial cells
and even in the presence of amantadine, the pH of the Golgi in
epithelial cells is not sufficiently low to trigger the conformational
change in Weybridge HA but is low enough to trigger the Rostock
HA. In the fibroblasts, the pH is sufficiently low to trigger the HA
of both strains.
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Furthermore, the specific action of amantadine is counteracted
by agents that elevate the pH of intracellular compartments involved
in endocytosis and exocytosis. These include, for example, an
extracellular pH greater than 8.5, millimolar concentrations of
acidotropic amines, for example, methylamine and NH4CI, and low
concentrations of ionophores such as monensin and nigericin. By
analogy, the low concentration optimum of the specific action of
amantadine and rimantadine, in the range of 0.05 to 5 /zM, can be
explained by the antagonistic action of higher drug concentrations.
This may be because at higher doses these drugs themselves raise
the pH of the Golgi by virtue of being weak bases and therefore the
HA will not be exposed to low pH.
The conclusion reached from the above evidence is that, since
M2 is instrumental in amantadine action, this protein, like the above
compounds, effects a similar change in pH, which is blocked by the
drug. This role of M2 is supported by observations that, in the
absence of drug, cells infected with certain strains of virus,
including HA mutants that undergo the conformational transition at
higher pH values (as above), may express elevated levels of low pH
HA that display a cell dependence and reversibility similar to that
just discussed. This is also true if reassortant viruses are prepared
containing a heterologous M gene. This further emphasises the
important relationship between HA and an M gene product
(presumably M2) in preserving the integrity of the HA, apparently
by influencing the pH of certain vesicular compartments during its
transport to the plasma membrane.
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It may be postulated from these observations that the M2
protein forms a transmembrane channel involved in reducing the pH
gradient across the membrane of normally acidic vesicles and that
amantadine and rimantadine interfere by blocking ion flux (Hay,
1989). This is therefore analogous to the anticholinergic action of
amantadine and related compounds (Warnick et al., 1982) and is
similar to that of other noncompetitive antagonists that block the ion
channel of the nicotinic acetylcholine receptor. A further interesting
parallel concerns the possible sites of amantadine interaction.
Affinity labeling of the nicotinic acetylcholine receptor with certain
noncompetitive antagonists indicated that their interaction with serine
residues occurred towards the inner surface of the membrane, in
homologous positions of the Mil transmembrane segments of the
four different polypeptide subunits of the pentamer (Changeaux et
al., 1987). The interaction of amantadine with an equivalent region
of the virus M2 protein is indicated by the locations of the amino
acid substitutions in drug-resistant mutants. The positions of these
altered amino acids and the position of the polar and charged amino
acids in wild-type and mutant viruses on the same face of an a-
helical configuration of the postulated transmembrane domain of M2
would be consistent with its proposed amphiphilic nature. Recent
evidence indicating that M2 polypeptides form disulphide-linked
tetramers (Sugrue and Hay, 1991; Panayotov and Schlesinger, 1992)
is consistent with the ability of the protein to form a transmembrane
channel. The consequences of the amino acid substitutions are not
known. They may alter the interaction of amantadine with M2, or,
more drastically, change the protein structure itself. Studies of
amphiphilic peptides have shown that similar changes in sequence
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can dramatically alter their ion channel conductance and cation
selectivity (Lear et al., 1988).
From the above, it is possible to imply the mechanism of drug
action early in infection - this being the stage at which most strains
are affected. Since the same mutations in M2 abolish susceptibility
to both early and late actions of amantadine and rimantadine, it is
evident that the two actions have the same basis and are directed
against a related function of M2.
The monitoring of virus/liposome interactions may be used as a
model system for virus/endosome fusion. Concentrations of
amantadine comparable to those found to be effective in cell culture
specifically reduce the rate of in vitro membrane fusion between
viruses whose replication is inhibited by amantadine and liposomes
(Dr A.J. Hay, National Institute for Medical Research, Mill Hill,
London, U.K.; personal communication). This is not accompanied
by any reduction in the extent of fusion or the rate of the
conformational change in the HA. It may be that this effect is
exerted upon some feature of the uncoating process, for example,
disassembly of the Ml protein shell (Bukrinskaya et al., 1982).
Subsequent observations that if monensin is added to this system
then the rate of virus/membrane fusion in vitro increases, and that
Ml solubilises at acidic pH (Gregoriades, 1973) lend support to the
idea that, in endosomes, the M2 protein is involved in the transfer
of protons across the viral membrane and that the resultant drop in
pH destabilises the viral structure. Further support for this theory
comes from recent work which showed that a lowered pH is
required to dissociate the influenza Ml protein from the RNP's
(Zhirnov, 1990). This is probably directly related to the in vivo
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experiments that indicated that, in the presence of amantadine, Ml
fails to dissociate from the RNP's (Martin and Helenius, 1991) and
transport of the RNP's to the nucleus does not occur.
Thus, it appears that the role of M2 is important both in
uncoating virus particles and in preserving the integrity of HA
during its transport through acidic compartments to the cell surface
(Figure 1.3).
Whilst this thesis was in preparation, Pinto et al. published a
paper (May 1992) that is particularly noteworthy in that it shows
monovalent cation flow (Na+ and K+) through M2 expressed in
Xenopus laevis oocytes (see later). The electrophysiological study
reported as part of this thesis was, in fact, submitted two months
before the Pinto study was published (March 1992) and, in addition,
is the first study to fully illustrate the Hay theory in that it shows,
specifically, proton transport (Chapter 4).
1.5 Aims of thesis
It is the aim of this thesis to investigate fully the theory
discussed in the previous section. It is therefore intended that a
variety of biophysical techniques will be employed to assertain the
structural and functional properties of influenza A M2 protein.
The unique attributes of influenza M2 protein have been
described in Section 1.4 as being a function of the proposed
transmembrane domain of that protein. The experiments reported
here will therefore concern a synthetic peptide whose primary
structure represents a 'transmembrane' sequence common to several
strains of influenza A (see Section 2.7 for details).
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Initially, the secondary structure of this M2 peptide will be
investigated in liposomes, using circular dichroism (CD). Such
studies are also intended to act as confirmation that the domain is
indeed transmembraneous, will produce low resolution information
on the gross positions of the amino acids, reveal any structural
dependence based on the lipids used and show any effects on
secondary structure upon the addition of amantadine.
Subsequently, the orientation of the M2 in phospholipid
multilayers will be studied to high resolution with neutron
diffraction. Both native (amantadine-sensitive) and mutant
(amantadine-resistant) M2 peptides will be located, and amantadine
will be added to both. The exact position of the M2/amantadine
interaction will be investigated.
Finally, using electrophysiological techniques, it is proposed to
test the theory that M2 is a proton channel. It is intended to study
the effects of amantadine on any such channel activities.
In conclusion, the idea that viruses may code for ion channels
is a novel one in biology. To date only one, Semliki Forest Virus,
has been suspected of possessing such a potential, however, the
protein responsible has not yet been positively identified (Schlegel et
al., 1991). In addition, other proteins have been named as
structural analogues of M2 and these may be found to have
functional similarities too. These include the NB protein of
influenza B (Williams and Lamb, 1986), the SH protein of
paramyxovirus SV5 (Hiebert et al., 1985) and the vpu protein of
HIV-1 (Terwillinger et al., 1989). If groups of enveloped viruses
in general are found to possess similar methods of uncoating and
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reassembly then this information may open-up an innovative and





Figure 1.3 Theory of M2 action - role in virus uncoating and
protection of HA in the Golgi (see Section 1.4).
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CHAPTER 2 INVESTIGATION OF THE SECONDARY
STRUCTURE OF INFLUENZA A M2 TRANSMEMBRANE
DOMAIN IN PHOSPHOLIPID LIPOSOMES USING CIRCULAR
DICHROISM
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2. Investigation of the secondary structure of influenza A M2
transmembrane domain in phospholipid liposomes using circular
dichroism
2.1 General introduction
The importance of conformation in the function of biological
molecules is now an accepted fact. The specific three-dimensional
organisation of such molecules, when known, has been shown in
almost all cases to be intimately linked with function. The
measurement of circular dichroism (CD) spectra has become a
routine means of studying such molecular structures in solution.
This spectroscopic technique represents one of the most sensitive and
versatile probes of biopolymer conformation. Rapid progress has
been made over the last two decades on both the experimental and
theoretical sides of this chiroptical method. In the 1960's CD
developed from a little-known and poorly understood phenomenon to
a widely applicable method for studying the configuration and
conformation of optically active molecules. Simultaneously, the
understanding of the phenomena and the ability to make explicit
calculations made rapid advances. Today experimental methods are
at the point where CD can be measured at high sensitivity from the
ultraviolet through to the infrared. Theoretical calculations on even
quite complex systems can be done with considerable confidence at
the semiquantitative level.
Examination of polynucleotides with CD has shed light on,
amongst other things, base stacking and tilting which has helped
define conformational assignments. CD has also been used, to a
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lesser degree, to investigate the structure of various polysaccharides.
In the field of protein chemistry, it has proved possible to
investigate, in the far UV peptide bond absorption region, protein
secondary structure, and, in the near UV aromatic sidechain region,
protein tertiary structure. Other chromophores, for example haem
groups, have characteristic absorptions and CD spectra. This
therefore provides a sensitive analytical tool with which to
investigate protein structure, amino acid substitutions and the effects
of both ligand binding and solvent. Results may be obtained
quickly and with relatively small amounts of sample.
2.2 CD theory
The basic CD experiment consists of placing a sample in a
beam of alternating left and right circularly polarised light and
recording the differential absorption of both components. (For
reviews see Bayley, 1973; Woody, 1977; Campbell and Dwek,
1984.)
Production ofcircularly polarised light
Electromagnetic radiation may be thought of as possessing two
wave motions at right angles to each other - a magnetic M
component and an electric E component. The energies associated
with M and E are equal, but most optical effects are concerned with
the electric wave.
Although the amplitude of the E wave in Figure 2.1 oscillates
in the zx plane, it could oscillate equally well in any direction
perpendicular to the direction of propagation (z). Unpolarised light
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Figure 2.1 The electromagnetic wave. M represents the magnetic
component and E represents the electric component - see text for
details.
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contains oscillations of the E components in all directions
perpendicular to the direction of propagation. Plane or linearly
polarised light has E oscillations in only one plane.
Plane-polarised E radiation of the sort described in Figure 2.1
can be considered to arise from a source that oscillates parallel to
the x-axis. If the source also oscillates parallel to the y-axis in the
same phase, then the two waves superimpose to produce a new,
single plane-polarised wave. For example, if the two waves display
identical amplitudes, the resultant wave will be orientated at 45° to
the x-axis. If the two components do not have the same phase
relationship, then the superimposition of the two oscillations does
not lead to a fixed direction for E. For example, if the phase
difference is 7t/2 , as shown in Figure 2.2, then the path the E
vector describes is a helical trajectory about the z-axis and the
projection of this onto the xy plane describes a circle (Figure 2.3, a
and b).
When the amplitudes of the two waves are equal, and if the
phase difference is ir/2, then the resultant wave is said to be
circularly polarised. If the two components of oscillation along xy
are unequal in amplitude, then the resultant wave is ellipticalty
polarised. The polarisation is right-handed when the vector appears
to rotate clockwise on looking in a direction opposite to the
direction of propagation, and left-handed if the rotation is
anticlockwise. Circularly polarised light may be produced if plane
polarised light is passed through a quarter-wave plate, a transparent
window made from a birefringent medium in which the velocities of
the two plane-polarised waves differ, and is of a thickness such that
the phase difference between the components of the emergent beam
34
Figure 2.2 Circular polarisation. Two beams polarised along xz and
yz, 90° phase shifted with respect to each other.
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A
Figure 2.3 Illustration of (a) how two beams polarised along xz and
yz, 90° phase shifted with respect to each other, generate a
circularly polarised beam (b) when thay are superimposed.
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is 90°. From the above, plane-polarised light may be considered
equivalent to two circularly polarised beams rotating in opposite
directions.
Optical activity
Many transparent substances affect the state of polarisation of
light entering them. One such interaction that may occur between
polarised light and matter is dichroism, which is a difference in
absorption of left and right circularly polarised light.
Dichroism of circularly polarised light (CD) results when the
absorbance of a medium varies with the direction of rotation of a
circularly polarised measuring beam. Therefore, the experimentally
observed parameter is change in absorbance (5A), which is defined
as
<5A = <5e (Cd) = Al - Ar 2.1
where Al and Ar are the absorbances of the L and R beams, C is
the concentration in g mH, d is the path length in decimeters and e
is the molar extinction coefficient. CD is caused by an inherent
helicity in the molecular structure of the medium, or to other forms
of non-planar asymmetry (chirality). If plane-polarised light is
transmitted through such a material, the circular components undergo
different amounts of absorption. The emergent beam consists of
elliptically polarised light (Figure 2.4), the major and minor axes of
the ellipse being respectively the sum of and difference between the
amplitudes of the emergent circular components.
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Figure 2.4 Resultant ellipticity due to differential absorption of the
circular components of plane polarised light.
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Although change in A is measured, the molar ellipticity is often
reported. The ellipticity, 0, is defined as the angle whose tangent
is the ratio of the minor and major axes of the ellipse. The molar
ellipticity, [0], is defined as -
|0] = GM/lOOCtf 2.2
where M is the molecular weight of the dichroic solute, C is its
concentration in g mH and d is the optical path length in
decimeters.
These parameters can be related by the expression -
|0] = 3300 (<5e) degree x cm^ x dmol-1 2.3
Circular dichroism represents the manifestation of a specific
phenomenon, the interaction between polarised light and an
asymmetric structure. It exhibits a variation with wavelength and,
near an absorption band, the refractive index of the absorbing
medium undergoes large changes and the CD spectrum exhibits a
Cotton effect, that is, a change in the direction of rotation or
ellipticity with increasing wavelength, resulting in an S-shaped
spectrum. The Cotton effect associated with each absorption band is
easily identifiable in CD spectra, since differential absorption is only
measurable within the band itself.
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Molecular basis of optical activity
In general, spectrophotometric techniques involve the
component molecules of the sample absorbing electromagnetic
radiation of a specific wavelength and thereby entering an excited
state. Such transitions from the ground state to the excited state
involve a displacement of charge. A linear displacement with an
electric transition dipole moment is denoted by p. The transition
can also have a circular component; this (rotating current) then
generates a magnetic dipole moment m perpendicular to the plane of
the circular motion (Figure 2.5).
Optical activity requires a finite p and a finite m. This
corresponds to a helical displacement of charge. The result is that
left- or right-circularly polarised beams then interact differently with
the molecules in solution. These interactions do not average to zero
even in molecules randomly orientated in solution - the magnitude of
the transition is proportional to the vector product of p and m.
In the experiments discussed here, the required helical
displacement of charge arises lfom the intrinsic nature of the
chemical bonds. The amplitude and location of the Cotton effect at
wavelengths between 180 and 240 nm, which is due primarily to the
peptide linkages, are each specific to the conformation of the amino
acid chain. Therefore, each protein secondary structure has a
corresponding CD spectra, and, the spectra of a complex protein
may be derived from the sum of the spectra of the component
secondary structures. The proportion of each type of structure in
the parent molecule may therefore be estimated using a
multicomponent analysis (Chen et al., 1974) which compares the
experimental CD spectra with sets of reference proteins whose
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Figure 2.5 Helical displacement of charge can be considered to
comprise a linear displacement plus a circular displacement.
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secondary structure fractions are known from other sources, eg. X-
ray diffraction data. In a liposomal sample, the weak CD spectra
due to lipids are dominated by those of the proteins. Vesicles,
liposomes and membrane fragments larger than 1 000 nm or so in
diameter give rise to a slight red shift of the Cotton effect and a
considerable reduction in its amplitude, but when these distortions
are corrected for, reasonably accurate estimates of the component
structures may be obtained.
2.3 Experimental hardware
CD arises from the differential absorption of left and right
polarised light. Thus it could be detected by a double beam
instrument that puts left in one beam and right in the other. In
practice, it is possible to use a crystal that can be made to pass
either left or right depending on the applied voltage of an electric
field. This device, known as a Pockels cell, can thus produce a
beam that is alternately switched between left and right polarised
light. The beam then passes through the sample to a
photomultiplier. The detected signal can then be processed to give a
plot of change in absorbance versus wavelength. All experiments
discussed in this section were recorded at Stirling University on a
Jasco J-600 spectropolarimeter.
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2.4 Introduction to the experimental section
Chapter 1 has presented a general background study of
influenza and a more specific account of M2 and its potential
importance. Chapter 2 will initiate the M2 studies described in this
thesis by investigating, using CD, the secondary structure of M2
peptide incorporated into 1,2-dioleoykv/2-glycero-3-phosphocholine
(DOPC) liposomes. The CD work was carried out with Dr N. C.
Price, Department of Biological and Molecular Sciences, University
of Stirling.
2.5 The secondary structure of influenza A M2 transmembrane
domain - an introduction
In protein structure prediction, the definition of what is and is
not a transmembrane domain is unfortunately rather subjective. In
essence, a transmembrane domain may be defined as such if it
includes a region of hydrophobic amino acids bounded on either side
by two charged residues. Initially, it was suggested that M2
contained a region of amino acids (25-43) that were sufficiently
hydrophobic to interact with membranes (Lamb et al., 1981; Lamb
et al., 1985). Subsequently, almost all papers referring to this
protein have described such a postulated transmembrane domain as
an actual transmembrane domain, without any definitive evidence
over and above the sequence data.
The premise that such membrane-spanning regions often have
an a-helical secondary structure is generally based on theoretical
predictions and observations of such in bacterial photosynthetic
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reaction centres (Deisenhofer et al., 1985; Allen et al., 1987; Roth
et al., 1989). In addition, specifically, when the M2
'transmembrane' domain is modelled as an a-helix the residues
which are substituted in amantadine-resistant mutants all appear on
the same face of the helix (Hay, 1989). Thus, it is an attractive
assumption that this domain is indeed both transmembraneous and a-
helical.
However, several caveats exist. An amantadine-resistant
influenza virus has been isolated that contains a proline substitution
(residue 30) deep in the proposed transmembrane domain - this is
not usually thought to be compatible with a helical conformation
(Hay et al., 1985). In addition, Pinto et al. (1992), observed that
both deletion of four transmembrane residues and addition of one
extra residue still permitted ion channel activity. The Pinto study
concludes by stating '...clearly it is of importance to determine the
structure of the transmembrane domain of the influenza virus M2...'
Therefore, this present study describes CD investigations of the
secondary structure of influenza A M2 'transmembrane' domain
reconstituted into DOPC liposomes. The results of adding
amantadine at different concentrations and the effects of temperature
on any secondary structure initially observed were also investigated.
In addition, data have been collected regarding any M2 structural
dependence with reference to the liposomal lipid-type used.
44
2.6 Materials
All chemicals, phospholipids and amantadine hydrochloride
were purchased from Sigma Chemical Company Ltd. (Fancy Road,
Poole, U.K.).
The M2 liposomes were prepared in a 10 mM Tris-
hydrochloride, 0.1 mM EDTA buffer system, pH 7.4 (Section 2.7).
All liposomes were determined to have protein concentrations
between 0.1 and 0.3 mg ml~l (results were corrected for
concentration). Two concentrations of amantadine were added to the
reconstituted liposomes, 4 fig mH and 12 fig ml~l. These were
designated low and high concentration respectively.
Liposomal and control protein concentrations were determined
colorimetrically following the Lowry modification of Markwell et al.
(1981) using bovine serum albumin as standard.
2.7 Sample preparation for CD
The peptides
Synthetic, twenty-five residue, M2 peptides (amino acid
sequence: SSDPLVVAASIIGILHL1LWILDRL), corresponding to
the predicted nineteen amino acid transmembrane sequence (25-43)
plus a tail of three commonly occurring residues at each end, were
produced. This sequence is common to several strains of influenza
A (Ito, et al., 1991; Belshe, et al., 1988; Hay et al., 1985).
Mutants with a single amino acid substitution were also prepared -
residue 27, V is replaced by A (Hay et al., 1985). Some of these
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peptides were deuterated for experiments described in Chapter 3.
For a complete list of synthesised M2 peptides see Figure 3.7. In
this chapter, only the first, above designated peptide, was used.
All influenza A M2 peptides used in this thesis were
synthesised by F-MOC chemistry. This was carried out by the
MRC Cellular Immunology Unit, Sir William Dunn School of
Pathology, South Parks Road, Oxford, U.K. Finished peptides were
subsequently sequenced at the MRC Immunochemistry Unit,
Department of Biochemistry, South Parks Road, Oxford, U.K. and
also at the Welmet Protein Sequencing Laboratory, Department of
Biochemistry, Edinburgh University.
After synthesis, crude peptide was removed from the synthesis
resin, deprotected and purified.
Deprotection and removal of the peptide from the resin
involved the following procedure. (All glassware was acid-washed
to minimise the possibility of contamination.) 0.3 g of the M2
resin was incubated at 30 °C with a total of 3 ml deprotection
cocktail (76% high purity trifluoroacetic acid |TFA|, 20%
ethanedithiol, 4% distilled water). Incubation occurred over ninety
minutes and the tubes were shaken at least once every fifteen
minutes. The resin was subsequently removed from the deprotected
peptide by slow filtration through glass pipettes containing acid-
washed glass wool. Approximately 0.75 ml of the filtered M2
eluent was collected in four tubes each containing 8 ml of ice-cold
ether (the comparatively large volume is to stop the acidic TFA
concentration increasing and holding the peptide in solution). The
peptide was seen to precipitate on contact with the ether. The
precipitated peptide was spun down in a MSE Centaur 2 centrifuge
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(3 000 rpm for four minutes) and the supernatant aspirated-off.
Finally, the peptide pellet was washed at least five times with the
addition of 8 ml of ice-cold ether followed by centrifugation as
above. After the last spin the tubes were aspirated and placed in a
dessicator under vacuum for approximately twelve hours. Resulting
samples were weighed.
These were then purified using reverse-phase HPLC. This was
performed with a Beckman C-8 ultrapore preparation column (4.6
mm x 25 cm) fitted with a 2 ml injection loop. 1 ml of a 10 mg
ml-' sample (dissolved in 50:50, acetonitrile:water) was loaded per
run and the following programme was developed -
Time(mins) Function Value(%) Duration!mins)
0 %B 60 3
3 %B 75 5
8 %B 100 15
23 %B 100 15
38 %B 60 5
53 End
NB. Solvent A - water / 0.01 % TFA, B - acetonitrile / 0.01 % TFA
[Both solutions were filtered (0.2 /xm filter) and degassed.] The
flow rate was held at 3 ml min~l. The elution profile is
represented in Figure 2.6. The central peak was collected,
lyophilised, sequenced and ascertained to be M2.
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t (mins)
Figure 2.6 HPLC elution profile of M2 peptide - superimposed is
the % acetonitrile (60-100%). [NB. Absorbance was measured at
275 nm; times relevant to the elution programme are shown.)
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The liposomes
The native, undeuterated M2 thus prepared was reconstituted
into phospholipid liposomes in the following manner. A molar ratio
of 150:1 (lipoprotein) was chosen for the CD study and the
detergent selected was /z-octyl glucopyranoside (OG). One of the
criteria for an adequate CD sample is a total protein concentration
of approximately 0.2 mg ml"C After deducing the M2 molarity for
such a concentration and calculating the corresponding lipid
molarity, a solution of OG at a final molar concentration four times
that of the lipid (Sizer et al., 1987) was prepared in Tris-HCl buffer
(10 mM Tris-HCl, 0.1 mM EDTA, 0.001% sodium azide, pH 7.4).
Measured amounts of both peptide and dried lipid were separately
dissolved in the detergent solution and sonicated in brief intermittent
bursts to ensure thorough mixing and micelle formation. The two
solutions were then added together and briefly sonicated again. This
was followed by extensive dialysis against Tris-HCl (4x51 for
approximately ninety hours). The dialysate was observed to turn
cloudy after twenty-four hours and, indeed, this phenomenon can be
used to determine liposome formation spectrophotometrically (Huang
et al., 1969). The dialysate was transferred to Eppendorf tubes and
centrifuged (Microcentaur 5 800 g for twenty minutes) to remove




CD spectra were recorded on a JASCO J-600
spectropolarimeter; analysis of the spectra in terms of secondary
structure content was undertaken using the methods of Provencher
and Glockner (1981) (the CONTIN procedure), Chang et al.(1978)
and Siegel et al. (1980).
2.9 Results and discussion
The far UV CD spectrum at 20°C (cell path length 0.02 cm)
of M2 peptide incorporated into DOPC liposomes is shown in
Figure 2.7 (green line). Under these conditions, satisfactory data
could be obtained down to 200 nm; below this wavelength, the
noise levels precluded accurate measurements of ellipticity. The
spectrum shows the characteristic double minima at 223 nm and 209
nm of a-helices (Chang et al., 1978). Estimates of 92%, 79% and
100% a-helix were obtained using the methods of Provencher and
Glockner (1981), Chang et al. (1978) and Siegel et al. (1980)
respectively. Although the exact values of these estimates should be
treated with caution in view of the fact that data could only be
collected down to 200 nm instead of 190 nm which is preferred
(Provencher and Glockner, 1981; Chang et al. 1978), it is clear that
under these conditions the M2 peptide exists largely, if not
completely, in an a-helical form. In addition, estimates of helix
approaching 100% have been obtained both when M2 peptide is










Figure 2.7 Far UV CD spectra of (i) M2 peptide in DOPC
liposomes, at 20°C - green line (ii) M2 peptide in DOPG
liposomes, at 20°C - red line (iii) M2 peptide in DOPC liposomes
plus amantadine ('high' concentration), 20°C - blue line. For
details see text.
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(v/v) 2,2,2-trifluoroethanol (TFE) (Table 2.1). These solvents are
commonly used to promote helix formation in peptides. Peptide
reconstituted into lecithin liposomes (bovine brain PC) also displayed
maximal helical conformation (Table 2.2). Such results are in direct
contrast to that obtained when M2 is dissolved in buffer (Figure 2.8
- green line). In aqueous solution, the M2 peptide apparently did
not adopt any stable secondary structure; the low value of the molar
ellipticity at 225 nm (Table 2.1) is typical of a random coil.
The DOPC liposomal measurements were repeated at 37 °C and
no change was observed in the spectrum when compared with the
20°C data (Figure 2.8, blue and red lines, respectively).
On addition of amantadine to the liposomes, to give final
concentrations of 4 fig mH or 12 fig mH, there were no
significant changes in the CD spectra (see the molar ellipticity
values in Table 2.1). Both low and high drug concentrations were
used in order to examine any possible concentration dependence
(Hayden and Hay, 1992). These results are significant in that they
clearly demonstrate that amantadine itself has no discernible effect
upon the helical nature of the M2 peptide (Figure 2.7, blue line) as
was previously mooted (Hay et al., 1986). This, along with recent
direct findings that amantadine does indeed inhibit ion flow through
M2 (Duff and Ashley, 1992; Pinto et al., 1992) augments the thesis
that the efficacy of amantadine is due to its channel-blocking
abilities and not to any actual conformational interference with the
transmembrane region.
The M2 peptide incorporated into 1,2-dioleoyl-xn-glycero-3-
phosphoglycerol (DOPG) liposomes showed a considerably reduced
CD spectrum (Figure 2.7 [red line] and Table 2.1). Analysis of
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Figure 2.8 Far UV CD spectra of (i) M2 peptide dissolved in
buffer, at 20°C - green line (ii) M2 peptide in DOPC liposomes, at
20°C - red line (iii) M2 peptide in DOPC liposomes, at 37°C -
blue line. For details see text.
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this spectrum by the CONTIN procedure (Provencher and Glockner,
1981) yielded unacceptably high errors of estimates of secondary
structure; the methods of Chang et al.(1978) and of Siegel et
al. (1980) yielded values of 41% and 47% a-helix respectively, in
accord with the reduced values of the ellipticity at 225 nm (Table
2.1). These experiments demonstrate a relationship between bilayer
composition and the secondary structure of the peptide.
Whilst this is not intended to be a comprehensive, comparative
study, these DOPG results, taken together with others, presented in
Table 2.2, do invite comment. [%-helicities in Table 2.2 were
calculated by taking a mean of a-helix values produced by the
methods of Provencher and Glockner (1981), Chang et al. (1978)
and Siegel et al. (1980)]. From such data, it would appear that
neutral lipid liposomes allow M2 peptide to adopt a more a-helical
conformation than negatively charged lipids. If a 50:50 (molar)
ratio of neutral and negative lipids was used then a slight rise in
helical content was observed over and above the negative lipid-only
results. Chain length does not appear to effect helicity. Such
differences may also be due, in part, to differences in the lipid
phase at 20°C. The lower M2 helical content characteristic of
myristic and palmitic chains (dimyristoyl-PC [DMPC] and
dipalmitoyl-PC [DPPC]) may be a result of these moieties adopting
a crystalline (Lg') phase, whereas, at 20°C, DOPC and the mixed
chains of lecithin adopt a fluid (Lq,) phase (Tardieu et al., 1973).
The M2 peptide may be structurally constrained in the crystalline
phase, where the lipid chains are slanting with relation to the bilayer
surface, and unable to fully adopt its preferred conformation; in
effect, the M2 'cylinder' would be trying to insert 'against the
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grain' of the lipids. It may also be postulated that, with the
negative lipids, the higher amount of a-helical structure shown by
bovine brain L-a-phosphatidyl-L-serine (PS), which contains a
variety of fatty acid chains, in comparison to the DOPG, is due to
the mixed lipid tails associated with the PS somehow permitting the
M2 molecule to adopt more secondary structure.
Epand et al.{ 1983) have demonstrated that the helical content of
salmon calcitonin, a thirty-two amino acid peptide hormone, is
dependent on the percentage of phosphatidylglycerol; altering the
charge state of the membrane alters the helical content of the
hormone. A similar phenomenon may also be found with peptide
toxins where, for example, cardiotoxin and melittin are able to
modulate lipid surface curvature and polymorphism in a lipid-
specific manner (Batenburg and de Kruijff, 1988).
Regarding the caveats mentioned in Section 2.5, it would be
interesting to examine with CD, M2 mutants that include either
transmembrane proline substitutions or hydrophobic stretches that are
apparently too short to cross a membrane. It may be that, if amino
acids are deleted from a transmembrane domain then other residues,
previously exterior to the bilayer, are pulled in; a proline
substitution may indeed confer amantadine-resistance by disrupting
any potential drug binding site without disrupting channel function.
This would imply a degree of structural elasticity in tetramer
formation in order to negate any helix-breaking effects due to the
imino structure of proline.
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Sample Ellipticity at 225 nm
(deg.cm2.dmol"l)
M2 peptide/DOPC liposomes 20 C -22 260
M2 peptide/DOPC liposomes 37 °C -21 660
M2 peptide/DOPC liposomes 20°C/aman 4fig ml~l -21 970
M2 peptide/DOPC liposomes 20°C/aman 12/xg mH -23 190
M2 peptide/DOPG liposomes 20 °C -11 430
M2 peptide in 0.4% (w/v) SDS -22 840
M2 peptide in 50% (v/v) TFE -24 440
M2 peptide in buffer 20 °C 700
Table 2.1 Values of molar ellipticities at 225 nm for M2 peptide
incorporated into liposomes. Molar ellipticity values were calculated
from the observed CD spectra using a value of 110 for the mean





M2 peptide/lecithin liposomes 100.0*
M2 peptide/DMPC liposomes 52.0
M2 peptide/DPPC liposomes 37.8
M2 peptide/DOPE liposomes 40.5
negative lipids
M2 peptide/DOPG liposomes 43.8
M2 peptide/bovine brain PS liposomes 51.9
mixed lipids
M2 peptide/DOPC:DOPG liposomes 48.2
Table 2.2 Mean percent values of a-helical secondary structure for
M2 peptide incorporated into liposomes composed of different
phospholipids (see text for details). These were calculated from the
observed CD spectra. The error is estimated to be ±5%.
N.B. (i) data were also analysed for B-sheet, random coil and turn
contributions, however, only the a-helical results displayed strongly
consistent results (ii) * only performed once.
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In summary, the transmembrane domain of M2 adopts an a-
helical conformation in DOPC liposomes. This structure is not
affected by the presence of the drug amantadine or by temperature.
However, the secondary structure can be shown to be affected by
lipid composition. In view of recent developments in the study of
M2 protein, these results answer the questions raised regarding M2
in bilayers (Pinto et al., 1992; Hay, 1989; Hay et al, 1986); the
transmembrane region adopts a predominantly a-helical structure and
the efficacy of amantadine is not due to it altering this structure in
any major way.
A possible model for such an ce-helical conformation has been
produced using the molecular modelling package SYBYL (Tripos
Associates, 1991), as shown in Plates 2.1, 2.2 and 2.3. It is clear
from this model that the peptide contains a large hydrophobic area
which is consistent with its ability to exist in a membrane.
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Plate 2.1 Influenza A M2 transmembrane domain modelled as an a-
helical moiety (SYBYL) - the central ribbon represents the helix
backbone.
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Plate 2.2 The transmembrane helix of M2 represented as a space¬
filled model.
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Plate 2.3 The M2 peptide shown as in Plate 2.1, but here it is
orientated perpendicular to 2.1 in order to demonstrate the side-chain
distribution.
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CHAPTER 3 NEUTRON DIFFRACTION STUDIES
CONCERNING THE RELATIVE POSITIONS OF AMANTADINE
AND M2 TRANSMEMBRANE PEPTIDE IN DOPC
MULTILAYERS
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3. Neutron diffraction studies concerning the relative positions of
amantadine and M2 transmembrane peptide in DOPC multilayers
3.1 General introduction
The amount of biological information obtained over the last
forty years using neutron and X-ray diffraction has been enormous.
The three-dimensional structure of thousands of different crystalline
proteins have been determined and it would appear that such
structures are identical in living cells. Such detailed information has
greatly enhanced the understanding of enzyme mechanism and
specificity, ligand-induced conformational changes and the role and
evolution of protein structures. Nucleic acids have also been
studied, both in fibre and crystalline form, yielding a wealth of
information on base pairing and structure. Diffraction has been
employed very successfully in the study of viral structure and
composition. In addition, increasingly, this analytical tool is being
turned on the very structures that underlie ail cellular and enveloped
virus integrity, namely, the membrane proteins and the membranes
themselves.
3.2 Diffraction theory
The basic diffraction experiment consists of placing a specimen
in a beam of radiation and recording the intensity of the scattered
radiation as a function of angle. If the specimen consists of lipid
bilayers which are completely disorientated with respect to the beam,
then a diffraction pattern can be obtained by simply holding the
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specimen stationary in the beam. Such a pattern is diffuse and
characteristically circularly symmetrical. More information can be
obtained if the lipid bilayers are orientated about an axis parallel to
the beam. In practice, these are usually regularly stacked and
hydrated. This results in a conformation of alternating layers of
lipid and water.
Diffraction only occurs when the stacked bilayers are orientated
at certain angles around an axis perpendicular to the incoming beam
of radiation. This condition must be satisfied by the diffraction
geometry. For a random dispersion of stacked membranes this
condition is met since all angles are equally probable. For
orientated multilayers such conditions can be met by preparing the
sample on a curved support or by rotating a flat support.
Specimens for neutron diffraction are conveniently prepared on a
flat, quartz, microscope slide, therefore it is necessary to rotate the
sample using a neutron diffractometer. In such a case, the neutron
beam passes through the sample and the scattered radiation is
recorded by a neutron detector; both sample and detector are rotated
about a common axis.
If the lipid multilayers are regularly stacked, the diffraction
pattern will consist of a series of sharp peaks which are
approximately equally spaced. These peaks are commonly called
Bragg reflections since their position on the pattern are described by
Braggs Law -
nA = 2d sin0g 3.1
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where n is the order number, A is the radiation wavelength, d is the
bilayer repeat distance (in nm) and 9g is the Bragg angle (which is
equal to half of the angle dividing the incident beam from the
diffracted beam).
The derivation of Braggs Law explains the conditions necessary
for diffraction to occur. If radiation of wavelength \ is incident at
an angle 85 upon a multilamellar array with a repeat distance d
(this includes an interlipid layer of water), then at certain incident
angles (the Bragg angles, 9g) the reflected waves will be in phase
and thus constructively interfere. This constructive interference will
occur between radiation reflected from points A and B in adjacent
bilayers provided that the path length difference (CB + BD) is an
integral number of wavelengths (Figure 3.1). W.L. Bragg was the
first person to describe how diffraction from a regularly repeating
structure could be considered in terms of 'reflections' from planes of
equal scattering density (Bragg, 1913). In practice, only a small
proportion of the incident radiation is scattered and, of that scattered
radiation, in most cases there will have been a 180 phase shift.
Therefore, it may be deduced that beam line flux will have an
immediate bearing on scattering intensity and experimental time.
If equation 3.1 is rewritten then it may be observed that a
reciprocal relationship exists between the structure under examination
and its diffraction pattern -
2 sin9B = nA / d 3.2
Since, at low angles, sin9B ~ 9b, and the scattering angle 9$ =
29b , it can be seen that -
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Figure 3.1 Diagram illustrating Bragg's Law - see text for details.
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0S ~ n > / d 3.3
Therefore, structures with large d repeats will diffract closer to the
centre of the diffraction pattern than structures with small repeat
distances.
As can be seen from Figure 3.1, if the angle between the main
beam and the glass slide is 0g, then the angle between the main
beam and the scattered beam is 20g Thus, if the specimen rotates
through 0 radians then the detector must be made to rotate through
20 radians. A diffraction pattern recorded in this manner is termed
a 0:20 scan. An advantage of this diffraction geometry is that the
diffraction angle 0$ (the angle between the main beam and the
scattered beam) is obtained directly, whereas, when using X-rays
and photographic film, this angle must be calculated by measuring
the distance between the diffraction peak and the centre of the
pattern and then using Bragg's equation.
It is possible to obtain a great deal of information regarding the
multilayer structure by simply looking at its diffraction pattern and
measuring the positions of the observed diffraction maxima. This
approach reveals the bilayer repeat distance (d), whether the lipid
experiences structural phase changes, any off-meridional peaks
(indicating two-dimensional organisation) and whether more than one
structural phase is present in the specimen. However, very much
more information about the detailed structure of the bilayer can be
obtained by quantitatively analysing the diffracted intensity. This is
because the diffracted intensity describes the distribution of scattering
matter in the lipid bilayer.
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X-rays are scattered by electrons due to the interaction of
electromagnetic radiation with the charged electron cloud. Neutrons,
being uncharged, penetrate this cloud and are scattered by atomic
nuclei. The radiation scattered from a sample is of two types:
coherent and incoherent. It is the coherent radiation which
interferes to produce the diffraction pattern whilst the incoherent
radiation produces an isotropic background. Incoherent scattering is
a function of nuclei in the sample which possess spin properties.
These nuclei scatter neutrons differently for different spin
orientations. The resultant background must first be subtracted from
the diffraction peaks before the coherently diffracted intensity can be
analysed.
For both X-rays and neutrons the strength of the coherent
scattering from a particular type of atom is described by its coherent
scattering amplitude. There are two important differences between
X-ray and neutron coherent scattering amplitudes. Firstly, X-ray
amplitudes are directly proportional to the atomic number, therefore
hydrogen atoms are relatively transparent compared to the other
atoms forming the bilayer. Secondly, with both X-rays and
neutrons, there is a phase shift of 180° upon diffraction of the
incident beam upon encountering biological molecules. However,
there is an exception to this rule - neutrons diffracted by hydrogen
exhibit no phase change (Bacon, 1975). By convention, the neutron
scattering amplitude for hydrogen is therefore termed 'negative'.
X-ray and neutron scattering amplitude densities for water, lipid
polar groups, hydrocarbon chains and methyl groups, amongst
others, may be calculated as the sum of the coherent scattering
amplitudes of the individual atoms divided by the molecular volume.
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It may he seen from Figure 3.2 that, for X-rays, the scattering
density distribution for a hydrated lipid bilayer will have peaks at
the electron-dense phosphate groups and a trough at the centre of
the bilayer where the terminal methyl groups are located, with water
somewhere between the two. With neutrons, the scattering density
distribution is slightly different with the main peaks occurring at the
fatty acid ester region (due to the relative absence of hydrogen
atoms here). These two techniques emphasise different physical
features demonstrating the complimentary nature of X-ray and
neutron diffraction.
However, a major difference may be seen in the neutron
scattering density profile of a phospholipid sample if it is hydrated
with deuterium oxide (D2O) instead of water. By far the largest
peak will now occur in the 'water' region. This example serves to
illustrate the most important advantage in using neutrons to study
bilayer systems, the use of hydrogen/deuterium exchange to localise
certain molecular groups by introducing large changes in scattering
density with minimal change in structure. Hydrogen/deuterium
exchange offers two further advantages. Firstly, this change in
scattering density at localised positions in the structure can help
solve the phase problem (see below). Secondly, it is the incoherent
scattering from hydrogen which causes much of the background
encountered in neutron diffraction experiments. Thus, its
replacement with deuterium greatly improves the signal-to-noise
ratio.
Full analysis of a diffraction pattern involves the final
production of an electron density profile or a neutron scattering



















Figure 3.2 Neutron and X-ray coherent scattering amplitude densities
for water and various portions of a typical phospholipid (see text).
The scattering density histograms are both on the same absolute
scale.
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cosine waves calculated, in turn, by transforming the amplitude
functions of the diffraction patterns into wave functions. These
amplitude functions are the square root of the recorded intensity of
each diffracted order. However, with centrosymmetric structures, it
may be seen that in taking the square root of the intensity, the
resulting amplitude may be either positive or negative; information
has been lost concerning the sign of the amplitude. Reconstruction
of a structure from its diffraction pattern is therefore only possible if
we can determine both the amplitude and the phase of each
diffracted beam (see below).
Transforming the amplitude function into a wave function
which summates into the density profile is a process which may be
performed using the Fourier transformation.
First, consider the diffraction from a single centrosymmetric
structure with an arbitrary scattering density distribution g(x) along a
coordinate x. The scattered intensity from such a single structural
unit is equal to the square of the Fourier transform of g(x), that is -
I(R) = [F.T.{?(x)}]2 = [F(R)]2 3.4
where the intensity I(R) is measured along a coordinate R, which is
simply related to distances from the centre of the diffraction pattern.
This variable R, with dimensions of length"* and usually called the
reciprocal space coordinate, is related to the scattering angle 0s; by
R = 2 sin(0s / 2) /> 3.5
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The Fourier transform of the distribution q(x) is given by -
Oo
F.T.{q(x)} s- F( R) = 2\9(x)cos(27rRx)dx 3.6
O
Because there is an identical inverse relationship -
F.T.{F(R)} = s(x) = F(R)cos(27rRx)dR 3.7
o
then, if F(R) is known at every value of R, the scattering density
distribution g(x) can be directly calculated.
For a random dispersion of N structures, which will scatter
independently, the total diffraction intensity is N times the
diffraction intensity from a single structural unit.
For a regular stack of N structural units, the scattered waves
will only be in phase and thus constructively interfere at certain
angles. At these angles the reciprocal space coordinate, R, will
have values -
using the definition of R (Equation 3.5) and Bragg's Law (Equation
3.1). At these values of R the total scattered amplitude will still be
proportional to F(R) (the Fourier transform of g(x) for the single
structural unit), but N times larger. Therefore, the scattering from
a stack of structural units can best be described in terms of sampling
the transform F(R) of a single structural unit at discrete points
R = (2sin(0s / 2)} / A = {2sin(0g)} / A = n / d 3.8
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R = n/d. Since the intensities of these points will be proportional
to N^, compared to N in the case of a random dispersion,
diffraction patterns from orientated multilayers are far quicker to
record. Here, the Fourier transformation of a large stack of
individual structural units with a repeat distance, d, only has values
when the reciprocal space coordinate R = n/d.
When the Fourier transform is a continuous function, as in the
case of a random dispersion of structures, then the scattering density
distribution q(x) can be evaluated using the integral in Equation 3.7.
When, however, the Fourier transform is only sampled at discrete
points, as in the case of a regular stack of structural units, it is
more convenient to obtain q(x) using the summation -
q(x) = {F(0)/d} + (2/d) EF(n/d) cos(27rnx/d) 3.9
A scattering density distribution calculated in this way is called a
Fourier synthesis. The first term {F(0)/d} is the mean scattering
density over the repeat distance, d. The variation in scattering
density about this mean level is given by the summation of cosine
terms. As cosine terms of higher frequency are added to the
synthesis (ie. as n increases), finer details can be resolved in the
structure. In practice, the resolution which can be obtained is
limited because only a finite number of reflections can be observed.
Also, since F(0) is proportional to the amplitude of the radiation
scattered in the same direction as the main beam, it cannot be
observed experimentally. This is not usually a serious problem
however, since F(0) only affects the mean level of the scattering
density profile.
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The amplitude of the Fourier transform, F(R), cannot be
directly obtained from the intensity distribution, I(R), since the
intensity is the square of the amplitude. To obtain the amplitude,
the square root of the intensity must be obtained. This is the origin
of the phase problem -
F(R) = ±I(R) 3.10
Phase information is often only available by indirect methods and
elaborate techniques have been developed for its retrieval. The
phase problem can be considerably simplified, however, if it can be
shown that the diffracting object is symmetrical, since a symmetrical
structure gives rise to diffracted beams which are always in phase or
180° out of phase.
It is important to appreciate that the reliability of a scattering
density distribution usually rests far more upon the correct choice of
signs than upon the precise determination of the diffracted
intensities. Three main methods may be applied, either individually
or in series, in order to phase complete data sets for all n values.
Diffraction patterns of membranes which have been extensively
studied using other techniques can frequently be phased by means of
model building techniques. If a model of the expected membrane
structure can be devised, its Fourier transform may be calculated
and compared with the measured diffraction pattern. If the
intensities of the theoretical and experimental transforms are in
reasonable agreement, the phases of the experimental transform can
be assumed to be those of the theoretical transform. If the
agreement is poor the model is refined until a good fit is obtained.
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A variation of the model building technique involves combining the
measured amplitudes with all possible phases. Scattering density
profiles are calculated for each combination, but only those
consistent with plausible structures are accepted as being possible
solutions. Providing a sufficiently detailed model is available, it is
usually possible to assign phases to all but the highest orders.
Another phasing method which may be employed is to perform
a series of multilayer swellings. An important relationship arising
from Fourier theory is that the Fourier transform of a repeating
function is that of the repeating unit sampled at multiples of the
repeat frequency. Increasing the membrane spacing, by
incorporating more water, results in a decreased sampling frequency,
although the underlying diffraction pattern of the single membrane
remains unaltered. If a series of swelling experiments are carried
out, by altering cell humidity by using salt solutions of different
concentrations to cause various degrees of swelling, the data can be
combined to plot a continuous profile of diffraction and thereby
obtain the Fourier transform amplitude distribution of a single
repeating unit. The relative phases of different parts of the
transform may be inferred if enough swelling points are used.
The most rigorous method for phasing diffraction patterns
involves replacement of certain atoms in the specimen with atoms of
relatively high scattering length. These atoms give rise to a pattern
of scattering which modifies the diffraction pattern intensity
distribution, and if their location is known, the phase distribution of
the original pattern can be inferred. Obviously, the incorporated
atoms must not perturb the original structure, ie. replacement must
be isomorphous. A variation on this theme, used with neutrons, is
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to exchange the solvent water with heavy water. Subtracting the
phased amplitudes of, for example, lipid and water from lipid and
heavy water leaves the difference scattering profile of the D2O
region between the lipid bilayers. With the correct choice of phase
for both data sets, this distribution has been shown to be accurately
described by a pair of Gaussian curves (Weiner et al., 1991). The
original lipid data sets can now be phased using the phases that
produced the Fourier transform of the Gaussians upon subtraction.
If data sets are to be used in conjunction with each other, as
above, then they must be properly scaled to each other with respect
to amplitude. This may be achieved by using four or more data
sets where it is possible to perform a complete set of subtractions
resulting in the production of two pairs of D2O Gaussians. The
data sets can be rescaled to each other until both Gaussians are
similar in size. Scaling on an absolute scale is also possible.
In conclusion, having obtained a set of amplitudes and having
deduced their signs (these are now called structure factors), then the
scattering amplitude density profiles may be produced using a
simplified version of Equation 3.9 -
g(x) = EF(n/d) cos(27rnx/d) 3.11
The term F(0)/d, which defines the mean scattering density, is
missing since it will not have been observed and it is possible to
leave out the factor 2/d in front of the summation if the amplitudes
F(n/d) are only to be put on a relative scale. Thus the
experimentally derived profiles, g(x), will also be calculated on a
relative scale (the M2/Brookhaven data).
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3.3 Experimental hardware
All neutron data in this thesis were obtained either at the
Institut Laue Langevin (ILL), France or at Brookhaven National
Laboratory, U.S.A. The initial amantadine study was undertaken on
instrument D16, ILL and the subsequent M2 peptide work on
instrument H3B, High Flux Beam Reactor (HFBR) at Brookhaven.
Both instruments work on the same principles and comprise similar
features. As an example, the details of H3B will be discussed.
From Figure 3.3 it can be seen that the instrument is made up
of six main functional components. The collimator is inserted into
the face of the nuclear reactor to allow release of a parallel beam of
neutrons. The resulting 'white' neutron beam is monochromated by
reflection from two thin-film monochromators. These multilayers
typically have a periodicity of about 6 nm and, if placed in the
direct beam, will themselves produce a beam of diffracted radiation
of variable wavelength dependent on the angle of incidence. It is
theoretically possible on H3B to adjust the wavelength over the
range 1.7 - 4.5 A, although for studies of the type described herein
a value of around 2.45 A was deemed suitable. A main beam
shutter is next and this housing also incorporates a low efficiency
fission detector which intercepts a small fraction of the neutron
beam and may be taken to be a measure of the neutron flux. Data
may therefore be either collected for a given period of time or for a
specified neutron count. Data collection for a given number of
monitor counts has the advantage that it automatically compensates
for any changes in reactor flux. The main function of the
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experimental requirements and to reduce the angular divergence of
the beam. For a neutron beam reflected by a multilayer
monochromator, the wavelength spread ([change in \\ / » is
primarily determined by the angular divergence of the final beam,
and its magnitude can be increased or decreased by adjusting the
collimation accordingly. Lamellar samples are mounted on a
goniometer and the slides are held vertically inside an aluminium
can (Plate 3.2) during data collection which allows them to be kept
at the desired temperature and humidity. Copper plates welded to
the top and bottom of the can are connected to a constant
temperature, circulating water bath. Humidity, and therefore bilayer
spacing, is controlled by placing small water baths filled with a
solvent (either D2O, H2O, or a mixture of both) and/or salt inside
the can. This can is mounted on a shaft attached to a rotational
stage and its motion is dictated by the geometry of the 0:20 scan.
Finally, the diffracted intensities are collected with a gas filled area
detector. A few channels close to each edge of the detector record
spurious counts and are not therefore considered in data analysis.
These channels are removed from all consideration by defining a
'useable area'.
3.4 Introduction to the experimental section
Chapter 2 presented CD data collected on the secondary
conformation of native M2 transmembrane peptide incorporated into
liposomes. Chapter 3 locates to high resolution the position of M2
peptide in the bilayer and its orientation with regard to amantadine.
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Plate 3.1 Membrane spectrometer H3B (HFBR) at Brookhaven
National Laboratory, overall view. Note the detector, temperature
control bath and the location of the reactor.
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Plate 3.2 Membrane spectrometer H3B (HFBR) at Brookhaven
National Laboratory, detail of lamellar sample can - collimated beam
comes from the left, the detector is on the right.
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Such experiments were repeated using amantadine-resistant mutant
M2 transmembrane sequences (see Section 2.7 for details of peptide
preparation).
A useful preliminary study to such work was undertaken in
order to locate both amantadine hydrochloride (HC1) and amantadine
free base (FB) individually in bilayers of DOPC. Such a study has
value in itself as amantadine may have properties other than its
pharmacological ones.
Section 3.5 will therefore describe this preliminary study whilst
Section 3.6 will be concerned with the bilayer position of M2 (both
native and mutant) and with any interactions between the M2
peptides and amantadine. The diffraction work was carried out with
Dr J.P. Bradshaw, Department of Biochemistry, University of
Edinburgh.
3.5.1 The location of amantadine HC1 and FB within
phospholipid multilayers - an introduction
Amantadine (1-aminoadamantane hydrochloride) is licensed for
the prophylaxis of influenza A infection and for treatment of both
influenza and Parkinson's disease (Oxford and Galbraith, 1980;
Obeso and Martinez-Lage, 1987). In the case of influenza, the
efficacy of amantadine is postulated to involve interruption of viral-
host cell membrane fusion and/or interference in haemagglutinin
maturation (Hay, 1989; Sugrue et al., 1990). The mechanism of
action of amantadine in Parkinson's disease is probably related to its
ability to increase presynaptic synthesis and release of dopamine.
This effect is potentiated by the drug inhibiting dopamine reuptake
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(Gilman et ai, 1990). These therapeutic processes are thought to
include the involvement of the hydrophobic, lipophilic properties of
the molecule (Phonphok and Rosenthal, 1991).
Amantadine studies undertaken so far have been wide-ranging,
including its effect on influenza infection and, more recently, its
specific molecular effect on the viral protein which is implicated in
this drug-induced prophylaxis, namely M2 (Sugrue and Hay, 1991).
However, other work has been published in which amantadine has
been reported to affect bilayer stability. A recent study has noted
the role of amantadine in the stabilisation of clathrin-coated
membrane vesicles, similar to those formed upon initial viral
penetration by influenza, Semliki Forest and vesicular stomatitus
virus (Phonphok and Rosenthal, 1991). However, others have
reported that, although tromantadine (an amantadine derivative: N-l-
adamantyl-N-[2-(dimethylamino) ethoxyj acetamide-hydrochloride)
appears to stabilise phospholipid bilayers, amantadine itself slightly
lowers the temperature of the bilayer to hexagonal phase transition.
Also, NMR studies have shown that amantadine is perturbing to the
organisation and motional properties of phospholipids in the bilayer
phase (Cheetam and Epand, 1987). These results indicate an
amantadine-mediated increase in disorder. It can therefore be seen
that a certain degree of ambiguity exists in the interpretation of the
available data.
As a prerequisite to further mechanistic studies of amantadine,
and in order to examine the ambiguous results reported above, a
series of experiments were undertaken to investigate the location of
the drug within bilayers of DOPC. To reduce possible ambiguity in
the results a single lipid species was used; DOPC being the most
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physiologically representative. Positional differences between
amantadine hydrochloride (HC1) and amantadine in its free base
form (FB) have also been examined.
In addition, this section describes the use of a specific
deuterium labelling technique to locate amantadine in synthetic
multilayer membranes using neutron diffraction. These results are
both quantitatively and qualitatively supported by, and are discussed
in relation with, a concomitant X-ray diffraction study using
unlabelled amantadine. [The X-ray work was undertaken by another
member of the group (Andrew Cudmore).]
3.5.2 Materials
DOPC was purchased from Sigma Chemical Company Ltd.
(Fancy Road, Poole, U.K.) and confirmed to be a single species by
thin layer chromatography. Amantadine was obtained from the same
source in both FB and FtCl forms. Deuterated amantadine FB was
obtained from Dr M. R. Alecio of the Shell Research Centre
(Sittingbourne, Kent, U.K.).
3.5.3 Sample preparation for neutron diffraction
Good sample preparation is of paramount importance in
diffraction studies as correct multilayer orientation and hydration are
prerequisites for diffraction data collection. In addition, if data sets
are to be analysed in conjunction with each other, then all such
samples must be prepared in a rigorous, reproducible manner.
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Figure 3.4 The two forms of 1-aminoadamantane used in this study:
(a) amantadine free base (b) amantadine hydrochloride.
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Orientated phospholipid bilayer stacks were prepared as follows.
Samples comprising 20 mg of DOPC in chloroform, as supplied by
Sigma, were dried-down under oxygen-free nitrogen. The lipid was
then dissolved in approximately 0.5 ml of methanol. Any
amantadine added (5% molar ratio with respect to the DOPC) to the
final sample was dissolved separately in a similar volume of
methanol. The solutions were then whirlimixed, added together and
whirlimixed again. The sample was slowly applied to a quartz glass
microscope slide using a fine-tipped stretched pipette, allowing each
layer of solvent to dry partially in a stream of warm air from a
hairdrier before the addition of more sample. After all the solvent
was applied to the slide, it was given time to dry (usually about ten
minutes) and then a further application of methanol was spread over
the sample. This step produces a smooth, even finish. After
subsequent drying, the slide was placed in vacuo for at least two
hours. This drives-off any residual organic solvent. The
multilayers were then rehydrated by transfering the quartz slide into
a dessicator over the rehydration solvent of choice. This dessicator
was placed in an oven at 20 °C (at which DOPC adopts the La-
phase) for at least four hours. Subsequent to this, after moving the
sample from its dessicator into the sample-can for the experiment
(which contained identical conditions to the dessicator), a re-
equilibration time was allowed for conditions to stabilise before data
collection commenced. From studies performed previously at the
ILL, it was known that this period never exceeded fifteen minutes,
therefore, re-equilibration was allowed to proceed for at least thirty
minutes. In effect, this time is to allow the multilayers to replace
any solvent that they may have lost, during transfer between
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containers, by absorbing moisture from the humid atmosphere inside
the can. During this period the equilibration process was monitored
by recording the angular position of the third or fourth order of
lamellar diffraction which increased as the multilayers dehydrated
and decreased as they took up water from the atmosphere. Each
sample was judged to have achieved equilibrium when there was no
further shift in the position of the Bragg peaks and the calculated
lamellar repeat distance was that predicted for the experimental
conditions by previous X-ray work. Any sample which did not
fulfil both of these criteria was discarded.
When changing the D20:H20 ratio, the samples were allowed
to dry out in normal atmospheric conditions for about an hour
before being replaced in a dessicator containing the next solvent.
Each recorded diffraction pattern consisted of up to eight well
defined orders. The mosaic spread of each sample was determined
using the D16 software.
3.5.4 Neutron data analysis - ILL
Corrections : Once the diffracted intensities had been corrected
for detector response and background, then integrated, the following
corrections were applied -
(1) Lorentz factor. The Ewald construction is a mathematical
tool which enables the prediction of the geometry of diffraction
(Ewald, 1921). If the diffracting sample is taken to be the centre
of a sphere of possible diffraction, then only on the circumference
of this sphere, and where it complies with Bragg's Law, is it
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possible to observe intensities. Higher orders will be
correspondingly less intense as the sphere curves away from them.
The Lorentzian factor corrects for this -
CLor(n) = sin(20n) 3.12
(2) Absorption. When the angle of diffraction is low, the
incident and diffracted beam have a significant path length within
the sample and thus will be subject to a greater degree of absorption
than when the angle is high and the corresponding path lengths low.
Moreover, the degree of absorption will also be affected by the
H2O/D2O composition of the sample. The appropriate correction
for absorption by the lipid film, was applied -
CAbs(n) = l/(sin9n/2ut)(l-exp[-2ut/sin0n]) 3.13
where u = (6.04-0.75mf), mf being the mole fraction of D2O
(Worcester and Franks, 1976). The mass of lipid on each slide, the
area over which it was spread and the unit cell size, as determined
by diffraction, were used to calculate a value of 30 fim for t, the
thickness of the lipid film.
(3) Sampling by the Detector. As a result of lattice disorder in
the sample, the diffraction peaks may be so wide that the whole of
each diffraction peak is not recorded by the detector, and a
correction must be applied to the data to account for this. In this
study the mosaic spread of each sample was small enough to ensure
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that each diffraction peak was regular in shape and contained wholly
within the central part of the detector so no correction was applied
in this case.
The final neutron structure factor amplitudes were therefore
calculated as -
l^(n)l^ = InCLor(n)CAbs(n) 3.14
where I is the measured intensity.
Phasing : Neutron scattering profiles may only be obtained
upon solving the individual phases of the recorded amplitudes. In
this study two different techniques were employed to phase the
neutron data sets: D2O/H2O exchange and isomorphous replacement.
Neutron data are routinely phased by carrying out experiments
hydrated at various H2O/D2O ratios (Worcester and Franks, 1976;
Biildt et al., 1979; Franks and Leib, 1979; Jacobs and White,
1989). This method was used in the present study, with additional
phasing information coming from a variation of the isomorphous
derivative technique (Biildt et al., 1978) in which use was made of
the presence or absence of amantadine in the multilayers. Assigning
phases to the neutron data proceeded by altering the sign of the
individual structure factors until a result was achieved in which both
the differences caused by replacing H2O with D2O and the
DOPC/amantadine minus DOPC differences were consistent within
each set of comparable data.
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The two diffraction techniques, X-rays and neutrons, emphasise
different features within the bilayer structure, and further
confirmation that the correct phases had been assigned was given by
the fact that the two methods agreed and thereby showed the
complementary nature of the techniques.
White and his co-workers (Wiener et al., 1991) have produced
an elegant method for scaling neutron data. This approach was used
in the present study and basically involved using the size of the
D2O and the amantadine distributions to scale the different sets of
data to each other. The results put the profiles on a 'relative
absolute' scale in which they are scaled with respect to the unit cell
contents, but not on an absolute per volume scale.
3.5.5 Results
Table 3.1 gives the corrected, scaled neutron diffraction
structure factors for all three samples, DOPC, DOPC with
amantadine HC1, DOPC with amantadine FB, at 0% and 100%
D2O. Figure 3.5 shows reconstructed transbilayer profiles of DOPC
alone (a, b) and difference profiles defining the distribution of
amantadine HC1 (c, d) and FB (e, f) respectively. The dotted line
represents the neutron data with the bold line representing the
complementary X-ray data. The difference profiles were calculated
by subtracting structure factors of pure DOPC from those of DOPC
with 5% (mol) amantadine and placed on a relative absolute scale
using the method of Wiener et al., 1991. The horizontal scale is
distance, measured from the bilayer centre, in Angstroms. Figure
3.6 contains difference neutron density scattering profiles showing
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the distribution of water between bilayers of (a) pure DOPC, (b)
DOPC with amantadine HC1 and (c) DOPC with amantadine FB, all
at 20°C. Also shown are Gaussian distributions fitted to the water
profiles in reciprocal space over all eight observed orders of
diffraction, using a development of the method of Wiener et al.,
1991. Each curve consists of the sum of two Gaussians with the
following parameters: (a) Z (distance from the centre of the bilayer)
= + 26.53 ± 0.35 A, AW (1/e halfwidth) = 8.82 ± 0.20 A; (b)
Z = ± 26.04 ± 0.55 A, AW = 8.75 + 0.25 A; (c) Z = +
25.58 + 0.45 A, AW = 8.65 + 0.25 A. The difference between
the observed and modelled water profiles may be taken as an
approximation of error in the reconstructions. Each graph therefore
also shows this difference, plotted on an enlarged scale,
corresponding to that used in Figure 3.5 (right hand side).
The mosaic spread of the DOPC bilayers ranged from 0.4° to
0.6°, these very low values being quite characteristic of unsaturated
fatty acyl phospholipids. The mosaic spread was not significantly
changed upon the addition of amantadine.
3.5.6. Discussion
DOPC
Figure 3.5 displays both X-ray and neutron scattering density
profiles across the phospholipid bilayer with the water component
occupying the outer region of the graphs. With X-rays, the DOPC
profile (a) agrees with previously published data (Bradshaw et al.,
1989; Weiner and White, 1991) in that it displays the classic
phospholipid leaflet form with a main peak representing the electron-
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DOPC Amantadine D-Amantadine %D_0
HC1 Free Base 0% D2O 100% D2O






7) -0.30 -0 . 67
8) 0.00 0.00




5) -1.37 -1. 86
6) -0.18 0 . 06
7) 0.26 0.15
8) -0.30 -0.27
20 0.25 1) -13.55 -96.41





7) 0.00 -0 .16
8) 0.00 -0.15
Table 3.1 Relative absolute neutron structure factors of lamellar
arrays of pure DOPC and DOPC with 5% (mol) amantadine HC1 or




Figure 3.5 Reconstructed trans-bilayer scattering profiles (neutron -
dotted lines, X-ray - bold lines), (a) and (b) represent pure DOPC,
(c) (d) and (e) (f) represent difference profiles of amantadine HC1
and FB respectively. [NB. X-ray data produced by A. Cudmore.]
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Figure 3.6 Difference neutron scattering density profiles showing the
distribution of water between bilayers of (a) pure DOPC, (b) DOPC
with 5% (mol) amantadine HC1 and (c) DOPC with 5% (mol)
amantadine FB, all at 20° C. Included are Gaussian distributions
fitted to the diffraction patterns of the water profiles. For details
see Section 3.5.5.
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dense region which encompasses the phosphate groups and fatty acyl
ester bonds. A secondary peak appears within the hydrophobic
region which corresponds to the double-bond in the oleic acid
chains. It can be seen from (b) that less detail results from the
neutron data. This is probably due to the lower contrast
characteristic of neutron scattering (all these diffraction experiments
were sampled through eight orders so this phenomenon does not
involve the X-ray data being collected to a higher resolution than
the neutron).
The differences between the X-ray and neutron profiles are due
to inherent atomic scattering differences across the unit cell (see
Section 3.2). X-rays are more strongly scattered by the phosphate
groups in the repeat motif whereas maximum neutron scattering
corresponds to the fatty acyl ester bond positions (Franks and Lieb,
1981). Profile (b) clearly displays this scattering dichotomy with
the neutron data peak appearing markedly closer to the hydrophobic
interior of the bilayer than the X-ray result (a). The sharper X-ray
profile displays a second, highly-defined peak in the fatty acyl chain
region of the leaflet.
Amantadine HCl
Figure 3.5 (c) to (f) are difference profiles which were
calculated by subtracting the lipid and water structure factors from
the lipid, water plus amantadine structure factors and therefore
represent only the amantadine distribution across the bilayer. They
are displayed in the same orientation as the pure DOPC but it can
be seen that these profiles, both X-ray and neutron, are substantially
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different from the DOPC data. Amantadine, in both its
hydrochloride and free base forms, appears to have been
incorporated into the multilayer system.
The highest peak in the X-ray profile (c), representing the
greatest distribution of amantadine HC1, lies between the phosphate
and ester linkages. This surface location is also represented in the
neutron profile (d) but its shape has changed with additional density
encroaching into the water. It is proposed that the difference
between the X-ray and neutron profiles is due to the relatively
higher scattering length of nitrogen for neutrons compared to that
for X-rays, which emphasises the amine group in the neutron
profiles. These results therefore orientate amantadine HC1 in the
bilayer; the hydrophobic, cyclic region of the drug located between
the phosphate and ester linkages of the phospholipids with the
NH3 + group protruding into the water space.
Importantly, this interpretation is supported by changes in the
distribution of water between adjacent bilayers when amantadine HC1
is added. Figure 3.6 shows difference profiles representing the
location of the deuterons of heavy water, calculated by subtracting
neutron scattering profiles of multilayers containing H2O from
corresponding ones hydrated with D2O. It can be seen that
incorporation of amantadine HC1 into the DOPC bilayers reduces the
area under the water profiles, indicating that the drug is displacing
some of the water from the system.
Both profiles (c) and (d) of Figure 3.5 include additional
features in the lipid tail region which may be caused by termination
error; ie. errors caused by not collecting all possible orders of
diffraction. The resolution of the present study procludes
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unambiguous assignment of these features to the presence of
amantadine deep within the bilayer, but it should be noted that
evidence from the FB profiles (see below) indicates that full
penetration of the bilayer by a proportion of the amantadine can
occur. This is particularly noticeable in the neutron profiles and is
either a product of the relatively high concentration of drug used
saturating preferential surface sites, or it may represent amantadine
which has reverted to the uncharged, FB form by deprotonation.
Amantadine FB
At this resolution, both amantadine peaks are in the same
position in the X-ray profile (e) as in the amantadine HC1 result (c).
Positionally, therefore, the data are identical. However, there is a
difference in the proportional representation of amantadine across the
bilayer with relatively more now appearing in the fatty acid tail
region of the phospholipids. The neutron results (f) agree with
these findings. Here the main scattering density at the surface
location has moved slightly into the bilayer reflecting the fact that
the amantadine FB is deuterated on the hydrophobic carbons only
and that the NH2 amine group is unlabelled and therefore scatters
much less intensely compared to the labelled mass; it can be
observed as a shoulder on the water side of the main peak. This
observation again orientates the amantadine with its NH2 group at
the lipid/water interface.
Profiles (e) and (f) clearly show that a proportion of
amantadine has penetrated almost to the centre of the bilayer. The
height of the profiles above zero can only be explained in terms of
a considerable mass of drug being present in this region. Consistent
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with this finding, the amount of water associated with the bilayers
containing amantadine FB is much greater than that for bilayers
containing amantadine HC1 (Figure 3.6) and almost equates with that
present in the bilayers in the absence of either form of amantadine.
Clearly a proportion of the drug has moved away from the water-
penetrated surface of the bilayers to take up a deeper location in the
bilayers. This evidence, taken together with the HC1 results, leads
to the proposal that the interaction between amantadine and DOPC
bilayers takes the form of an equilibrium between two possible
regions. One of these is located at the water-bilayer interface, the
other is less defined and broadly represents the fatty acid tail region.
The balance of this equilibrium between the two sites appears to
depend upon the starting protonation state of amantadine. However,
this does not necessarily imply that the initial charge state of the
amine is preserved throughout the experiment. This result compares
with tetracaine where its interaction with phospholipids is also
reported to be influenced by the charge state of the drug (Smith et
al., 1991, Shimooka et al., 1992).
Amantadine!Phospholipid interactions
If the optical parameters and the sample dimensions are kept
constant throughout a series of diffraction experiments then the
mosaic spread may be used as a measure of the macroscopic order
of each sample; the smaller the mosaic spread, the less the degree
of disorder in the system (Schwartz et al., 1975; Blaurock and
Nelander, 1976). The values obtained for stacked bilayers of pure
DOPC in this study are in good agreement with previous
observations (Bradshaw et al., 1989, White et al., 1991). The
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mosaic spread did not change upon the addition of 5 % (mol)
amantadine, which indicates that the interaction between the drug
and the bilayer did not disturb the macroscopic order. There was
no evidence of phase separation in the multilayers containing
amantadine. It seems that, under these experimental conditions,
amantadine does not markedly perturb the bilayer system.
It has been reported that amantadine reduces the extent of
dissociation of clathrin from coated vesicles (Phonphok and
Rosenthal, 1991) in a study which used relatively small amounts of
the amine. The ability of amantadine and related compounds to
stabilise or destabilise phospholipid bilayers has also been
extensively investigated. Cheetam and Epand (1987) concluded from
NMR studies that amantadine perturbs the organisation and increases
the fluidity of bilayers. This present neutron study, using a much
lower drug:lipid molar ratio, does not indicate any such perturbation
but it may be that this anomaly reflects the different drug
concentrations used in such studies.
Another variable involves the lipid type used. The work
reported here employed DOPC which has a large headgroup and two
unsaturated chains giving the phospholipid a quasi-hourglass shape,
creating an area of increased steric freedom in the neck region when
the lipids are formed into a bilayer. The amantadine may be
accomodated within such an area, fitting in between the phospholipid
molecules. These data, which indicate that the cyclic carbon
component of amantadine orientates on the hydrophobic side of the
phospholipid headgroup, support this model. This would suggest
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that the effects of amantadine upon bilayer structure and stability are
likely to be complex and to be dependant upon intrinsic and
environmental factors.
X-ray work (carried out by A. Cudmore) shows that the bilayer
repeat distance was reduced by up to 2.5A at low humidities (Duff
et al., 1993). A similar effect is produced by the addition of 1,2-
dioleoyl-SAZ-glycero-3-phosphoethanolamine (DOPE) (Bradshaw et al.,
1989) to DOPC, where the smaller PE headgroup allows the choline
moiety of DOPC to lie in a more perpendicular orientation and
therefore closer to the plane of the bilayer surface (Dr J.P.
Bradshaw, Biochemistry Department, University of Edinburgh,
U.K.; personal communication). Amantadine may have a similar
effect on DOPC. Unfortunately, the relatively low contrast between
the PC headgroup and water makes it impossible to determine the
headgroup conformation with the present data. However, this also
means that any drug-induced changes in headgroup conformation will
not have an adverse effect on the profile subtractions. Future
neutron work using specifically deuterated phospholipid headgroups
may be able to resolve this question.
The finding reported here that uncharged, amantadine FB has
the ability to penetrate more easily into the bilayer is supported by
diffusion data performed on other similar compounds (Miller and
Lenard, 1981). This phenomenon could be related to the
zwitterionic nature of DOPC, the lipid chosen for our study.
Further work could investigate the possible relationship between the
lipid composition of the bilayer and the nature of its interaction with
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amantadine. For example, including a proportion of negatively-
charged lipid may induce major changes (Kim, et al., 1991)
particularly with the charged amantadine HC1.
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3.6.1 Introduction to M2 work
Using the same basic techniques employed above to locate
amantadine, the study presented in the rest of this chapter
determined the orientation of the M2 peptide (using deuterated and
undeuterated moieties, Section 2.7) in DOPC multilayers. In
addition, interactions with deuterated amantadine FB were
investigated.
From the CD results, it appears obvious that the M2
transmembrane domain must cross the liposomal bilayer. However,
it could be argued that the peptide may orientate in an a-helical
conformation adsorbed onto the surface of the vesicle and that
therefore, if this situation holds, it is not transmembraneous. This
diffraction work, in producing neutron scattering profiles across the
phospholipid bilayer, will clarify this point. In addition, by using
the same methods used to locate amantadine, namely, scattering
differences and a variation of the isomorphous derivative technique,
the relative position of amantadine to the M2 peptide will be
identified. Also, the use of amantadine-resistant mutant sequences
will show how an amino acid substitution effects the amantadine
population with regard to the M2.
3.6.2 Materials
DOPC was purchased from Sigma Chemical Company.
Deuterated amantadine FB was obtained from Dr M R. Alecio of
the Shell Research Centre. Influenza A M2 peptides were
synthesised at the MRC Cellular Immunology Unit (see Section 2.7).
Peptides with sequences displayed in Figure 3.7 were used.
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(Peptide 1 is wild-type with 2 and 3 being the identical sequence but labelled
on, respectively, amino acids 27 and 36. Peptide 4 is amantadine-resistant
with 5 being the identical sequence but labelled on amino acid 27. The amino
acids between the dotted lines are thought to be within the membrane.)
Figure 3.7 Recipe sheet of five peptides - amino acid abbreviations






















































































































































































Sequence 1 is wild-type with 2 and 3 having the same primary
structure but being labelled with deuterated amino acids (Section
3.2) at residues 27 and 36 respectively. The valine is labelled with
deuterium instead of hydrogen at each methyl group and at its other
non peptide-bond hydrogens giving it 8 deuterons. The leucine is
labelled in an similar manner giving it 10 deuterons. Sequence 4
represents an amantadine-resistant mutant with residue 27 being
substituted by an alanine (Hay et al., 1985). In sequence 5 this
amino acid is deuterated at its hydrogens (4 deuterons). It was
sequence 1 that was used exclusively in Chapters 2 and 4.
3.6.3 Sample preparation
Sample preparation was as described in Section 3.5.3 for the
amantadine neutron experiments. The M2 peptides and amantadine
FB were added at, respectively, 1% and 2% (molar ratio with
respect to the lipid). Deuterated amantadine FB was used in this
study since the much lower concentration, in respect to Section 3.5,
dictated that greater contrast was necessary.
3.6.4 Neutron data analysis - Brookhaven
The ILL data is partially prepared for subsequent analysis by
the in-house software, however, at Brookhaven (where data
discussed in this section were collected), the individual diffraction
peaks must be manually integrated together and subtracted from the
background scatter. Although this means more time must be spent
preparing the Brookhaven data for subsequent analysis it also means
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that new, more accurate methods of treating the data may be
introduced at this early stage.
Initially, the data was collected in small, discrete packets across
the x and y-axes of the detector. The first step in data analysis was
to summate these packets of information into a coherent set of data.
This involved calculating where each peak lay (this can also be
observed) and selecting which data correspond with what peak.
This may be termed an x,y-axes integration and was carried out as
follows.
The information, which is in the form of a three-dimensional
detector pattern, was collapsed onto a two-dimensional spectrum.
This spectrum consisted of a graphic representation of the diffracted
intensities where the x-axis represented scattering angle and the y-
axis represented intensity. The areas of Bragg scattering appeared
as discrete peaks.
These peaks were defined from the background and the area
under them measured. A commercial program, Sigmaplot (Jandel
Scientific, Corte Madera, California, U.S.A.), is available that is
capable of achieving this. The background was calculated by base¬
line fitting and the area under each peak measured by fitting
Gaussian curves to the spectrum. When a best-fit was achieved, the
area under the Gaussian was recorded.
A complete scan of the sample across the Bragg plane was
built-up by adding together, in the x-axis, the collected peaks. In
practice, this was accomplished by recording the diffraction peaks
only, ie. by placing the sample only where scattering was expected
(20b). However, it is possible that some peak intensity may be
missed on either side of the peak due to slight angular orientation
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errors regarding the sample slide itself (0) or by limiting the scan
too severely. These missing data were corrected for by assuming,
at first, that all nineteen data files (the small discrete packets
mentioned earlier) representing each peak were present. Then it
became a simple matter to assign the area under the previously fitted
Gaussian an arbitrary value of 100%. The programme then
calculated the percentage of the theoretical peak represented by the
actual collected nineteen files. If this result (z) was less than 100%,
then the observed intensity was sc~'ed-up by 100 / z.
The d repeat was calculated for each data set by measuring the
distances between the peaks, the sample to detector distance and
then applying the Bragg equation (the wavelength was already
known). Intensity files were created which contained all the data
necessary for future analysis, ie. the order number (one through four
in these data), its corresponding intensity and the d repeat.
The next stage involved creation of amplitude files from the
intensity data. The intensity data was corrected and then square-
rooted to amplitudes.
Corrections : The corrections described in Section 3.5.4 were
applied. In addition, an acceptance angle factor was included
because on H3B the beam is narrower than the sample, in contrast
to the ILL where it is wider.
Acceptance angle. The area of specimen sampled by the beam
is dependent upon the relative angle of the slide to the beam. If the
slide presents a very low angle (0b) to the incident beam, the area
illuminated represents most of the sample. At 90° the area of
sample illuminated is the cross-sectional area of the beam itself.
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This means that the diffraction peaks recorded for the lower orders
will be correspondingly higher than they should be. As long as the
neutron beam is narrower than the maximum projected width of the
sample slide and the neutron flux is constant across the width of the
beam, the angular correction factor, takes the form -
C-Ang(n) ~ sin0n 3.15
Phasing : The Brookhaven data were phased in a novel
manner. Each sample was run at four different D2O concentrations
(0, 33, 66 and 100%). It may be deduced that, therefore, the
scattering density of the region between the bilayers (representing
the H2O or D2O) will progressively increase with increasing D2O
concentration. Even order reflections will increase in amplitude
whilst odd orders will decrease. [NB. However, if the water layers
peak at ± d/2, rather than at the origin, the odd numbered orders
will behave in the opposite manner - a shift in the origin of d/2 is
equivalent to changing the signs of the odd orders.] This phasing
method is shown in Figure 3.8. Such a method is possible with 0
and 100% D2O data points but the use of only two points does not
produce a straight line which inspires confidence.
Subsequent to this four-point method, a variation on the
isomorphous replacement technique was employed where the peaks
corresponding to amantadine were used as end-points in Fourier
subtractions and phases were assigned in order to obtain such
profiles. Excellent agreement was achieved between these
complementary phasing approaches.
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Figure 3.8 An example of the D2O phasing method. The
amplitudes change linearly with the % of D2O - with positive slopes
for even orders and negative slopes for odd orders (see Section
3.6.4). The numbers refer to order number (n).
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3.6.5 Results
Table 3.2 gives the corrected, scaled neutron diffraction
structure factors for all samples. It should be noted that structure
factors were obtained for each sample at 33 and 66% D2O, in
addition to the results shown at 0 and 100%. However, as these
data were used only in assignment of phase and not in subsequent
Fourier subtractions they are omitted in the interests of clarity and
brevity. It was the 0% data that was used in the subtractions.
100% data are presented in Table 3.2 when used in subtractions to
produce water peaks. Difference neutron scattering profiles are
shown in Figures 3.9 through 3.13. These profiles were calculated
as in Section 3.5.5. Also shown are Gaussian distributions fitted to
specific profiles in order to provide an accurate reconstruction free
of termination error (Section 3.5.5).
The mosaic spread of the DOPC bilayers ranged from 0.4° to




Figure 3.9 displays the DOPC phospholipid bilayer profiles
with the water component occupying the outer region of the graphs
(such an orientation is followed in all subsequent difference profiles
- except for water profiles). Profile (a) is the DOPC result obtained
in Section 3.5 (ILL, 20°C) and (b) is that calculated here
































































Table 3.2 Relative neutron structure factors of lamellar arrays of
various mixes of DOPC, five different M2 peptides (1% molar) and
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Figure 3.9 Reconstructed trans-bilayer neutron scattering profiles,
(a) represents pure DOPC, 20°C (from Section 3.5) and (b)
represents pure DOPC, 37°C. Both at 100% rh. (No vertical scale
is shown as (a) is scaled absolutely and (b) is scaled relatively [two
different data setsJ. Therefore, comparisons between the two may
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Figure 3.10 Difference neutron density scattering profiles. (a)
represents the distribution of native M2 peptide, (b) and (c)
represent, respectively, the d27 and d36 labels. Gaussian
distributions are shown fitted to (b) and (c).
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Z (A)
Figure 3.11 Difference neutron density scattering profiles. (a)
represents the distribution of native M2 peptide, (b) and (c)
represent, respectively, the distribution of M2 mutant and the label
position on deuterated M2 mutant.
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z (A)
Figure 3.12 Difference neutron density scattering profiles showing
the distribution of water associated with bilayers containing (a)




Figure 3.13 Difference neutron density scattering profiles. (a)
represents the distribution of amantadine when associated with
DOPC, (b) and (c) represent, respectively, amantadine distributions
associated with DOPC plus 1 % native M2 and DOPC plus 1 %
mutant M2. Gaussian distributions are shown fitted to all three.
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more detail in the fatty acid tail region. Maximum neutron
scattering corresponds to the fatty acyl ester bond positions (Franks
and Lieb, 1981; Section 3.5.6). Profile (b) was used in all
subsequent subtractions.
M2 peptide
Figure 3.10 (a) represents the native, undeuterated M2 peptide
population. Almost all of the scattering density can be seen to be
located within the bilayer region indicating that the proposed
transmembrane domain of influenza A M2 protein does indeed span
the membrane. The small peak in the water region may indicate a
population of water-soluble M2.
Figure 3.10 (b) shows the position of the d27 label (produced
by subtracting the native, undeuterated peptide from the native,
deuterated (d27) peptide). The mass of label lies predominantly in
the bilayer, however, if Gaussian fitting is applied, it may be seen
that two separate populations may be defined - one peaking 8 A
each side of the centre of the bilayer (the two parts of this
population are summed in the Fourier profile making it appear to
peak in the centre of the bilayer) and the other, much smaller one
peaking in the middle of the water region (24 A from the bilayer
centre). This result corresponds to the deuterated valine position in
the peptide (peptide insertion into the bilayer will occur in both
possible orientations perpendicular to the plane of the lipids) and
also with some label appearing in the water. The relative amounts
of label represented by each population may be calculated by simply
measuring the Gaussian widths at half height, multiplying this by
their heights, and then dividing one by the other. Such a
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calculation shows that approximately 9% of the total label may be
found in the water. This relatively low amount may be explained if
some of the peptide is excluded from the lipid phase, perhaps
because the concentration used is too high, or if an equilibrium is
set-up where M2 moves into and out of the bilayer (but at any one
time it is ten times more likely to find peptide associated with the
lipid [diffraction is a time-averaged technique]).
The d36 profile, Figure 3.10 (c), includes a large peak in the
centre of the bilayer, where it would be expected (deuterated
leucine). However, two other substantial peaks may be observed.
Gaussian fitting confirmed that this result represented a three-
component population. Such a phenomenon cannot be explained and
it may be that one or more of the other six leucines were deuterated
in error. Since all of these peptides are extremely hydrophobic,
many difficulties were reported in their synthesis and purification -
the d36 peptide was the first to be prepared.
In summary, it may be said that the native M2 peptide was
observed to be transbilayer and that the d27 label could be isolated
to a single, discrete population identifiable within this region.
Figure 3.11 displays similar difference profiles but with the
mutant M2 peptide instead of the native (the native, undeuterated
M2 is shown again (a) for comparison). The mutant sequence (b)
can be seen to be transbilayer. The profiles differ slightly in that,
with the mutant, the hump observed approximately 12 A from the
centre of the bilayer is smaller. This area is where the valine to
alanine substitution was engineered.
Profile (c), which represents a deuterated mutant M2 minus
mutant M2 subtraction, can be seen to be very similar to the non-
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deuterated M2 profde. It proved impossible to locate a discrete
mass of label in the mutant, labelled peptide (as was done with the
native d27 data). This may be an anticipated result of using small
amounts of label to ensure isomorphism. The labelled amino acid
in the mutant sequence was alanine, d4. The amount of deuterium
incorporated into the deuterated, mutant peptide was therefore half
that incorporated into either of the other two labelled sequences. It
would appear that such levels of labelling are not enough and that
the resulting profile (c) simply displays the tiny difference between
the M2 mutant concentrations in the two samples due to
experimental error in preparation.
In summary, the mutant M2 is also transbilayer and the two
profiles, native and mutant, are extremely similar but with,
importantly, slight observable differences in the region of the amino
acid substitution.
Additional information on the nature of the peptides was
obtained by subtracting the DOPC/M2 data collected at 0% D2O
from the DOPC/M2 data collected at 100% D2O. The resultant
difference profile is the water peak [Figure 3.12 (b) and (c)l
associated with the M2 peptides. (Note that the water is shown in
the centre of the profile and not at the periphery as in the other
results.) This was compared with the profile obtained by subtracting
the DOPC-only data collected at 0% D2O from the DOPC-only data
collected at 100% D2O. This subtraction also results in a water
peak but one that is produced in association with phospholipid
bilayers alone [Figure 3.12 (a)J. Profiles (b) and (c) may be seen
to be much wider, graphically demonstrating that, in bilayers
incorporating M2, water is free to penetrate at least 12 A into the
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bilayer at both sides of the lipid face. This may be compared with
about 5 A in lipid-only systems. At this resolution, it may be seen
that the M2 peptides form an almost continuous channel across the
bilayer. Although the peptides used in these studies were
monomeric, it must be assumed that some form of equilibrium
functions in which, for example, tetrameric channels are being
continuously formed and dissociated, thereby allowing the inclusion
of solvent (see Chapter 4).
Amantadine and M2 peptide
Figure 3.13 (a) shows the amantadine FB distribution in lipid-
only systems. This can be described by two Gaussians; the first and
larger of the two centred on the middle of the bilayer, and the
second centred 10 A on either side of the first, ie. halfway down
the fatty acid moieties. Such a result is in broad agreement with
that obtained in Section 3.5.6, where amantadine FB was reported to
be located deep in the bilayer. However, Figure 3.13 (a) shows
that more of the amantadine FB has penetrated into the centre of the
lipid environment than was observed in the previous study. It is
thought that this relative distribution dichotomy is probably due to
experimental differences in amantadine FB concentration and
temperature between the two studies. [NB. The ILL data were
gathered on 5% (mol) amantadine FB and at a temperature of 20°C,
whereas the Brookhaven data were gathered on 2% (mol)
amantadine FB and at a temperature of 37°C. |
The difference distributions of amantadine associated with
native [Figure 3.13 (b)] and mutant M2 (c) are shown. It is
immediately apparent that both of these profiles are quite different
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from each other and, indeed, quite different from the amantadine
distribution in the lipid-only system (a).
When native M2 is present (b), the population profile of drug
appears as two discrete peaks in contrast to that described in (a).
Gaussian fitting to difference profile (b) indicates that these peaks
are centred 6 A and 20.5 A from the middle of the bilayer - the
amantadine now appears to adopt a much more specific orientation.
Recent molecular modelling studies, which have examined possible
tetrameric associations of the M2 transmembrane domain and its
interactions with amantadine (Sansom and Kerr, 1993), have
identified a minimum in the vicinity of the Ser3i oxygen atoms
when energy interactions were evaluated as amantadine was moved
along the length of the channel. This was shown to derive from a
favourable electrostatic interaction between the cationic amine group
and the ring of Ser3i O atoms. In addition, van der Waals contacts
were observed between the Val27 side-chains and the amantadine
ring. It was shown that the ring fits into a pocket formed by the
Val27 side-chains (the M2 was modelled as a tetramer) and at the
same time the protonated amine group forms favourable electrostatic
interactions with the Ser3 j oxygens. (It was concluded that the
combination of a steric cut-off at Ile42 and the favourable
interaction at Val27/Ser3] provided a molecular explanation for
block of M2 channels by amantadine.)
This thesis has already indicated that Val27 (the d27 label data)
may be found 8 A from the centre of the bilayer (see above). It
can be calculated that the Ser3i lies approximately 6 A from this
(one amino acid in an a-helix represents a translation of 1.5 A). If
the amantadine molecule is placed in the position described in the
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reported modelling study, between the Val and Ser, then its spatial
centre will occur at approximately 5 A from the middle of the
bilayer (ie. midway between the two amino acids). As reported at
the start of the previous paragraph, amantadine was located 6 A
from the centre of the bilayer. Interestingly, because the mass of
deuterons occur on the fused ring (the opposite end from the amine
head), the scattering centre of deuterated amantadine does not
correspond with the spatial centre. Indeed, the centre of scattering
density of the mohcule is displaced towards the adamantane-ring,
thereby off-setting the centre of scattering density by approximately
1 A in the direction of the Val27 - exactly as observed in these
neutron diffraction experiments. Therefore, remarkably, all
detectable amantadine in the bilayer appears to be in the position,
with regards native M2, that Sansom and Kerr (1993) have proposed
as the site of channel blockade.
No amantadine was observed in the water region in the lipid-
only data, however, considerable amounts appear in this area when
native M2 is present (the 20.5 A peak). The drug may be
interacting at the lipid/water interface (as was observed in Section
3.5) or it is possible that it may be in contact with the other amino-
terminal serines that project out into the water (Figure 3.7). NB.
Amantadine analogues have been shown to interact with serines in
the nicotinic acetylcholine receptor (see Section 1.4).
In contrast to the above, when mutant M2 (Val27 becomes
Ala27) is considered [Figure 3.13 (c)], it may be seen that, instead
of discrete populations of amantadine as in (b), the drug distribution
is much more generally dispersed across the bilayer with a
maximum at the centre of the water layer - perhaps again interacting
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with the terminal serines. Indeed, it now requires three Gaussians
to describe this new distribution. This result may be interpreted as
demonstrating that the mutation results in a more general membrane
flow-through of drug.
It is important with diffraction data not to over-interpret
scattering profiles, especially if fewer orders have been used,
however, regarding the above results, it is tempting to postulate that
here we are observing the mechanism of action of amantadine-
sensitivity and resistance in influenza A.
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CHAPTER 4 ELECTROPHYSIOLOGICAL STUDIES OF
INFLUENZA A M2 TRANSMEMBRANE DOMAIN AND THE
EFFECTS OF AMANTADINE
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4. Electrophysiological studies of influenza A M2 transmembrane
domain and the effects of amantadine
4.1 General introduction
Nearly all cells contain macromolecular pores embedded in
their cellular plasma membranes. These include ionic channels,
carriers and pumps. Their functions include the transport of
necessary ionised substrates and the transmission of signals. Within
multicellular organisms, ion pores produce the sparks of electrical
activity that are recognised as the essence of life itself, they control
the muscular movements of organisms and, in sensory organs, the
pores translate physical or chemical stimuli into electrical signals for
the nervous system. Even cells not directly connected to the
nervous system, such as those in the blood, the immune system, the
liver and other organs, use ion pores for both transport and
transmission processes.
During the twentieth century, major cellular roles have been
discovered for most of the inorganic ions endogenous to the body
fluids. None are passively distributed across the cell membrane.
Each has been assigned, by evolution, at least one special
regulatory, transport or metabolic task. And, importantly, each ion
has at least one transport pore.
Since the 1950's biologists have been able to study the electric
currents arising from these ions fluxes at a macroscopic level. Only
since the 1970's, however, could they examine the individual ion
pores themselves. This advance was due to the development of a
sensitive, electrophysiological technique known as patch-clamping.
124
This initial technique has been developed and refined over the
years and has produced a family of related electrophysiological
processes. One such development involves the reconstitution of
protein into planar lipid bilayers and the recording of single-channel
currents.
Over the last fifteen years such techniques have helped in the
study of, for example, the effects of acetylcholine on sodium
channels, how K+ and Ca^T channels are controlled, signalling
mechanisms at a cellular level and the role of pore-formers in
intracellular signalling. As the number of channels that have been
isolated and defined grows, it would appear that such
electrophysiological techniques will help reveal the major role such
pores play in the control of almost all cellular processes.
4.2 Electrophysiological theory
Introduction
Ionic channels may be regarded as excitable molecules. They
are specifically responsive to some stimulus: a membrane potential
change; certain ligands, small molecules or ions; mechanical
deformation, and so on. Once activated, the channel response,
called gating, is apparently a simple opening, or closing, of the
pore. The open pore has the important property of selective
permeability, allowing some restricted group of small ions to flow
passively down their electrochemical gradients at a very high rate -
usually greater than a million ions per second. This high
throughput actually aids in defining channels as opposed to other
pore-forming transporters that, in some manner, actively cross the
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membrane. In addition, channels may be observed to restrict ion
flow to downhill fluxes and are not coupled to any energy input
systems.
Physical definitions
Much of what has been discovered about ionic channels has
been deduced from electrical measurements. In order to study the
results of electrical experiments, some essential principles must be
observed. (Detailed reviews on electrophysiological theory appear in
Sakmann and Neher, 1983; Miller, 1986; Stein, 1986; Stein, 1990;
Hille, 1992.)
All matter is made up of charged particles. They are normally
present in equal numbers, so most bodies are electrically neutral. A
mole of hydrogen atoms contains Avogadro's number (N = 6.02 x
1()23) of protons and the same number of electrons. Quantity of
charge is measured in coulombs (abbreviated C), where the charge
of a proton is e = 1.6 x 10"^C. Avogadro's number of
elementary charges is called the Faraday constant: Fc = Ne = 6 x
10^3 x 1.6 x 10"19 « io5 C / mol. This is thus the charge on a
mole of protons or on a mole of Na+, K+, or any other
monovalent cation. The charge on a mole of Ca^ + , Mg^ + , or on
other divalents cations is 2 Fc and the charge on a mole of CI" ions
or other monovalent anions is - Fc.
Electrical phenomena arise whenever charges of opposite sign
are separated or can move independently. Net flow of charge is
called current and is measured in amperes (abbreviated A), where
one ampere corresponds to a steady flow of one coulomb per
second. By the convention of Benjamin Franklin, positive current
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flows in the direction of movement of positive charge. Hence if
positive and negative electrodes are placed in Ringer's solution
(physiological saline), Na + , K+, and Ca2+ ions will start to move
toward the negative pole, CI" ions will move toward the positive
pole, and an electric current is said to flow through the solution
from positive to negative pole. Michael Faraday named the positive
electrode the anode and the negative the cathode and, in his
terminology, anions flow to the anode, cations to the cathode, and
current from anode to cathode. The size of the current will be
determined by two factors: the potential difference between the
electrodes and the electrical conductance of the solution between
them. Potential difference is measured in volts (abbreviated V) and
is defined as the work needed to move a unit test charge in a
frictionless manner from one point to another. To move a coulomb
of charge across a 1 V difference requires a joule of work. In
common usage the words 'potential', 'voltage', and 'voltage
difference' are used interchangeably to mean potential difference,
especially when referring to a membrane.
Electrical conductance is a measure of the ease of flow of
current between two points. The conductance between two
electrodes in salt water can be increased by adding more salt or by
bringing the electrodes closer together, and it can be decreased by
placing a nonconducting obstruction between the electrodes, by
moving them farther apart, or by making the solution between them
more viscous. Conductance is measured in Siemens (abbreviated S
and formerly called mho [reciprocal Ohms]) and is defined by
Ohm's law in simple conductors -
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I = gE 4.1
Current (I) equals the product of conductance (g) and voltage
difference (E) across the conductor. The reciprocal of conductance
(resistance, symbolized R) is measured in ohms (abbreviated 0).
Ohm's law may also be written in terms of resistance -
Homogenous conducting materials may be characterized by a
bulk property called the resistivity (abbreviated p). It is the
resistance measured by two 1 cm^ electrodes applied to opposite
sides of a 1 cm cube of the material and has the dimensions ohm •
centimeter (0- cm). Resistivity is useful for calculating resistance of
arbitrary shapes of materials. For example, for a right cylindrical
block of length 1 and cross-sectional area A with electrodes of area
A on the end faces, the resistance is -
Resistivity decreases as salts are added to a solution. Consider the
following examples at 20°C: frog Ringers solution 80 0 • cm,
mammalian saline 60 fl • cm, and sea water 20 Q • cm. Indeed, in
sufficiently dilute solutions, each added ion gives a known increment
to the overall solution conductance, and the resistivity of electrolyte
solutions can be predicted by calculations from tables of single-ion
equivalent conductivities, like those in Robinson and Stokes (1965).
In saline solutions the resistivity of pure phospholipid bilayers is as
E = IR 4.2
R = pi/A 4.3
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high as 1()15 Q . Cm, because although the physiological ions can
move in lipid, they far prefer an aqueous environment over a
hydrophobic one. The electrical conductivity of biological
membranes comes not from the lipid, but from the ionic channels
embedded in the lipid.
To summarise what has been discussed so far, when one volt is
applied across a 10 resistor or 1 S conductor, a current of one
ampere flows; every second, 1/Fc moles of charge (10.4 /zmol)
move and one joule of heat is produced. Ohm's law plays a central
role in membrane biophysics because each ionic channel is an
elementary conductor spanning the insulating lipid membrane. The
total electrical conductance of a membrane is the sum of all these
elementary conductances in parallel. It is a measure of how many
ionic channels are open, how many ions are available to go through
them and how easily the ions pass.
In addition to containing many conducting channels, the lipid
bilayer of biological membranes separates internal and external
conducting solutions by an extremely thin insulating layer. Such a
narrow gap between two conductors forms, of necessity, a
significant electrical capacitor.
To create a potential difference between objects requires only a
separation of charge. Capacitance (C) is a measure of how much
charge (Q) needs to be transferred from one conductor to another to
set up a given potential and is defined by -
C = Q/E 4.4
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The unit of capacitance is the farad (abbreviated F). A 1 F
capacitor will be charged to 1 V when +1.0 C of charge is on one
conductor and -1.0 C on the other. In an ideal capacitor the
passage of current simply removes charge from one conductor and
stores it on another in a fully reversible manner and without
evolving heat. The rate of change of the potential under a current
Ic is obtained by differentiating Equation 4.4 -
dE/dt = Ic/C 4.5
The capacity to store charges arises from their mutual attraction
across the gap and by the polarization they develop in the insulating
medium. The capacitance depends on the dielectric constant of that
medium and on the geometry of the conductors. In a simple
capacitor formed by two parallel plates of area A and separated by
an insulator of dielectric constant e and thickness D, the capacitance
is -
C = ee0A/D 4.6
where eo, called the polarisability of free space, is 8.85 x 10"'2
CV"'nrl. Cell membranes are parallel-plate capacitors with specific
capacitances near 1.0 /xF/cm^. According to Equation 4.6, this
means that the thickness D of the insulating bilayer is only 23 A
(2.3 nm), assuming that the dielectric constant of hydrocarbon
chains is 2.1. Hence the high electrical capacitance of biological
membranes is a direct consequence of their molecular dimensions.
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Working formulae
It may be intuitively seen that, in channel systems, the ions on
both sides of the membrane will seek equilibrium. However, if the
ionic concentration on one side of the barrier is due to two or more
populations of counterions and the channel is permeable to only one
of these types, then an interesting phenomenon may be observed.
The diffusional forces causing net diffusion of the permeant ion are
countered by a growing electrical force tending to oppose the ions
flow. The potential builds up until it finally reaches an equilibrium
value, Ek, where the electrical force balances the diffusional force
and the system no longer changes. Equilibrium potentials are
important in describing biological membrane potentials. If a mole
of an arbitrary ion S with charge Z§ is considered then -
ES = Ei-E2 = RT/ZSFC In [S]2/[S]i 4.7
where E$ is the membrane potential difference, R is the gas
constant, T is the temperature in Kelvin, and Fc is Faraday's
constant. Side 1 is usually defined as being intracellular and side 2
as being extracellular. This equation is known as the Nernst
equation (Nernst, 1888) and it describes how ionic equilibrium
potentials vary linearly with the absolute temperature and
logarithmically with the ionic concentration ratio. Equilibrium
potentials change sign if the charge of the ion is reversed or if the
direction of the gradient is reversed, and they fall to zero when
there is no gradient.
So far, the membrane has been discussed as a capacitor and the
channel as a conductor. However, if Ohm's law is tested with this
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capacitor/conductor system which includes an ionic concentration
gradient across the membrane, then it may be seen that current in
the pores goes to zero at E$ and not at 0 mV. This is because of
the effect of the concentration gradient. The current/voltage law
becomes -
IS = gS (E-Es) 4.8
where I is current, g is the conductance and the electromotive force
is E$ and, therefore, the net driving force on the S ion is E-E§ and
not E. To a first approximation this linear law works, but many
pores are known to have nonlinear current/voltage relations when
open.
Simple current/voltage measurements can be used to gain much
information on ionic channels. With reference to a simplified
system (Figure 4.1) it can be seen that if a positive potential is
applied to electrode (1) then the positive ions will, if possible, cross
the membrane from A to B. As the potential difference across the
membrane is increased then the current, or number of ions flowing,
will also increase. If the polarity of the electrodes is reversed then
the current flow will also reverse. This may be graphed on an I/E,
or, as they are more commonly termed, I/V plot (Figure 4.2, red
line). When the plot passes through the origin it denotes that the
channels are nonselective or that there is no effective ionic gradient.
If the slope of the I/V plot decreases (Figure 4.2, blue line), then
the equivalent conductance, and hence the number of open channels,
differs correspondingly. Thus conductance gives a useful measure
of how many channels are open in an area of membrane.
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Figure 4.1 Electrophysiological apparatus (see text for explanation).
133
It" the I/V plot has the same slope but a different zero current
potential (Figure 4.2, green line), then the channel has equal
conductance but a different electromotive force. This indicates that
the channel is either different from the other channel described
above, with a different ion selectivity, or, that it is the same
channel but now it is bathed on both sides with different
concentrations of its permeant ion. Therefore, zero current
potentials are useful in studies of selectivity.
In summary, it may be said that, in a situation where there is
only one ion diffusing across a membrane, a transmembrane
potential will be set up that, when equilibrium is reached, is a
function of the ratio of the concentrations of the diffusing ion at the
two sides of the membrane. However, if more than one type of ion
is able to diffuse then the ion concentration ratios will not be
exactly those given in the Nernst equation (Equation 4.7). This
problem is solved by the Goldman-Hodgkin-Katz (GHK) voltage
equation (Hodgkin and Katz, 1949), which relates the overall
membrane potential to a diffusion potential contributed by each ion,
which is determined by the concentration of the diffusing ion at
each membrane face and by the permeability of the ion across the
bilayer in question. Essentially, each ion tends to develop a
membrane potential given by its concentration ratio across the
membrane. The extent to which it reaches this potential depends on
what fraction of the total amount of charge carried across the
membrane is carried in the form of that particular ion, ie., on its
permeability and its concentration -
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Figure 4.2 Specimen 1/V plots. Red line (1) represents double the
amount of open channels as the blue line (2). The green line (3)
shows a data set with a different zero current potential. See text
for full explanation.
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E = RT / ZFc In {Px [xnl + Py |yn| + Pz fzjj] 4.9
{Px [xj| + Py [yj] + Pz [zj]
where P is the permeability of the ions x, y and z, and [x], [y] and
[z] are the concentrations of these ions at sides I and II of the
membrane.
To understand this equation (Equation 4.9) consider some
special cases: (a) When only one ion can permeate (say, x), P
exists for that ion but is zero for all others. Equation 4.9 therefore
reduces to the Nernst equation (Equation 4.7). (b) When one ion
(say, y) is overwhelmingly permeant, all other values of P are
insignificant and, once again, Equation 4.7 is recovered, (c) It also
follows that an ion that is present at a very low concentration
relative to other permeant ions will contribute very little to the
potential, although it might well be as permeant as the other ions.
The current flow (and it is this parameter that determines the
potential) depends on both permeability and the absolute
concentration of an ion.
4.3 Experimental hardware
The equipment used in the experiments discussed in this chapter
may appear simple in description. However, that is only a
superficial impression and, underneath, a great deal of electronic
ingenuity is employed, predominantly in order to produce and
maintain an extremely low background noise so that the movement
of a few elementary charges may be detectable. It is not the aim of
this section to describe the experimental hardware in such detail -
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further information may be obtained from advanced
electrophysiological texts (eg. Hamill et al., 1981; Sakmann and
Neher, 1983).
The basic experimental set-up is illustrated in Figure 4.1. The
perspex block, D, consists of two chambers, designated cis and
trans. The solution in each chamber is in contact with an electrode.
By convention, the cis chamber (A) is the side to which the peptide,
drug, etc. is added and the trans chamber (B) is opposite. The
lipid membrane is positioned so that it effectively blocks the gap
between these chambers (Section 4.7), and the ion channel under
scrutiny must be incorporated into this barrier. Thereafter, the
solutions of one or both chambers may be carefully changed by
perfusion in order to examine the channel characteristics of the
protein.
It may be seen from Figure 4.1 that, for example, when both
chambers are filled with solutions of equimolar cationic
concentration and a positive voltage is applied to the cis
microelectrode, if the particular reconstituted ion channel permits,
then cations (current) will flow from cis to trans. From Equation
4.2 it is observed that, if the resistance of the system has not
changed, then the potential difference will now decrease. It would
therefore prove difficult to characterise any ion channel
electrophysiologically if the applied voltage was constantly changing.
However, it is possible with suitable electronic circuitry to hold
the membrane potential steady at any given voltage. This is
accomplished by connecting the recording electrodes to a device
called a feedback amplifier (Figure 4.1, C) which compensates for
any potential change sensed by these electrodes by applying a back-
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off potential to keep the voltage constant (Vg). This arrangement is
known as a voltage-clamp (V^), and the designated value of V is
called the command voltage. By setting different command voltages
and measuring the injected current that is required to maintain them,
it proves possible to investigate systematically the membrane
conductance as a function of the membrane potential. The ions that
carry the transmembrane current can be identified by monitoring the
effect of changing the concentration of specific ions in the cis and
trans chambers.
The recorded current flow is low-pass filtered to remove high
frequency noise, displayed on an oscilloscope and simultaneously
recorded onto magnetic tape.
4.4 Introduction to the experimental section
The work described so far in this thesis has concentrated on
structural studies of the M2 transmembrane domain. Chapter 2
presented CD data concerning the secondary structure of the M2
peptide incorporated into liposomes and Chapter 3 defined the
position of both the peptide and amantadine within the bilayer. It is
intended that Chapter 4 will detail studies of the functional
properties of the molecule. Specifically, using reconstitution
techniques, native M2 peptide will be incorporated into voltage-
clamped planar lipid bi layers and the transmembrane domain will
then be examined electrophysiologically in order to determine
whether it possesses any proton channel properties.
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4.5 Introduction
In 1989 it was proposed that influenza A M2 protein forms a
transmembrane channel which is involved in reducing the interior
pH of the virus at the uncoating stage and, in addition, that M2
reduces acidification of post-Golgi vesicles involved in the transport
of haemagglutinin (HA) during viral assembly (Hay, 1989). The
method by which the protein achieves these results was suggested to
be by allowing the passage of protons.
The elegant experiments which led to this conclusion, described
in Section 1.4, were all, in effect, circumstantial. Although it
certainly appeared likely that M2 was a channel, definitive evidence
was lacking. Indeed, it was not until two years later that workers
reported the presence of the first ion channel to be found in any
virus - Semliki Forest Virus (Schlegel et al., 1991).
Recently, it has been stated that other viruses possess proteins
with sequences analogous to M2 (Section 1.5). There may,
therefore, exist a functional similarity too. It is possible that groups
of enveloped viruses use similar strategies within their infectivity
cycles and this would mean that they could be challenged with
broad-based, anti-viral therapies. Therefore, it would appear
important, and timely, to determine exactly what M2 may be
capable of and how.
In response, this present study, which has been carried out with
Dr Richard Ashley, Department of Biochemistry, University of
Edinburgh, describes electrophysiological investigations of the
possible function of influenza A M2 transmembrane domain
reconstituted into planar lipid bilayers. The effects of adding
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amantadine to this system and altering the pH and the constituents
of the bathing solvents will be discussed.
4.6 Materials
All chemicals, including amantadine hydrochloride, were
purchased from Sigma Chemical Company Ltd. Organic solvents
were purchased from the same address. The phospholipids used
were high-purity, stored at -70°C, and were obtained from Avanti,
U.S.A. The M2 peptide used was native and was prepared as
described in Section 2.7.
4.7 Experimental practice
A typical single-channel recording experiment began with the
pipetting of lipid, which is dispersed in organic solvent, into an
Eppendorf tube. The solvent was evaporated-off under a gentle
stream of oxygen-free nitrogen and the lipid resuspended in decane
and whirlimixed thoroughly.
The 'cup', ie. the machined styrene copolymer cylinder that
houses the cis chamber, may be removed and cleaned with detergent
then thoroughly rinsed. The cis and trans chambers in the perspex
block were filled with the buffer of choice and the lipid 'painted'
across the aperture (0.3 mm) between the two. Lipid painting is
performed with a sharpened, plastic spatula.
The capacitance of the membrane is checked in order to
ascertain optimum thickness. The ion channel of interest is added,
in a minimal volume of solvent, to the cis chamber and the solution
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is stirred briefly using a tiny, magnetic stirrer. With the
experiments described here, it was observed that channel
incorporation proceeded more rapidly if the system was exposed to a
positive potential difference (~ +40 mV) at this point.
Successful channel reconstitution is deemed to have occurred
when unit current flow is observed (events). The contents of the
two chambers may now be changed, if so desired, by careful
perfusion. A record of events is made on magnetic video tape for
subsequent data analysis.
4.8 Results, subsequent data analysis, and discussion
The observation ofproton channel activity
Initially, it was attempted to incorporate native M2 peptide into
DOPC bilayers. However, this resulted in poor peptide
incorporation and, after further trials, it was found that a equimolar
mixture of palmitoyl-oleoyl phosphatidylethanolamine (POPE) and
palmitoyl-oleoyl phosphatidylserine (POPS) (each at an initial
concentration of 15 mg ml"l) maximised channel reconstitution. In
addition, after successful M2 reconstitution, if buffer solutions at
approximately physiological pH were used in the cis and trans
chambers then prohibitively small currents were observed. This was
deemed to be due to a paucity of potential translocating ions and
therefore, it was decided that experiments measuring proton flow
characteristics would be performed at more acidic pH. To control
for these rather non-physiological conditions, membranes of similar
capacitance to those described above were held for up to one hour
at pH's of between 2.3 and 7.0. In subsequent control experiments
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it was observed that membrane stress occurred only if the pH
dropped below 1. Bilayer stability was always monitored before the
addition of peptide and the pH was only exceptionally reduced
below 2.3.
When commencing such electrophysiological experiments as are
described here, cis and trans chambers were both filled with 600 fA
of 50 mM glycine HC1, pH 2.3. The cis chamber was voltage-
clamped at a range of possible holding potentials relative to the
trans, which was grounded. The bilayers were monitored by
measuring their capacitance (~ 250 pF) and those used had
resistances of at least 10'' Ohms. After successful M2
incorporation, the contents of the trans chamber was usually
replaced by perfusion with 50 mM glycine HC1, pH 3.0.
Transmembrane currents were commonly seen within thirty minutes
of adding up to 1 /zg of the peptide in 6 ixl of methanol to the cis
compartment. Channel incorporation could be accelerated by
breaking and reforming the POPE/POPS membrane. Control
bilayers exposed to 1 % (v/v) methanol in the same buffer remained
stable for up to three hours and exhibited no channel-like activity.
All experiments described in this section were repeated many times
and single-channel currents were obtained whenever successful
reconstitution occurred (Figure 4.3).
The observation of current flow indicated that influenza A M2
protein, or, at least, the transmembrane region thereof, was indeed
capable of proton translocation.
Importantly, such proton channel activity could be blocked by
the addition of 20 fiM amantadine hydrochloride. Furthermore,







Figure 4.3 Single-channel currents (downward deflections) across a
planar lipid bilayer with incorporated M2 peptide, subsequently
inhibited by 20 /xM amantadine HC1 (added to both sides of the
membrane). Holding potential +100 mV, glycine-HCl (pH 2.3 cis
and 3.0 trans).
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extensive perfusion with fresh buffer after amantadine block,
channel activity was restored. A control experiment with the
twenty-six amino acid peptide melittin (Tosteson and Tosteson,
1981) showed that, when it was incorporated in a similar manner
under the same conditions, it acted as an anion channel but was
insensitive to amantadine.
These results illustrate the specific action of amantadine upon
the associated function of the transmembrane domain of influenza A
M2 protein.
Lifetime distributions - a briefsojourn
For any two-state channel model, the gate in the channel opens
and shuts randomly. If the gate is open, it has a certain probability
of shutting. This probability is expressed as a transition rate
constant (a) with units of s~* (ie. per second). Conversely, if the
gate is shut, it has a certain probability of opening, again expressed
as a transition rate constant (B) -
a
open < = > shut 4.10
6
The value of a shows that for every accumulated second that the
channel is in the open state, it will on average shut a times, and
conversely, for every accumulated second that the channel is shut, it
will on average open B times. For example, if the gate shuts on
average one thousand times for every second that it is open, it
means that the average length of time that the gate is open is 1 /
1000 seconds, or 1 ms. The mean length of time the channel stays
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in a particular state, the 'sojourn' in that state, is the reciprocal of
the transition rate constant that leads out of the state.
From the data illustrated in Figure 4.3, four and a half minutes
of the pre-amantadine recording were inspected to identify discrete
openings which were collected in a frequency histogram (Figure
4.4). [NB. The data collected in all these experiments were
analysed using Axotape and PClamp software (Axon Instruments).]
The mean open time (tq) was determined to have a duration of 20
msec. Therefore, from the above, it can be seen that the transition
rate constant for channel closure (1/ro) is ~ 50 s~l. Such lifetime
analyses are consistent with a model for channel formation of the
general type -
a
4p < = > p4 4.11
6
where incorporated peptide monomers (p) associate briefly to form
an oligomeric channel (here shown as a tetramer, however, '4' may
be replaced Dy 'n').
Closed lifetime distributions, on the other hand, appeared to
contain at least two components, with mean lifetimes of about 10
msec and 1 msec. Because of the relatively small number of
events, a complete analysis of the absolute values of the closed-state
lifetimes proved impossible and it was observed that these values
varied considerably between experiments, as would be expected for
different peptide concentrations. However, the repeated finding of
more than one component is consistent with the formation of clusters
of peptides (eg. tetramers), with short 'intraburst' intervals reflecting
the temporary dissociation of one monomer within a given group
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Open time (ms)
Figure 4.4 Frequency distribution of all the openings collected from
4.5 minutes of pre-amantadine recording (with typical events shown
in detail). The smooth curve is a single exponential function with a
time constant of 20 msec. Events lasting < 4 msec were
discarded.
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and longer 'interbursf intervals corresponding to more extensive
disruption, eg. -
p + p< = >p2 + p< = >p3+p< = >p4 412
With higher peptide concentrations, bursts of channel activity
tended to overlap to give openings to more than one unit current
level (see below). It was noted that channel activation showed little
obvious voltage-dependence.
Multichannel currents
It was observed that peptide incorporation increased markedly
on addition of >10 fxg mH but this usually resulted in the
appearance of multichannel currents (up to 50 pA) which were
difficult to analyse. However, occasionally, distinct conductance
levels could still be resolved, and in the experiment shown in Figure
4.5, current transitions appear to occur between the closed level
(which is more obvious after the application of amantadine) and
several open levels. An amplitude histogram was constructed from
one hundred seconds of these data (Figure 4.6) and it shows three
main equally spaced peaks, consistent with the simultaneous
formation of up to three channels in this bilayer. The third peak is
not a single Gaussian, suggesting that some large events of ~ 2.6
pA arose by a different mechanism (possibly ion channels formed
from higher oligomers, eg. five peptides rather than four). In
addition, apparently direct transitions between levels 1 and 3
occurred much more often than would be expected from the random
superimposition of unit events (Krouse et al., 1986). This is
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Figure 4.5 Current transitions in a peptide-containing bilayer
voltage-clamped at +80 mV. The bilayer was formed in 25 mM
Tris-HCl (pH 7) and the pH of the cis solution was then lowered to
1 by adding HC1. Downward proton currents flow cis to trans.
Amantadine (20 mM), added to both chambers where indicated (*),
confirmed the zero current level (0). Openings have been assigned
to three marked current levels.
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Amplitude (pA)
Figure 4.6 Amplitude histogram from 100 seconds of contiguous
data displayed in Figure 4.5. Main peaks 1 and 2 were each fitted
to a single Gaussian and peak 3 to two Gaussian distributions.
Peaks 1:2:3 have been rescaled in the ratio 9:5:2 to share the same
axis.
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consistent with some cooperativity of oligomer association and
dissociation or the formation of channel clusters.
If very large proton gradients were imposed across the bilayer
(Figure 4.7), then highly nonlinear I/V relationships were produced
(Figure 4.8) which appeared to be well described by electrodiffusion
theory - Equation 4.9 (Hodgkin and Katz, 1949). Conductance could
be seen to be ohmic (linear) in the more moderate gradients
provided by citrate or glycine HC1 buffers (eg. glycine HC1, pH 2.3
cis vs 3.0 trans, Figure 4.9, solid line). Reversal potentials were
shifted slightly from the proton equilibrium potential but remained
consistent with a H+:C1" permeability ratio of at least 5:1 (derived
from the GHK equation, Equation 4.9). On the same basis, the
shift in the reversal potential when the trans chamber was perfused
with 3.0 M NaCl (leaving glycine HC1, pH 2.3 cis) indicated a
H + :Na+ permeability ratio of at least 3:1 (Figure 4.9, dotted line).
It must be pointed out that these values correspond to very
unphysiological conditions for the peptide and for all the ions
involved. Relative permeabilities in normal cellular conditions (and
with the complete protein) may differ.
Nevertheless, these experiments, taken together, do provide
clear evidence that the transmembrane domain of M2 protein can
form proton-conducting ion channels which are blocked by
amantadine and this therefore supports the original hypothesis of
Hay and his colleagues that proton translocation by M2 plays an






Figure 4.7 Single-channel currents across an M2-containing bilayer
voltage-clamped at the indicated holding potentials (50 mM KC1




Figure 4.8 I/V plot from the experiment described in Figure 4.7.
The smooth curve is a best-fit to the GHK equation (equation 4.9),





Figure 4.9 I/V relationship from an experiment with glycine HC1 cis
and trans, pH 2.3 and 3.0 respectively fl , and after changing the
trans solution by perfusion with 3.0 M NaCl, pH 7.0 £ . The





An initial diffraction project investigated the position of
amantadine in phospholipid multilayers (Duff et al., 1993). The
thesis has then proceeded in a structure/function manner. The M2
transmembrane domain of influenza A has been demonstrated to
adopt an a-helical secondary structure when incorporated into
liposomes. This structure is influenced by phospholipid composition
but not by temperature or the presence of amantadine. The M2
peptide, both native and mutant, has been shown to adopt a
transmembrane position. Within this sequence a distinct area of
amantadine interaction has been located which agrees spatially with
such a proposed site deduced from recent molecular modelling
studies. With amantadine-resistant mutant M2 sequences,
peptide/drug interactions are not discernable in this area. The native
M2 peptide, when incorporated into bilayers and studied from a
functional perspective, has demonstrated an amantadine-sensitive
proton channel ability.
It may therefore be reported that the results in this thesis
indicate influenza A M2 transmembrane domain is an a-helical,
membrane-spanning proton channel and that amantadine interacts
with this channel, at a specific region, resulting in the blockade of
its function.
At the outset of this thesis, January 1990, very little was
known about M2. It had been recognised (Winter and Fields,
1980), been found in infected cells (Lamb and Chopin, 1981) and in
virions (Zebedee and Lamb, 1988) and had been hypothesised to be
involved in proton transfer at two possible stages in the infectivity
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cycle (Hay, 1989). Three years later, after some extensive research
from numerous workers, we now know that the transmembrane
domain possesses a-helical secondary structure (Duff et al., 1992),
its precise orientation in the bilayer (Duff et al., in prep.), that it
forms tetrameric structures (Sugrue and Hay, 1991) and that it
allows passage of protons (Duff and Ashley, 1992) and other cations
(Pinto et al., 1992), and, in addition, one of the possible areas of
amantadine action has been described (Duff et al., in prep; Sansom
and Kerr, 1993).
It is expected that such diverse work will lead to a general
understanding of the nature of enveloped virus infectivity and the
basis of drug efficacy. It is hoped that the work described in this






Allen, J.P., Feher, G., Yeates, T.O., Komiya, H. and Rees, D.C.
(1987) Structure of the reaction centre from Rhodobacter
sphaeroides R-26: the protein subunits Proc. Natl. Acad. Sci.
U.S.A. 84 6162-6166
Anderson, R.G.W. and Orci, L. (1988) A view of acidic
intracellular compartments J. Cell Biol. 106 539-543
Bacon, G.E. (1975) Neutron diffraction (third edition) Oxford
University Press, London, U.K. pp. 48-50
Batenburg, A.M. and de Kruijff, B. (1988) Modulation of
membrane-surface curvature by peptide-lipid interactions Biosci.
Rep. 8 299-307
Bayley, P.M. (1973) The analysis of CD of biomolecules Progress
in biophysics and molecular biology 27 3-79
Belshe, R.B., Hall-Smith, M., Hall, C.B., Betts, R. and Hay, A.J.
(1988) Genetic basis of resistance to rimantadine emerging
during treatment of influenza virus infection J. Virol. 62 1508-
1512
Beveridge, W.I.B. (1977) Influenza - the last great plague
Heinemann Books Ltd., London, U.K.
Blaurock, A.E. and Nelander, J.C. (1976) Disorder in nerve myelin
: analysis of the diffuse X-ray scattering J. Mol. Biol. 103
421-431
Both, G.W., Sleigh, M.J., Cox, N.J. and Kendal, A.P. (1983)
Antigenic drift in influenza virus H3 HA from 1968-1980 :
multiple evolutionary pathways and sequential amino acid
changes at key antigenic sites J. Virol. 48 52-60
Bradshaw, J.P., Edenborough, M., Sizer, P.J.H. and Watts, A.
(1989) A description of the phospholipid arrangement
intermediate to the humidity produced La and Hji phases in
dioleoylphosphatidylcholine and its modification by
dioleoylphosphatidylethanolamine as studied by X-ray diffraction
Biochim. Biophys. Acta 987 101-110
Bragg, W.L. (1913) The diffraction of short electromagnetic waves
by a crystal Proc. Cambridge Philos. Soc. 7743-57
Bukrinskaya, A.G., Vorkunova, N.K. and Pushkarskaya, N.L.
(1982) Uncoating of a rimantadine-resistant variant of influenza
virus in the presence of rimantadine J. Gen. Virol. 60 61-66
Buldt, G., Gaily, H.U., Seelig, A., Seelig, J., and Zaccai, G.
(1978) Neutron diffraction studies on selectively deuterated
phospholipid bilayers Nature 271 182-184
158
Buldt, G., Gaily, H.U., Seelig, J. and Zaccai, G. (1979) Neutron
diffraction studies on phosphatidylcholine model membranes J.
Mol. Biol. 134 613-691
Campbell, I.D. and Dwek, R.A. (1984) Biological spectroscopy,
Benjamin/Cummings Publishing Co., California, U.S.A.
Chang, C.T., Wu, C.-S.C. and Yang, J.T. (1978) Circular dichroic
analysis of protein conformation; inclusion of the B-turns Anal.
Biochem. 91 13-31
Changeaux, J.P., Giraudat, J. and Dennis, M. (1987) The nicotinic
acetylcholine receptor : molecular architecture of a ligand-
regulated ion channel Trends Pharmacol. Sci. 8 459-465
Cheetham, J.J. and Epand, R.M. (1987) Comparison of the
interaction of the antiviral chemotherapeutic agents amantadine
and tromantadine with model phospholipid membranes Biosci.
Rep. 7 225-230
Chen, Y-H, Yang, J.T. and Chau, K.H. (1974) Determination of
the helix and beta forms of proteins in aqueous solution by
circular dichroism Biochemistry 13 3350-3359
Curwen, M., Dunnell, K., Ashley, J. (1990) Hidden influenza
deaths Br. Med. J. 300 896-897
Davies, W.L., Grunert, R.R., Haff, R.M., McGahen, J.W.,
Neumayer, E.M. and Paulshock, M. (1964) Antiviral activity
of i-adamantanamine [amantadine] Science 144 862-863
Deisenhofer, J., Epp, O., Miki, K., Huber, R. and Michel, H.
(1985) Structure of the protein subunits in the photosynthetic
reaction centre of Rhodopseudomonas virdis at 3A resolution
Nature 318 618-624
Dubowitz, V. (1958) Influenzal encephalitis Lancet 1 140-142
Duff, K.C. and Ashley, R.H. (1992) The transmembrane domain of
influenza A M2 protein forms amantadine-sensitive proton
channels in planar lipid bilayers Virology 190 485-489
Duff, K.C., Cudmore, A.J. and Bradshaw, J.P. (1993) The location
of amantadine hydrochloride and free base within phospholipid
multilayers : a neutron and X-ray diffraction study Biochim.
Biophys. Acta 1145 149-156
Duff, K.C., Kelly, S.M., Price, N.C. and Bradshaw, J.P. (1992)
The secondary structure of influenza A M2 transmembrane
domain : a circular dichroism study FEBS Lett. 311 256-258
Duff, K.C., Saxena, A. and Bradshaw, J.P. (in prep.) The
orientation of native and mutant influenza A M2 transmembrane
domains in phospholipid multilayers and their interactions with
amantadine hydrochloride : a neutron diffraction study
159
Epand, R.M., Epand, R.F., Orlowski, R.C., Boni, L.T. and Hui,
S.W. (1983) Amphipathic helix and its relationship to the
interaction of calcitonin with phospholipids Biochemistry 22
5074-5084
Ewald, P.P (1921) Das 'reziproca gitter' in der strukturtheorie Z.
Kristoliagr. Miner 56 129-156
Franks, N.P. and Leib, W.R. (1979). The structure of lipid bilayers
and the effects of general anaesthetics : an X-ray and neutron
diffraction study J. Mol. Biol. 133 469-500
Franks, N.P. and Fieb, W.R. (1981) X-ray and neutron diffraction
studies of lipid bilayers Fiposomes : from physical structure to
therapeutic applications (Knight, ed) Elsevier/North-Holland
Press pp. 243-272
Gilman, A.G., Rail, T.W., Nies, A.S. and Taylor, P. (1990) The
pharmaceutical basis of therapeutics (8th Edition) Pergamon
Press pp. 472-473
Gottschalk, A. (1957) The specific enzyme of influenza virus and
Vibrio cholerae Biochim. Biophys. Acta 23 645-646
Gregoriades, A. (1973) The membrane protein of influenza virus :
extraction from virus and infected cell with acidic chloroform-
methanol Virology 54 369-383
Guo, Y., Jin, F., Wang, M. and Zhu, J. (1983) Isolation of
influenza C virus from pigs J. Gen. Virol. 64 177-182
Hamill, O.P., Marty, A., Neher, E., Sakmann, B. and Sigworth,
F.J. (1981) Improved patch-clamp techniques for high-
resolution current recording from cells and cell-free membrane
patches Pfluegers Arch. Eur. J. ofPhysiol. 391 85-100
Hay, A.J. (1989) The mechanism of action of amantadine and
rimantadine against influenza viruses Concepts in viral
pathogenesis III (A.L. Notkins and M.B.A. Oldstone, eds)
Springer Verlag, New York, U.S.A. pp 361-367
Hay, A.J., Wolstenholme, A.J., Skehel, J.J. and Smith, M.H.
(1985) The molecular basis of the specific anti-influenza action
of amantadine EMBO J. 4 3021-3024
Hay, A.J., Zambon, M.C., Wolstenholme, A.J., Skehel, J.J. and
Smith, M.H. (1986) Molecular basis of resistance of influenza
A viruses to amantadine J. Antimicrob. Chemother. 18 (suppl.)
19-29
Hayden, F.G. and Hay, A.J. (1992) Emergence and transmission of
influenza A viruses resistant to amantadine and rimantadine
Curr. Top. Microbiol. Immunol. 176 119-130
Hers, J.F., Masurel, N. and Mulder, J. (1958) Bacteriology and
histopathology of the respiratory and lungs in fatal Asian
influenza Lancet 2 1141 -1148
160
Hiebert, S.W., Patterson, R.G. and Lamb, R.A. (1985)
Identification and predicted sequence of a previously
unrecognised small hydrophobic protein, SH, of the
paramyxovirus simian virus-5 J. of Virol. 55 744-751
Hille, B. (1992) Ionic channels of excitable membranes Sinauer
Assoc, U.S.A.
Hodgkin, A.L. and Katz, B. (1949) The effect of sodium ions on
the activity of the giant axon of the squid J. Physiol. 108 37-
77
Huang, C., Charlton, J.P. and Litman, B.J. (1969) Studies on
phosphatidyl choline vesicles : dye-lipid interaction Biophys. J.
9 31
Inglis, S.C., Carroll, A.R., Lamb, R.A. and Mahy, B.W.J. (1976)
Polypeptides specified by the influenza virus genome I.
Evidence for eight distinct core products specified by fowl
plague virus Virology 74 489-503
Ito, T., Gorman, O.T., Kawaoka, Y., Bean, W.J. and Webster,
R.J. (1991) Evolutionary analysis of the influenza A virus M
gene with comparison of the Ml and M2 proteins J. Virol. 65
5491-5498
Jackson, D.C., Tang, X.-Li., Gopal Murti, K., Webster, R.G.,
Tregear, G.W. and Bean, W.J. (1991) Electron microscopic
evidence for the association of M2 protein with the influenza
virion Arch. Virol. 7/5 199-207
Jacobs, R.E. and White, S.H. (1989) The nature of the hydrophobic
binding of small peptides at the bilayer interface : implications
for the insertion of transbilayer helices Biochemistry 28 3421-
3437
Kawakami, K. and Ishitama, A. (1983) RNA polymerase of
influenza virus III. Isolation of RNA polymerase - RNA
complexes of influenza PR8 J. Biochem. 93 989-999
Kilbourne, E.D. (1969) Future influenza vaccines and the use of
genetic recombinants Bull. WHO 41 643-647
Kim, J., Mosior, M., Chung, L. A., Wu, H. and McLaughlin, S
(1991) Binding of peptides with basic residues to membranes
containing acidic phospholipids Biophys. J. 60 135-148
Kingsbury, D.W. (1990) Virology (second edition) Chapter 39
Orthomyxoviridae and their replication pp. 1075-1089
Krouse, M.E., Schneider, G.T. and Gage, P.W. (1986) A large
anion-selective channel has seven conductance levels Nature 319
58-60
Lamb, R.A. and Choppin, P.W. (1981) Identification of a second
protein (M2) encoded by RNA segment 7 of influenza virus
Virology 112 729-737
161
Lamb, R.A., Lai, C.-J. and Choppin, P.W. (1981) Sequence of
mRNA's derived from genome RNA segment 7 of influenza
virus: colinear and interrupted mRNA's code for overlapping
proteins Proc. Natl. Acad. Sci. U.S.A. 78 4170-4174
Lamb, R.A., Zebedee, S.L. and Richardson, C.D. (1985) Influenza
virus M2 protein is an integral membrane protein expressed on
the infected-cell surface Cell 40 627-633
Lear, J.D., Wasserman, Z.R. and Degrado, W.F. (1988) Synthetic
amphiphilic peptide models for protein ion channels Science
240 1177-1181
Lesslauer, W., Cain, J.J. and Blaisie, J.K. (1972) X-ray diffraction
studies of lecithin biomolecular leaflets with incorporated
fluorescent probes Proc. Natl. Acad. Sci. USA 69 1499-1503
Markwell, M.K., Haas, S.M., Tolbert, N.E. and Bieber, L.L.
(1981) Protein determination in membrane and lipoprotein
samples: manual and automated procedures Methods Enzymol.
72 269-303
Martin, C.M., Kunin, C.M., Gottlieb, L.S., Barnes, M.W., Liv,
C., Finland, M. (1959) Asian influenza A in Boston 1957-1958
Arch. Intern. Med. 703 515-518
Martin, K. and Helenius, A. (1991) Nuclear transport of influenza
virus ribonucleoproteins: the viral matrix protein (Ml) promotes
export and inhibits import Cell 67 117-130
Matthews, R.E.F. (1982) Classification and nomenclature of viruses
Intervirology 17 1-200
Miller, C. (Ed.) (1986) Ion channel reconstitution Plenum Press,
New York, U.S.A.
Miller, D.K. and Lenard, J. (1981) Antihistaminics, local
anaesthetics, and other amines as antiviral agents Proc. Natl.
Acad. Sci. USA. 78 3605-3609
Mims, C.A. and White, D.O. (1988) Viral pathogenesis and
immunology, Blackwell Scientific Publications, Oxford, U.K.,
pp. 292-293
Nernst, W. (1888) Zur kinetic der in losung befindlichen korper :
theorie der diffusion Z. Phys. Chem. 613-637
O'Callaghan, E., Shan, P., Takai, N., Glover, G., Murray, R.M
(1991) Schizophrenia after prenatal exposure to 1957 A2
influenza epidemic Lancet 337 1248-1250
O'Neill, G. (1991) Designer drugs to foil flu virus New Scientist
132 27
Obeso, J.A. and Martinez-Lage, J.M. (1987) Anticholinergics and
amantadine The handbook of Parkinson's disease (W.C. Koller,
ed) Marcel Dekker Inc., U.S.A. pp. 312-316
162
Oxford, J.S. and Galbraith, A. (1980) Antiviral activity of
amantadine : a review of laboratory and clinical data
Pharmacol. Ther. 11 181-262
Pacifici, G.M., Nardini, M. and Ferrari, P. (1976) Effect of
amantadine on drug induced Parkinsonism : relationship
between plasma levels and effect Br. J. Clin. Pharmacol. 3
883-889
Panayotov, P.P. and Schlesinger, R.W. (1992) Oligomeric
organisation and strain-specific proteolytic modification of the
virion M2 protein of influenza A H1N1 viruses Virology 186
352-355
Phonphok, Y. and Rosenthal, K.S. (1991) Stabilization of clathrin
coated vesicles by amantadine, tromantadine and other
hydrophobic amines FEBS Lett. 281 188-190
Pinto, L.H., Holsinger, L.J. and Lamb, R.A. (1992) Influenza virus
M2 protein has ion channel activity Cell 69 517-528
Potter, C.W. (1982) Inactivated influenza virus vaccine Basic and
applied influenza research (ed. Beare, A.S.) CRC Press,
Florida, U.S.A.
Provencher, S.W. and Glockner, J. (1981) Estimation of globular
protein secondary structure from circular dichroism
Biochemistry 20 33-37
Robinson, R.A. and Stokes, R.H. (1965) Electrolyte solutions p571
Butterworths, London, U.K.
Roth, M., Lewit-Bentley, A., Michel, H., Deisenhofer, J., Huber,
R. and Oesterhelt, D. (1989) Detergent structure in crystals of
a bacterial photosynthetic reaction centre Nature 340 659-662
Ruigrok, R.W.H., Hirst, E.M. and Hay, A.J. (1991) The specific
inhibition of influenza A virus maturation by amantadine : an
electron microscopic examination J. Gen. Virol. 72 191-194
Sacks, O. (1985) Awakenings, Pan Books, London, U.K.
Sakmann, B. and Neher, E. (1983) Single-channel recording Plenum
Press, New York, U.S.A.
Sansom, M.S.P. and Kerr, I.D. (1993) Influenza virus M2 protein:
a molecular modelling study of the ion channel Protein Eng. 6
65-74
Scadding, J.G. (1937) Lung changes in influenza Q. J. Med. 6
425-430
Schlegel, A., Omar, A., Jentsch, P., Morell, A. and Kempf, C.
(1991) Semliki forest virus envelope proteins function as proton
channels Biosci. Rep. 11 243-255
163
Schonberger, L.B., Bregman, D.J. and Sullivan-Bolyai, J.Z. (1979)
Guillain-Barre syndrom following vaccination in the National
Influenza Immunization Program, U.S., 1976-1977 Am. J.
Epidemiol. 770 105-110
Schwartz, S., Cain, J.E., Dratz, E.A. and Blasie, J.K. (1975) An
analysis of lamellar X-ray diffraction from disordered
membrane multilayers with application to data from retinal rod
outer segments Biophys. J. 15 1201-1233
Shaw, M.W. and Choppin, P.W. (1984) Studies on the synthesis of
the influenza B virus NB glycoprotein Virology 139 178-18^
Shinooka, T., Shibata, A. and Terada. H. (1992) The local
anaesthetic tetracaine destabilizes membrane structure by
interaction with polar headgroups of phospholipids Biochim.
Biophys. Acta. 1104 261-268
Siegel, J.R., Steinmetz, W.E. and Long, G.L. (1980) A computer-
assisted model for estimating protein secondary structure from
circular dichroic spectra : comparison of animal lactate
dehydrogenases Anal. Biochem. 104 160-167
Sizer, P.J.H., Miller, A. and Watts, A. (1987) Functional
reconstitution of the integral membrane proteins of influenza
virus into phospholipid liposomes Biochemistry 26 5106-5113
Smith, I.C., Auger, M. and Jarrell, H.C. (1991) Molecular details
of anaesthetic-lipid interaction Ann. N.Y. Acad. Sci. 625 668-
684
Stein, W.D. (1986) Transport and diffusion across cell membranes
Academic Press, London, U.K.
Stein, W.D. (1990) Channels, carriers and pumps Academic Press,
London, U.K.
Stuart-Harris, C.H., Schild, G.C., Oxford, J.S. (1985) Influenza :
the viruses and the disease (second edition) , Edward Arnold
Ltd, London, U.K.
Sugrue, R.J. and Hay, A.J. (1991) Structural characteristics of the
M2 protein of influenza A viruses : evidence that it forms a
tetrameric channel Virology 750 617-624
Sugrue, R.J., Bahadur, G., Zambon, M.C., Hall-Smith, M.,
Douglas, A. R. and Hay, A.J. (1990) Specific structural
alteration of the influenza haemagglutinin by amantadine
EMBO. J. 9 3469-3476
Tardieu, A., Luzzati, V. and Reman, F.C. (1973) Structure and
polymorphism of the hydrocarbon chains of lipids: a study of
lecithin-water phases J. Mol. Biol. 75 711-733
164
Terwilliger, E.F., Cohen, E.A., Lu, Y., Sodroski, J.G. and
Haseltine, W.A. (1989) Functional role of human
immunodeficiency virus type-1 vpu Proc. Natl. Acad. Sci.
U.S.A. 56 5163-5167
Tominack, R.L. and Hayden, F.G. (1987) Rimantadine HC1 and
amantadine HC1 use in influenza A virus infections Infect. Dis.
Clin. North Am. 1 459-478
Torbet, J. and Wilkins, M.H.F. (1976) X-ray diffraction studies of
lecithin bilayers J. Theor. Biol. 62 447-458
Tosteson, M.T. and Tosteson, D.C. (1981) The sting : melittin
forms channels in lipid bilayers Biophys. J. 36 109-116
Tripos Associates (1991) SYBYL : A molecular modelling package
Tripos Associates Inc., St. Louis, Missouri, U.S.A.
Warnick, J.E., Maleque, M.A., Bakry, N., Eldefrawi, A.T. and
Albuquerque, E.X. (1982) Structure-activity relationships of
amantadine : 1. Interaction of the N-alkylanalogues with the
ionic channels of the nicotinic acetylcholine receptor and
electrically excitable membrane Mol. Pharmacol. 22 82-93
Webster, R.G., Campbell, C.H., Granoff, A. (1971) The in vivo
production of 'new' influenza A viruses Virology 44 317-328
Weiner, M.C. and White, S.H. (1991) Transbilayer distribution of
bromine in fluid bilayers containing a specifically brominated
analogue of dioleoylphosphatidylcholine Biochemistry 30 6997-
7008
Weiner, M.C., King, G.I. and White, S.H. (1991) Structure of
fluid dioleoylphosphatidylcholine bilayer determined by joint
refinement of X-ray and neutron diffraction data Biophys. J. 60
568-576
White, J., Kartenbeck, J. and Helenius, A. (1982) Membrane fusion
activity of influenza virus EMBO J. 1 217-222
Wiley, D.C. and Skehel, J.J. (1987) The structure and function of
the haemagglutinin membrane glycoprotein of influenza virus
Ann. Rev. Biochem. 56 365-394
Williams, M.A. and Lamb, R.A. (1986) Determination of the
orientation of an integral membrane protein and sites of
glycosylation by oligonucleotide-directed mutagenesis - influenza
B virus NB glycoprotein lacks a cleavable signal sequence and
has an extracellular NH2-terminal region Mol. Cell Biol. 6
4317-4328
Wilson, I.A., Skehel, J.J. and Wiley, D.M. (1981) Structure of the
haemagglutinin membrane glycoprotein of influenza virus at 3A
resolution Nature 289 366-373
165
Winter, G. and Fields, S. (1980) Cloning of influenza cDNA into
M13 : the sequence of the RNA segment encoding the
A/PR/8/34 matrix protein Nucleic Acids Res. 8 1965-1974
Wolstenholme, A.J., Barrett, T., Nichol, S.T. and Mahy, B.W.J.
(1980) Influenza virus-specific RNA and protein synthesis in
cells infected with temperature-sensitive mutants defective in the
genome segment encoding nonstructural proteins J. Virol. 35 1-
7
Woody, R.W. (1977) Optical rotary properties of biopolymers J.
Polymer Sci. 12 181-321
Worcester, D.L. and Franks, N.P. (1976) Structural analysis of
hydrated egg lecithin and cholesterol bilayers : II neutron
diffraction J. Mol. Biol. 100 359-378
Zebedee, S.L. and Lamb, R.A. (1988) Influenza A virus M2
protein : monoclonal antibody restriction of virus growth and
detection of M2 in virions J. Virol. 62 2762-2772
Zhirnov, O.P. (1990) Solubilisation of matrix protein Ml/M from
virions occurs at different pH for orthomyxo- and
paramyxoviruses Virology 776 274-279
Zlychnikor, D.M., Kubar, O.I., Kovaleva, T.P. and Kamforin, L.E.
(1981) Study of rimantadine in the USSR : a review Rev.
Infect. Dis. 3 408-421
166
APPENDIX PUBLISHED PAPERS RESULTING FROM WORK
PRESENTED IN THIS THESIS
167
Volume 311, number 3, 256-258 FEBS 11672
© 1992 Federation of European Biochemical Societies 00145793/92/S5.00
October 1992
The secondary structure of influenza A M2 transmembrane domain
A circular dichroism study
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Using circular dichroism, this study investigated the secondary structure of the influenza A M2 transmembrane domain. When reconstituted into
l,2-dioleoyl-sn-glycero-3-phosphocholine liposomes, the M2 transmembrane domain was found to adopt a predominantly a-helical secondary
structure which was unaffected by both temperature and the addition of 1-aminoadamantane hydrochloride. Reconstitution into 1,2-dioleoyl-OT-
glycero-3-phosphoglycerol liposomes resulted in a marked decrease in helical content.
Spectrophotometry; Circular dichroism; Influenza M2 protein; Ion channel
1. INTRODUCTION
The influenza A virus M2 protein has recently been
the focus of extensive research. This protein is expressed
on the cell surface during viral synthesis [1] and has been
identified in viral particles [2], It is a disulphide-bonded
homotetramer [3] of 97 amino acids and is important
during two separate phases of the cell cycle [4], Immedi¬
ately after viral endocytosis, and concomitant with pH-
induced fusion between the endosomal and viral mem¬
branes, mediated by hemagglutinin (HA) [5], M2 is
thought to conduct protons into the interior of the virus,
leading to uncoating, the release of ribonucleoprotein
from the matrix protein (Ml), and eventual nuclear
infection [6], When HA is transported to the cell surface
in post-Golgi vesicles [7], M2 may also facilitate influ¬
enza synthesis and assembly by countering any vesicu¬
lar acidification. The relative importance of these
events, which occur at different stages of the infectivity
cycle, may depend on the particular viral strain [4],
Amantadine (1-aminoadamantane hydrochloride), the
only registered drug used in the prophylaxis and treat¬
ment of influenza infections, is thought to operate by
impeding proton flow during these events, however, it
is not yet clear if the mechanism of this action involves
an alteration in the secondary structure of the mem¬
brane-spanning domain or physical blockade. Impor¬
tantly, influenza A is thought to become resistant to
Correspondence address: K.C. Duff, Department of Preclinical Veter¬
inary Sciences, Royal 'Dick' School of Veterinary Science, University
of Edinburgh, Summerhall, Edinburgh, EH9 1QH, Scotland, UK.
Fax: (44) (31) 662 0790.
amantadine via single amino acid substitutions in the
membrane-spanning domain of M2 [8],
Regarding the thesis that M2 orchestrates proton
flow, it has recently been shown that, when expressed
in Xenopus laevis oocytes, it has an associated ion chan¬
nel activity selective for monovalent cations [9]; using
a two-electrode voltage-clamp procedure the Pinto
study observed Na+ and K+ currents. In addition, a
further electrophysiological study directly identified
proton translocation when the transmembrane domain
of M2 was incorporated into single-channel, voltage-
clamped, planar lipid bilayers [10]. Both studies re¬
ported current negation upon addition of amantadine.
The premise that membrane-spanning regions are
often a-helical is generally based on theoretical predic¬
tions and observations of such in bacterial photosyn-
thetic reaction centres [11-13]. In addition, when the
M2 transmembrane domain is modelled as an a-helix
the residues which are substituted in amantadine-resis-
tant mutants all appear on the same face of the helix
[14]. Thus it is an attractive assumption that the M2
transmembrane domain is a-helical, however, several
caveats exist. An amantadine-resistant influenza virus
has been isolated that contains a proline substitution in
the transmembrane domain, which is not usually
thought to be compatible with a helical conformation
[8]. In addition, Pinto et al. [9] observed that deletion of
four transmembrane residues and addition of one extra
residue still permitted ion channel activity.
The present study describes an investigation of the
secondary structure of the native influenza A M2 trans¬
membrane domain, and the influence of amantadine at
different concentrations, using circular dichroism (CD).
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The results are discussed in terms of the recent electro¬
physiological data available concerning the mode of
action of the M2 protein.
2. EXPERIMENTAL
In order to investigate the secondary structure of the influenza A
M2 transmembrane domain, a synthetic 25 residue peptide (sequence:
SSDPLVVAASIIGILHLILWILDRL), corresponding to the pre¬
dicted transmembrane sequence common to several strains of influ¬
enza A [15], was incorporated into l,2-dioleoyl-sn-glycero-3-phospho-
choline (DOPC) liposomes [16] and examined using CD. The peptide
was synthesized in the MRC Cellular Immunology Unit, Oxford, UK,
purified by reverse-phase HPLC and subsequently sequenced in the
WelMet Unit, University of Edinburgh, UK. The lipid was chosen for
this study because phosphatidylcholine is the most common phospho¬
lipid headgroup in mammalian systems and oleic acid represents the
most frequently occurring fatty acyl chain. The possible effects of
temperature, addition of amantadine, and liposomal lipid type used,
were also investigated. M2 was also reconstituted into l,2-dioleoyl-i«-
glycero-3-phosphoglycerol (DOPG) liposomes.
CD spectra were recorded on a JASCO J-600 spectropolarimeter;
analysis of the spectra in terms of secondary structure content was
undertaken using the CONTIN procedure of Provencher and
Glockner [17], the methods of Chang et al. [18] and of Siegel et al. [19].
The liposomes were prepared in a 10 mM Tris-HCl, 0.1 mM EDTA
buffer system, pH 7.4. Two concentrations of amantadine were added
to the reconstituted liposomes, 4 and 12 //g/ml. These were designated
low and high concentration, respectively. All chemicals were supplied
by Sigma Chemical Co., UK.
Liposomal and control protein concentrations were determined col-
orimetrically following the Lowry modification of Markwell et al. [20],
using bovine serum albumin as standard.
3. RESULTS AND DISCUSSION
The far UV CD spectrum at 20°C of the M2 trans¬
membrane peptide incorporated into DOPC liposomes
is shown in Fig. 1. Under these conditions, satisfactory
data could be obtained down to 200 nm; below this
wavelength, the noise levels precluded accurate meas¬
urements of ellipticity. The spectrum shows the charac-
[0] (deg.cmLdiioH)
Wavelength (ran)
Fig. 1. Far UV CD spectra of M2 peptide incorporated into liposomes.
Spectra were recorded at 20°C in a cell of path length 0.02 cm (—)
DOPC liposomes; ( ) DOPG liposomes. The liposomal peptide
concentrations were 0.16 and 0.27 mg/ml, respectively.
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teristic double minima at 223 nm and 209 nm of a-
helices [18]. Estimates of 92, 79 and 100% a-helix were
obtained using the methods of Provencher and
Glockner [17], Chang et al. [18] and Siegel et al. [19],
respectively. Although the exact values of these esti¬
mates should be treated with caution, in view of the fact
that data could only be collected down to 200 nm in¬
stead of 190 nm, which is preferred [17,18], it is clear
that under these conditions the M2 peptide exists
largely, if not completely, in an a-helical form. In addi¬
tion, estimates of helix approaching 100% have been
obtained both when M2 peptide is dissolved in 0.4%
(w/v) sodium dodecyl sulphate (SDS) and 50% (v/v)
2,2,2-trifluoroethanol (TFE) (see Table I). These sol¬
vents maximize possible secondary structure conforma¬
tion. Such results are in direct contrast to those ob¬
tained when M2 is dissolved in buffer. In aqueous solu¬
tion, the M2 peptide did not apparently adopt any sta¬
ble secondary structure; the low value of the molar el¬
lipticity at 225 nm (Table I) is typical of a random coil.
The DOPC liposomal measurements were repeated at
37°C, and no change was observed in the spectrum
when compared with the 20°C data.
On addition of amantadine to the liposomes, to give
final concentrations of 4 or 12 /rg/ml, there were no
significant changes in the CD spectra (see the molar
ellipticity values in Table I). Both low and high drug
concentrations were used in order to examine any possi¬
ble concentration dependence [21], These results are sig¬
nificant in that they clearly demonstrate that amanta¬
dine itself has no discernable effect upon the helical
nature of the M2 peptide, as was previously mooted
[22]. This, along with recent findings that amantadine
does indeed inhibit ion flow through M2 [9,10], aug¬
ments the thesis that the efficacy of amantadine is due
to its channel-blocking abilities and not to any confor¬
mational interference.
Table I
Values of molar ellipticities at 225 nm for M2 peptide incorporated
into liposomes
Sample Ellipticity at 225 nm
(degcnrdmol-1)
M2 peptide in DOPC liposomes (20°C) -22,260
M2 peptide in DOPC liposomes (37°C) -21,660
M2 peptide in DOPC liposomes (20°C) plus -21,970
amantadine (4 //g/ml)
M2 peptide in DOPC liposomes (20°C) plus -23,190
amantadine (12 //g/ml)
M2 peptide in DOPG liposomes (20°C) -11,430
M2 peptide in 0.4% (w/v) SDS -22,840
M2 peptide in 50% (v/v) TFE -24,440
M2 peptide in buffer (20°C) -700
Molar ellipticity values were calculated from the observed CD spectra
using a value of 110 for the mean residue weight. The error in the
ellipticity values is estimated to be ± 5%.
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The M2 peptide incorporated into DOPG liposomes
showed a considerably reduced CD spectrum (Fig. 1
and Table I). Analysis of this spectrum by the CONTIN
procedure [17] yielded unacceptably high errors of esti¬
mates of secondary structure; the methods of Chang et
al. [18] and of Siegel et al. [19] yielded values of 41 and
47% ct-helix, respectively, in accord with the reduced
values of the ellipticity at 225 nm (Table I). These exper¬
iments demonstrate a relationship between bilayer com¬
position and the secondary structure of the peptide.
Epand et al. [23] have demonstrated that the helical
content of salmon calcitonin is dependent on the per¬
centage of phosphatidylglycerol; altering the charge
state of the membrane alters the helical content of the
hormone. A similar phenomenon may also be found
with peptide toxins where, for example, cardiotoxin and
melittin are able to modulate lipid surface curvature and
polymorphism in a lipid-specific manner [24],
In summary, the transmembrane domain of M2
adopts an a-helical conformation in DOPC liposomes,
and this structure is not affected by the presence of the
drug, amandatine. In view of recent developments in the
study of M2 protein, these results answer the questions
raised regarding M2 in bilayers [9,14,22], and help to
explain its structural mechanism.
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Concomitant neutron and X-ray studies were undertaken in order to locate accurately the anti-influenza and Parkinson's disease
drug amantadine in multilayers of l,2-dioleoyl-in-glycero-3-phosphocholine. The X-ray data were phased using the swelling
series method and the neutron data were phased using D20/H20 exchange and a variation of the isomorphous replacement
technique. The sets of data complement each other and reveal two populations of amantadine within the bilayer. One site is
close to the bilayer surface, the other is much deeper. The majority of the amantadine occupies the surface site. The relative
occupancy, but not the position, of the two locations appears to be dependent upon the initial protonation state of the drug. No
evidence of bilayer perturbation was observed with either the protonated or the deprotonated forms of amantadine.
Introduction
Amantadine (1-aminoadamantane hydrochloride) is
licensed for the prophylaxis of influenza A infection
and for treatment of both influenza and Parkinson's
disease [1,2]. In the case of influenza, the efficacy of
amantadine is postulated to involve interruption of
viral-host cell membrane fusion and/or interference in
haemagglutinin maturation [3,4], The mechanism of
action of amantadine in Parkinson's disease is probably
related to its ability to increase presynaptic synthesis
and release of dopamine. This effect is potentiated by
the drug inhibiting dopamine reuptake [5]. These ther¬
apeutic processes are thought to include the involve¬
ment of the hydrophobic, lipophilic properties of the
molecule [6].
Amantadine studies undertaken so far have been
wide-ranging, including its effect on influenza infection
and, more recently, its specific molecular effect on the
viral protein which is implicated in this drug-induced
Correspondence to: J.P. Bradshaw, Department of Biochemistry,
University of Edinburgh, Hugh Robson Building, George Square,
Edinburgh, EH8 9XK, UK.
Abbreviations: amantadine FB, 1-amino adamantane free base;
amantadine HC1, 1-amino adamantane hydrochloride; DOPC, 1,2-di-
oleoyl-sn-glycero-3-phosphocholine; DOPE, 1,2-dioleoyl-in-glycero-
3-phosphoethanolamine; NMR, nuclear magnetic resonance spec¬
troscopy; rh, relative humidity.
prophylaxis, namely M2 [7]. A recent study has exam¬
ined the role of amantadine in the stabilisation of
clathrin-coated membrane vesicles, similar to those
formed upon initial viral penetration by influenza,
Semliki Forest and vesicular stomatitus virus [6]. How¬
ever, other authors have reported that, although tro-
mantadine (an amantadine derivative: A-l-adamantyl-
(V-[2-(dimethylamino)ethoxy]acetamide hydrochloride)
appears to stabilise phospholipid bilayers, amantadine
itself slightly lowers the temperature of the bilayer to
hexagonal phase transition. Also, NMR studies have
shown that amantadine is perturbing to the organisa¬
tion and motional properties of phospholipids in the
bilayer phase [8]. These results indicate an amanta-
dine-mediated increase in disorder. It can therefore be
seen that a certain degree of ambiguity exists in the
available data.
As a prerequisite of further mechanistic studies of
amantadine, we have undertaken a series of experi¬
ments to investigate the location of the drug within
bilayers of l,2-dioleoyl-xn-glycero-3-phosphocholine
(DOPC). To reduce possible ambiguity in the results a
single lipid species was used, DOPC being the most
physiologically representative. We have also examined
any differences between amantadine hydrochloride
(HC1) and amantadine in its free base form (FB).
This report describes the use of a specific deuterium
labelling technique to locate amantadine in synthetic
multilayer membranes using neutron diffraction. These
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Fig. 1. The two forms of 1-aminoadamantane used in this study: (a)
amantadine free base, (b) amantadine hydrochloride.
results are both quantitatively and qualitatively sup¬




was purchased from Sigma (Fancy Road, Poole, UK)
and confirmed to be a single species by thin-layer
chromatography. Amantadine was obtained from the
same source in both free base and hydrochloride forms
(Fig. 1). Deuterated amantadine FB was obtained from
Dr. M.R. Alecio of the Shell Research Centre (Sit-
tingbourne, Kent, UK).
X-ray diffraction
Oriented phospholipid bilayer stacks were prepared
as follows. Samples comprising 5 mg of DOPC with or
without 5% (mol) amantadine were dissolved in
methanol and applied to a curved glass support of
approx. 1 cm2 area. The solvent was allowed to evapo¬
rate before the slide was dried in vacuo for 2 h.
Subsequently, the samples were hydrated for at least 2
h at 20°C and 100% humidity. Once fully hydrated, the
samples were transferred to the sample cell of the
X-ray camera.
For at least 1 h before and subsequently throughout
the diffraction experiment, the samples were held in a
purpose built environmental cell which allowed the
temperature and humidity of the sample to be con¬
trolled. Temperature control was achieved by circulat¬
ing water from a thermostat bath through tubes in the
brass walls of the cell; all samples were run at 20°C at
which DOPC adopts the La-phase. The humidity, and
therefore the bilayer spacing, was controlled by passing
air through containers of saturated salt solutions and
then through the sample cell. Saturated solutions of
ZnS04 (90% rh), KC1 (81% rh), NaCl (74% rh) and
NaBr (57% rh) were used in addition to distilled water
(98% rh).
In the camera used to produce the diffraction pat¬
terns, 0.3 mm collimated, Nickel filtered copper Ka
radiation of 1.54 A from a Marconi-Elliot GX-13 rotat¬
ing anode X-ray generator was scattered by the sample
onto a pack of four 130 X 180 mm Agfa-Gevaert Osray
X-ray films positioned 175 mm from the sample. The
diffracted beam path was evacuated to reduce back¬
ground noise from air-scattered radiation. To record
the complete range of intensities without exceeding the
films' dynamic range, each sample was exposed twice,
typically for 20 h followed by a separate 4 min expo¬
sure. The developed films were scanned on a Joyce
Loebl Chromoscan 3 microdensitometer.
Neutron diffraction
Sample preparation was essentially the same as de¬
scribed for the X-ray experiments, with the exception
that each sample was 20 mg in weight and prepared on
a quartz microscope slide. D20/H20 exchange was
achieved by dehydrating the samples in vacuo before
re-equilibration over the new solvent.
Neutron diffraction data were collected using the
D16 instrument at the Institut Max von Laue - Paul
Langevin, Grenoble, France. After rehydration the
quartz slide bearing its oriented multi-bilayer phospho¬
lipid sample was placed in the temperature controlled
cell of the instrument along with water baths contain¬
ing either D20 or HzO where it was allowed a further
period of equilibration of 0.5-1 h. During this period
the equilibration process was monitored by recording
the angular position of the third or fourth order of
lamellar diffraction which increased as the multilayers
dehydrated and decreased as they took up water from
the atmosphere. Each sample was judged to have
achieved equilibrium when there was no further shift
in the position of the Bragg peaks and the calculated
lamellar repeat distance was that predicted for the
experimental conditions by previous X-ray work. Any
sample which did not fulfil both of these criteria was
discarded. Each recorded diffraction pattern consisted
of at least eight well defined orders. The mosaic spread
of each sample was determined using the D16 soft¬
ware.
X-ray data analysis
The background scattering level was estimated by
measuring the optical density of each X-ray film in the
region immediately adjacent to a diffraction peak and
interpolating across its base. Any peaks in which the
dynamic range of the film had been exceeded were
ignored. After integration of the diffracted intensities
the films were scaled together using overlapping peaks
and averaged to obtain the final set of intensities. A
Lorentz factor was applied to take into account the
spreading of the intensity in reciprocal space and the
sampling of the peaks by the Ewald sphere. The
diffraction peaks were discrete and well defined and
were restricted to the meridional region of the film. In
such situations, the Lorentz factor takes the form of
sin(20;,), where 6 is the Bragg angle and h the order of
diffraction. A further correction was applied for ab¬
sorption of the incident and diffracted beams by the
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lipid film [9], Data sets of Bragg intensities (Ih) were
scaled to each other using the expression:
E Ih = D/Dmin
where D is the Bragg spacing (bilayer repeat distance)
and £>min represents the minimum Bragg spacing of a
series run at different humidities.
D for each sample was determined using the Bragg
equation. The instrument offset angle for each sample
was calculated by iterative least squares regression of
this equation over all observed orders of diffraction.
Neutron data analysis
Once the diffracted intensities had been corrected
for detector response and background then integrated,
the following corrections were applied:
(1) Acceptance angle. The projection of the quartz
slide along the normal to the neutron beam is depen¬
dent upon its relative angle to the beam. If the slide
presents a very low angle (0) to the incident beam, it
only samples a small fraction of the total neutron beam
width and, therefore, flux. This means that the diffrac¬
tion peaks recorded for the lower orders will be corre¬
spondingly weaker than if the slide were able to sample
the whole width of the neutron beam. As long as the
neutron beam is wider than the maximum projected
width of the sample slide and the neutron flux constant
across the width of the beam, the angular correction
factor, takes the form:
^AngcA) = Vsin eh
(2) Lorentz factor. For the geometry used in this
study, the appropriate correction factor is:
CLorW = sin(20j
(3) Absorption. When the angle of diffraction is low,
the incident and diffracted beam have a significant
path length within the sample and thus will be subject
to a greater degree of absorption than when the angle
is high and the corresponding path lengths low. More¬
over, the degree of absorption will also be affected by
the H20/D20 composition of the sample. The appro¬
priate correction for absorption by the lipid film, was
applied:
CAbs(/o= l/(sin e/2ut){\ -exp[-2ut/sin 0])
where u = (6.04-0.75^), d being the mole fraction of
DzO [10]. The mass of lipid on each slide, the area
over which it was spread and the unit cell size, as
determined by diffraction, were used to calculate a
value of 30 gm for t, the thickness of the lipid film.
(4) Sampling by the detector. As a result of lattice
disorder in the sample, the diffraction peaks may be so
wide that the whole of each diffraction peak is not
recorded by the detector, and a correction must be
applied to the data to account for this. In this study the
mosaic spread of each sample was small enough to
ensure that each diffraction peak was regular in shape
and contained wholly within the central part of the
detector so no correction was applied in this case.
The final neutron structure factor amplitudes were
therefore calculated as:
~ ft ^Ang(h) ^Lor(h) ^Abs(7z)
Phasing
Electron density or neutron scattering profiles may
only be obtained upon solving the individual phases of
the recorded amplitudes. In this study three different
techniques were employed to phase the data sets:
swelling series, D20/H20 exchange and isomorphous
replacement.
The X-ray structure factors were phased using a five
point swelling series [11]. Our methodology comprised
of selecting from the swelling series one working set of
eight diffraction peaks and using this to compute a
continuous transform [12] against which the fit of all
the other observed sets were compared. The best fit
minimised the difference between the calculated and
the observed intensities for each of the possible 256
phase combinations. The selected working set alter¬
nated until all five had been used and sampled against.
The resulting transform represented the best, inte¬
grated fit for all data over all possible phases. This
process was carried out independently for the DOPC,
DOPC/amantadine HC1 and DOPC/amantadine FB
swelling series.
Neutron data are routinely phased by carrying out
experiments hydrated at various H20/D20 ratios
[9,10,13,14], This method was used in the present study,
with additional phasing information coming from a
variation of the isomorphous derivative technique [15]
in which use was made of the presence or absence of
amantadine in the multilayers. Assigning phases to the
neutron data proceeded by altering the sign of the
individual structure factors until a result was achieved
in which both the differences caused by replacing HzO
with D,0 and the DOPC/amantadine minus DOPC
differences were consistent within each set of compara¬
ble data.
The two techniques, using X-rays and neutrons,
emphasise different features within the bilayer struc¬
ture, and further confirmation that the correct phases
had been assigned was given by the fact that the two
methods agreed and thereby showed the complemen¬
tary nature of the techniques.
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White and his co-workers [16] have produced an
elegant method for scaling neutron data. This ap¬
proach was used in the present study and basically
involved using the size of the D20 and the amantadine
distributions to scale the different sets of data to each
other. The results put the profiles on a 'relative abso¬
lute' scale in which they are scaled with respect to the
unit cell contents, but not on an absolute per volume
scale. The method is also readily applicable to X-ray
data, although for this there is no equivalent of the
D20 peak therefore scaling is carried out on the size of
the amantadine distribution alone.
Results
Fig. 2 is a representative X-ray diffraction pattern,
in this instance obtained from DOPC with 5% (mol)
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Fig. 3. The relationship between the relative humidity at 20°C of the
sample and the observed bilayer spacing (in angstroms, A), v, pure
DOPC; A, amantadine hydrochloride; O, amantadine free base. The
error bars represent the standard deviation for each point. Sample
size varied from 3 to 9.
J L
Fig. 2. X-ray diffraction pattern of lamellar arrays of DOPC with 5%
(mol) amantadine FB at 90% relative humidity and 20°C.
ship between the relative humidity of the sample cham¬
ber and the bilayer repeat distance as observed by
X-ray and neutron di[fraction. Fig. 4 shuws the swelling
series data used to phase, the X-ray diffraction patterns
of pure DOPC (a), DOPC with 5% (mol) amantadine
HC1 (b) and DOPC with 3% (mol) amantadine FB (v).
In each case the continuous transform calculated from
98% rh data is shown superimposed upon the observed
diffraction amplitudes fnr 98, 90, 81, 74 and 5'/% rh.
Tablo I gives the corrected, scaled neutron diffraction
structure factors for all three samples at 0% and 100%
D20. Fig. 5 shows reconstructed tiansbilayer profiles
of DOPC alone (a, b) and difference profiles calcu¬
lated by subtraction of structure factor dala sets of
corresponding D-repeat to define the distribution of
amantadine HQ (e, d) mid FB (e, f), respectively.
The mosaic spread of the DOPC bilaycrs ranged
from 0.4° to 0.6°, these very low values being quite
characteristic of unsaturated fatty acyl phospholipids.
The mosaic spread was not significantly changed upon
Lhc addition of amantadine.
Discussion
DOPC
Fig. 5 displays both X-ray and neution sealtcring
density profiles across the phospholipid bilayer with
the water component occupying the outer region of the
graphs With X-rays, the DOPC profile (a) agrees with
previously published data [17,18] in that it displays the
classic phospholipid leaflet form with a main peak
representing the electron-dense region which encom-
pascs the phosphate groups and fatly acyl ester bonds.
A secondary peak appears within the hydiophubic re¬
gion which corresponds to the double-bond in the oleic
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acid chains. It can be seen from (b) that less detail
results from the neutron data. This is probably due to
the lower contrast characteristic of neutron scattering
(all diffraction experiments were sampled through eight
orders so this phenomenon does not involve the X-ray
data being collected to a higher resolution than the
neutron).
The differences between the X-ray and neutron
profiles are due to inherent atomic scattering differ¬
ences across the unit cell. X-rays are more strongly
scattered by the phosphate groups in the repeat motif
whereas maximum neutron scattering corresponds to
the fatty acyl ester bond positions [19]. Profile (b)
clearly displays this scattering dichotomy with the neu¬
tron data peak appearing markedly closer to the hy¬
drophobic interior of the bilayer than the X-ray result
(a). The sharper X-ray profile displays a second highly
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Fig. 4. Structure factors of lamellar arrays of bilayers of (a) pure
DOPC, (b) DOPC with 5% (mol) amantadine HC1 and (c) DOPC
with 5% (mol) amantadine FB, plotted against corresponding recip¬
rocals of Bragg spacings (A-1). The amplitudes of the structure
factors are equal to the square roots of the Bragg intensities, their
signs are those derived from the phasing procedure described in the
text. The swelling series data sets were collected at 98, 90, 81, 74 and
57% relative humidity. The continuous transforms calculated from
the 98% rh data is shown.
TABLE I
Relative absolute neutron structure factors of lamellar arrays of pure
DOPC and DOPC with 5% (mol) amantadine HCl or FB at 98% rh
and 20°C. The accuracy is estimated to be ± 0.15 units
Order DOPC DOPC+ 5 mol% DOPC+ 5 moI%
20°C, 98%rh amantadine HCl D-amantadine FB
(d2o) 20°C, 98%rh (DzO) 20°C, 98%rh (d20)
1 -89.31 -61.22 -96.41
2 25.56 10.02 18.80
3 -4.34 -1.68 -2.76
4 1.00 0.32 1.21
5 -2.84 -1.86 -2.97
6 0.77 0.06 0.57
7 -0.67 0.15 -0.16
8 0.00 -0.27 -0.15
Order DOPC DOPC+ 5 mol% DOPC+ 5 mol%
20°C, 98%rh amantadine HCl D-amantadine FB
(H2O) 20°C, 98%rh (H20) 20°C, 98%rh (H20)
1 -6.47 -19.74 -13.55
2 -12.09 -8.66 -17.65
3 5.16 3.17 6.53
4 0.34 0.00 0.00
5 -1.44 -1.37 -1.98
6 0.33 -0.18 0.33
7 -0.30 0.26 0.00
8 0.00 -0.30 0.00
Amantadine HCl
Fig. 5. (c) to (f) are difference profiles which were
calculated by subtracting the lipid component from the
lipid + amantadine structure factors and therefore rep¬
resent only the amantadine distribution across the bi¬
layer. They are displayed in the same orientation as the
pure DOPC but it can be seen that these profiles, both
X-ray and neutron, are substantially different from the
DOPC data. Amantadine, in both its hydrochloride
and free base forms, appears to have been incorpo¬
rated into the multilayer system.
The highest peak in the X-ray profile (c), represent¬
ing the greatest distribution of amantadine HCl, lies
between the phosphate and ester linkages. This surface
location is also represented in the neutron (d) profile
but its shape has changed with additional density en¬
croaching into the water. It is proposed that the differ¬
ence between the X-ray and neutron profiles is due to
the relatively higher scattering length of nitrogen for
neutrons compared to that for X-rays, which empha¬
sises the amine group in the neutron profiles. These
results therefore orientate amantadine HCl in the bi¬
layer; the hydrophobic, cyclic region of the drug lo¬
cated between the phosphate and ester linkages of the
phospholipids with the NHj group protruding into the
water space.
This interpretation is supported by changes in the
distribution of water between adjacent bilayers when
amantadine HCl is added. Fig. 6 shows difference
profiles representing the location of the deuterons of
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heavy water, calculated by subtracting neutron scatter¬
ing profiles of multi-bilayers containing HzO from cor¬
responding ones hydrated with DzO. It can be seen
that incorporation of amantadine HC1 into the DOPC
bilayers reduces the area under the water profiles,
indicating that the drug is displacing some of the water
from the system.
Both profiles (c) and (d) of Fig. 5 include additional
features in the lipid tail region which may be caused by
termination error. The resolution of the present study
precludes unambiguous assignment of these features to
the presence of amantadine deep within the bilayer,
but it should be noted that evidence from the FB
profiles (see below) indicates that full penetration of
the bilayer by a proportion of the amantadine can
occur. This is particularly noticeable in the neutron
profiles and is either a product of the relatively high




































Fig. 5. Reconstructed trans-bilayer X-ray scattering profile of pure
DOPC (a, left-hand scale) and neutron scattering profile of pure
DOPC (b, right-hand scale) at 98% rh and 20°C. (d) and (f) are
neutron scattering difference profiles of amantadine hydrochloride
and amantadine free base, respectively, (c) and (e) are the corre¬
sponding X-ray scattering difference profiles. The difference profiles
were calculated by subtracting structure factors of pure DOPC from
those of DOPC with 5% (mol) amantadine, after correction for
variations in bilayer repeat and placed on a relative absolute scale
using the method of Weiner et al. [18]). The horizontal scale (Z) is
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Fig. 6. Difference neutron density scattering profiles showing the
distribution of water between bilayers of (a) pure DOPC, (b) DOPC
with 5% (mol) amantadine HC1 and (c) DOPC with 5% (mol)
amantadine FB, all at 20°C. Also shown are Gaussian distributions
fitted to the water profiles in reciprocal space over all eight observed
orders of diffraction, using a development of the method of Wiener
et al. [18]. Each curve consists of the sum of two Gaussians with the
following parameters: (a) Z (distance from centre of bilayer) =
±26.53 ±0.35 A, Aw (1/e halfwidth) = 8.82 ±0.20 A; (b) Z = 26.04
± 0.55 A, A w = 8.75 ± 0.25 A; (c) Z = ± 25.58 ± 0.45 A, A w = 8.65 ±
0.25 A. The difference between the observed and modelled water
profiles may be taken as a crude approximation of error in the
reconstructions. Each graph therefore also shows this difference,
plotted on an enlarged scale, corresponding to that used in Fig. 5
(right-hand side).
face sites, or it may represent amantadine which has
reverted to the uncharged, FB form by deprotonation.
Amantadine FB
At this resolution, both amantadine peaks are in the
same position in the X-ray profile (e) as in the amanta¬
dine FIC1 result (c). Positionally, therefore, the data are
identical. However, there is a difference in the propor¬
tional representation of amantadine across the bilayer
with relatively more now appearing in the fatty acid tail
region of the phospholipids. The neutron results (f)
support these findings. Here the main scattering den¬
sity at the surface location has moved slightly into the
bilayer reflecting the fact that the amantadine FB is
deuterated on the hydrophobic carbons only and that
the NH2 amine group is unlabelled and therefore
scatters much less intensely compared to the labelled
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mass; it can be observed as a shoulder on the water
side of the main peak. This observation again orien¬
tates the amantadine with its NH2 group at the lipid/
water interface.
Profiles (e) and (f) clearly show that a proportion of
amantadine has penetrated almost to the centre of the
bilayer. Once again, the features in this region may
represent some part of the amantadine structure, or
may just be termination error. However, the height of
the profiles above zero can only be explained in terms
of a considerable mass of drug being present in this
region. Consistent with this finding, the amount of
water associated with the bilayers containing amanta¬
dine FB is much greater than that for bilayers contain¬
ing amantadine HC1 (Fig. 6) and almost equates with
that present in the bilayers in the absence of either
form of amantadine. Clearly a proportion of the drug
has moved away from the water-penetrated surface of
the bilayers to take up a deeper location in the bilay¬
ers. This evidence, taken together with the HC1 results,
leads us to propose that the interaction between aman¬
tadine and DOPC bilayers takes the form of an equi¬
librium between two possible regions. One of these is
located at the water/bilayer interface, the other is less
defined and broadly represents the fatty acid tail re¬
gion. The balance of this equilibrium between the two
sites appears to' depend upon the starting protonation
state of amantadine. However, this does not necessarily
imply that the initial charge state of the amine is
preserved throughout the experiment. This result com¬
pares with tetracaine where its interaction with phos¬
pholipids is also reported to be influenced by the
charge state of the drug [20,21].
Amantadine-phospholipid interactions
If the optical parameters and the sample dimensions
are kept constant throughout a series of diffraction
experiments then the mosaic spread may be used as a
measure of the macroscopic order of each sample; the
smaller the mosaic spread, the less the degree of
disorder of the bilayers [22,23]. The values obtained for
stacked bilayers of pure DOPC in this study are in
good agreement with previous observations [16,17], The
mosaic spread did not change upon the addition of 5
mol% amantadine, which indicates that the interaction
between the drug and the bilayer did not disturb the
macroscopic order of the system. There was no evi¬
dence of phase separation in the multilayers containing
amantadine. Unfortunately, in the liquid phase, DOPC
does not give discrete 4.5-4.8 A reflections so we are
unable to comment on the effect of amantadine on
chain packing. We can, however, conclude that, under
these experimental conditions, amantadine does not
markedly perturb the bilayer system.
It has been reported that amantadine reduces the
extent of dissociation of clathrin from coated vesicles
[6] in a study which used relatively small amounts of
the amine. The ability of amantadine and related com¬
pounds to stabilise or destabilise phospholipid bilayers
has also been extensively investigated. Cheetam and
Epand [8] concluded from NMR studies that amanta¬
dine perturbs the organisation and increases the fluid¬
ity of bilayers. Our present study, using a much lower
drug/lipid molar ratio, does not indicate any such
perturbation but it may be that this anomaly reflects
the different drug concentrations used in such studies.
Another variable involves the lipid type used. The
work reported here employed DOPC which has a large
headgroup and two unsaturated chains giving the phos¬
pholipid a quasi-hourglass shape, creating an area of
increased steric freedom in the neck region when the
lipids are formed into a bilayer. The amantadine may
be accomodated within such an area, fitting in between
the phospholipid molecules. Our data, which indicate
that the cyclic carbon component of amantadine orien¬
tates on the hydrophobic side of the phospholipid
headgroup, support this model. This would suggest that
the effects of amantadine upon bilayer structure and
stability are likely to be complex and to be dependant
upon intrinsic and environmental factors.
Fig. 2 shows that the bilayer repeat distance was
reduced by up to 2.5 A at low humidities. A similar
effect is produced by the addition of 1,2-dioleoyl-s-
glycero-3-phosphoethanolamine (DOPE) [17] to DOPC,
where the smaller PE headgroup allows the choline
moiety of DOPC to lie in a more perpendicular orien¬
tation and therefore closer to the plane of the bilayer
surface (unpublished data). Amantadine may have a
similar effect on DOPC. Unfortunately, the relatively
low contrast between the PC headgroup and water
makes it impossible to determine the headgroup con¬
formation with the present data. However, this does
mean that any drug-induced changes in headgroup
conformation will not have an adverse effect on the
profile subtractions. Future neutron work using specifi¬
cally deuterated phospholipid headgroups may be able
to resolve this question.
Our finding that uncharged, amantadine FB has the
ability to penetrate more easily into the bilayer is
supported by diffusion data performed on other similar
compounds [24], This phenomenon could be related to
the zwitterionic nature of DOPC, the lipid chosen for
our study. Further work will investigate the possible
relationship between the lipid composition of the bi¬
layer and the nature of its interaction with amantadine.
For example, including a proportion of negatively-
charged lipid may induce major changes [25] particu¬
larly with the charged amantadine HC1.
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The Transmembrane Domain of Influenza A M2 Protein Forms Amantadine-Sensitive
Proton Channels in Planar Lipid Bilayers
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In a direct test of the hypothesis that the M2 coat protein of influenza A can function as a proton translocator, we
incorporated a synthetic peptide containing its putative transmembrane domain into voltage-clamped planar lipid
bilayers. We observed single proton-selective ion channels with a conductance of ~10 pS at a pH of 2.3, consistent
with the association of several monomers around a central water-filled pore. The channels were reversibly blocked by
the anti-influenza drug amantadine. These experiments imply a central role for M2 protein in virus replication and
assembly and may explain the mechanism of action of amantadine. Analogous proteins may have a similar function in
other viruses, and these may be susceptible to similar antiviral agents. © 1992 Academic Press, inc.
The surface of the influenza virus has been the focus
of extensive research, leading to elucidation of the
structure of the external spike proteins, hemagglutinin
(HA) and neuraminadase (NA) (/, 2). Our knowledge of
other viral envelope and interior proteins is much less
complete (3). Several virus-coded proteins are present
in infected cells (4), including M2. This protein is ex¬
pressed on the cell surface during viral synthesis (4)
and has recently been identified in virus particles (5). It
is a homotetramer of 96 amino acid subunits which
associate as a pair of membrane-spanning disulphide-
linked dimers (6), and it has been suggested that the
protein forms a proton-conducting pore (7). Proton
translocation by M2 may be important during two sepa¬
rate phases of the viral cycle (S). Following endocytosis
of the virus, and concomitant with pH-induced fusion
between the endosomal and viral membranes me¬
diated by HA (9), M2 may conduct protons into the
interior of the virus, leading to uncoating, the release of
ribonucleoprotein from the matrix protein (M1), and
eventual nuclear infection (10). M2 may also facilitate
viral synthesis and assembly when HA is transported
to the cell surface in post-Golgi vesicles (11). Even
minor acidification of these vesicles by cellular proton
pumps is undesirable as the structure of HA might be
compromised; this may be countered by M2 incorpo¬
rated into the vesicle membrane. The relative impor¬
tance of these effects, which occur at different stages
in the viral cycle, will depend on the particular viral
strain (8). Importantly, influenza A is thought to become
resistant to amantadine (1-aminoadamantane hydro-
1 To whom reprint requests should be addressed.
chloride), the only registered drug used in the prophy¬
laxis and treatment of influenza infections, via single
amino acid substitutions in the putative membrane-
spanning domain of M2 (12).
In order to test the hypothesis that M2 protein can in
fact act as a proton channel, a synthetic 25-residue
peptide corresponding to the predicted transmem¬
brane sequence common to several strains of influ¬
enza A (13) (Fig. 1a) was incorporated into voltage-
clamped planar lipid bilayers. The peptide was synthe¬
sized in the MRC Cellular Immunology Unit, Oxford,
U.K., purified by reverse-phase HPLC and subjected to
confirmatory sequencing in the WelMet Unit, University
of Edinburgh, U.K. Bilayers formed spontaneously at
room temperature after decane suspensions of a mix¬
ture of palmitoyl-oleoyl phosphatidylethanolamine and
palmitoyl-oleoyl phosphatidylserine (Avanti), each '15
mg/ml, were cast across a 0.3 mm hole in a polysty¬
rene partition separating two solution-filled chambers
designated cis and trans [e.g., (14)]. Both chambers
contained 600 g\ of 50 mM glycine-HCI, pH 2.3, un¬
less otherwise indicated, which could be changed by
perfusion (usually replacing the contents of the trans
chamberwith 50 m/Wglycine-HCI, pH 3.0). Forsimplic-
ity we have not corrected salt concentrations for activ¬
ity and have assumed throughout that aH+ = 1.0. The
cis chamber was voltage-clamped (Biologic RK-300
patch clamp) at a range of holding potentials relative to
the trans chamber, which was grounded. The bilayers
were monitored by measuring their capacitance
(~250 pF) and those used had resistances of at least
1011 0hm. Unit transmembrane currents were usually
seen within 30 min of adding up to 1 ^9 of the hydro¬
phobic peptide in 6 p\ of MeOH to the cis compart-
485 0042-6822/92 $5.00
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exposed to 50 mM glycine-HCI containing up to 300
mM NaCI or KCI. The pH was varied between 2.3 and
5.7. Mellitin channels became incorporated preferen¬
tially at low pH, were markedly anion-selective, and
were insensitive to amantadine (results not shown).
Overall approximately 6 hr of M2 channel data were
recorded on magnetic tape or computer disc and ana¬
lyzed using Axotape and PCIamp software (Axon In¬
struments). Data were filtered with either an eight-pole
Bessel low-pass analogue filter (-3 dB at 0.03 kHz,
Frequency Devices) or, where indicated, a digital
Gaussian filter (0.1 kHz).
Single-channel currents were obtained in more than
50 independent experiments and typical examples are
shown in Fig. 1 b. The channels were blocked within 30
sec by 20 nM amantadine (e.g., Fig. 1b). In several
experiments the contents of both bilayer chambers
were replaced by extensive perfusion with fresh buffer
after amantadine block and channel activity was re¬
stored on each occasion. Four and a half minutes of
the illustrated pre-amantadine recording were in¬
spected to identify discrete openings which were col¬
lected in a frequency histogram (Fig. 2). The open life¬
times have been fitted to a single exponential distribu¬
tion with a mean open time (r0) of 20 msec. The
recording bandwidth limited our open time resolution
to events lasting at least 8 msec (e.g., Fig. 2, inset), and
typically only relatively few events (<1000) could be
collected (effectively confining any numerical kinetic
analysis to just one component). Lifetime analysis is,
0.5 pA
Fig. 1. (a) Sequence of synthetic 25-residue peptide containing the
putative transmembrane domain of M2 protein (inner ring) with ad¬
joining extramembrane residues. The helical wheel projection (16) is
oriented with the strongly hydrophobic intramembrane sector above
the dotted line, (b) Single-channel currents (downward deflexions)
across a planar lipid bilayer with incorporated synthetic peptide, in¬
hibited by 20 iiM amantadine HCI (added to both sides of the mem¬
brane). Holding potential +100 mV, glycine-HCI, pH 2.3, c/'s and
trans.
ment, and their appearance could be accelerated by
breaking and reforming the membrane. Control bi-
layers exposed to 1% (v/v) MeOH in the same buffer
remained stable for up to 3 hr and exhibited no chan¬
nel-like activity. As another technical control, the
26-residue channel-forming peptide mellitin (15) was
incorporated in the same manner into similar bilayers
72 -
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Open time (ms)
Fig. 2. Frequency distribution of all the openings collected from
4.5 min of pre-amantadine recording (with typical events in more
detail). The smooth curve is a single exponential function with a time
constant of 20 msec. Data were low-pass filtered at 0.1 kHz (digital
Guassian filter) and events lasting <4 msec were discarded. In addi¬
tion, the contents of the first bin were excluded from the fit.
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however, consistent with a model for channel forma¬
tion of the general type
4p P4.
a
where incorporated peptides (p) associate briefly to
form an oligomeric channel (here shown as a tetramer)
and a, the rate constant for channel closure, is ~50
per second (1/r0). Limited observations of single-chan¬
nel currents in bilayers of the same lipid composition
exposed to the same buffers at similar temperatures
suggested that a was, as expected, independent of
peptide concentration (40 ± 13 per second, mean ±
SD, n = 4 independent experiments). Closed lifetime
distributions, on the other hand, appeared to contain at
least two exponential components, with mean life¬
times of about 10 msec and about 1 sec, respectively.
Because of the small numbers of events these analy¬
ses are not detailed here, and the absolute values of
the closed-state lifetimes varied considerably between
experiments, as would be expected for different pep¬
tide concentrations. However, the constant finding of
more than one component is consistent with the for¬
mation of clusters of peptides (e.g., tetramers), with
short "intraburst" intervals reflecting the temporary
dissociation of one monomer within a given group and
longer "interburst" intervals corresponding to more
extensive disruption. Of course, with higher peptide
concentrations, bursts of channel activity tended to
overlap to give openings to more than one unit current
level (as described later). It was noted that channel
activation showed little obvious voltage-dependence.
The membrane lipid composition and bathing solu¬
tions were varied to optimize channel incorporation
and increase the amplitudes of single-channel
currents. Bilayer stability was always monitored before
adding the peptide. Diphytanoylphosphatidylcholine
(Avanti) bilayers were exceptionally stable at low pH
even when voltage-clamped at high potentials (up to
±150 mV), but the rate of channel incorporation was
poor. The use of mixtures of phosphatidylethanol-
amine and phosphatidylserine greatly increased the
rates of channel formation. These bilayers were some¬
times unstable when exposed to a pH below —1.0,
and therefore the pH was only exceptionally reduced
below 2.3 (Figs. 3a, 4a). Peptide incorporation in¬
creased markedly on addition of >10 /ug/ml but this
usually resulted in the appearance of multichannel
currents (up to 50 pA) which were difficult to analyze.
Occasionally distinct conductance levels could still be
resolved and in the experiment shown in Fig. 3a
current transitions appear to occur between the closed
level (which is more obvious after the application of
amantadine) and several open levels. The amplitude
3 pA
500 ms
peak 2 peak 3
Amplitude (pA)
Fig. 3. (a) Current transitions in a peptide-containing bilayer volt-
age-clamped at +80 mV. The bilayer was formed in 25 mM TrisCI
(pH 7.0) and the pH of the cis solution was then lowered to 1.0 by
adding HCI. Downward proton currents flow cis to trans. Amanta¬
dine (20 fiM), added to both chambers where indicated (*), con¬
firmed the zero-current level (0). Openings have been assigned to
three marked current levels. Filtered at 0.1 kHz. (b) Amplitude histo¬
gram from 100 sec of contiguous data. Transitions from the marked
levels which lasted <4 msec were ignored. Main peaks 1 and 2 were
each fitted to a single Gaussian, and peak 3 to two Gaussian distri¬
butions. Peaks 1:2:3 have been rescaled in the ratio 9:5:2 to share
the same axes.
histogram (Fig. 3b) shows three main equally spaced
peaks, consistent with the simultaneous formation of
up to three channels in this bilayer. The third peak is
not a single Gaussian, suggesting that some large










Fig. 4. (a) Single-channel currents (downwards deflexions) across
a peptide-containing bilayer voltage-clamped at the indicated hold-
(possibly ion channels formed from higher oligomers,
e.g., five peptides rather than four). In addition, appar¬
ently direct transitions between level 1 and level 3 oc¬
curred much more often than would be expected from
the random superimposition of unit events (77), con¬
sistent with some cooperativity of oligomer association
and dissociation or the formation of channel clusters.
We attempted to increase channel amplitudes by us¬
ing high concentrations (up to 3.0 M both cis and trans)
of neutral NaCI or KCI, but only obtained currents of
~0.25 pA at ±100 mV. We therefore continued to
maintain a pH < 3.0 (usually 2.3) on at least one side of
the bilayer. Unit currents with very large proton gra¬
dients (Fig. 4a) gave highly nonlinear l/V relationships
(Fig. 4b) which appeared to be well-described by elec-
trodiffusion theory (78). Conductance was ohmic in the
more moderate gradients provided by citrate or gly¬
cine—HCI buffers (e.g., glycine-HCI, pH 2.3, cis vs 3.0
trans, Fig. 4c, solid line). Reversal potentials were
shifted slightly from the proton equilibrium potential
(which is -42 mV for Fig. 4c), even after taking liquid
junction potentials of up to 5 mV into account, but re¬
mained consistent with a H+:CI1 permeability ratio of at
least 5:1 (derived from the GHK voltage equation (78)
and assuming glycine"1" is impermeant). On the same
basis, the shift in reversal potential when the trans
chamber was perfused with 3.0 M NaCI (leaving gly¬
cine-HCI, pH 2.3, cis) indicated a H+:Na+ permeability
ratio of at least 3:1 (Fig. 4c, dotted line). It must be
stressed that these values correspond to very unphy-
siological conditions for the peptide and all the ions
involved. Relative permeabilities in normal cellular con¬
ditions (and with the complete protein) may differ.
These experiments have been carried out near the
limits of useful resolution in a bilayer system (because
of the small currents involved) although one advantage
of this technique is a very stable current baseline. Bet¬
ter resolution of single-channel currents might be ob¬
tained by using smaller bilayers (for example, formed
on the tips of patch pipettes (79)), but single-channel
current transitions at more physiological pH values
(—5—7) may only be revealed by fluctuation analysis. It
is also important to draw attention to the fact that the
ing potentials with 50 m/W KCI both cis and trans, pH 1.5 and 7.0,
respectively (adjusted with HCI or KOH). (b) Current/voltage (l/V) rela¬
tionship from the same experiment. The smooth curve is a best-fit to
the Goldman-Hodgkin-Katz current equation (18) (assuming only
protons are significantly permeant under these conditions), (c) l/V
relationships from an experiment with glycine-HCI cis and trans, pH
2.3 and 3.0, respectively (■), and after exchanging the trans solution
by perfusion with 3.0 M NaCI (pH 7.0) (•). The lines are fitted by
linear regression and the reversal potential shifts from -34 mV to
+ 10 mV. (Each figure is representative of at least four similar experi¬
ments.)
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formation of ion channels in a bilayer does not neces¬
sarily prove that the peptide involved lines the pore in
vivo. For example, a functional channel has been
formed from peptides modeled on two quite different
sequences from the nicotinic acetylcholine receptor
(20, 21). Our experiments nevertheless do provide
clear evidence that the "transmembrane" domain of
M2 protein can form proton-conducting ion channels
which are blocked by amantadine and therefore sup¬
port the original hypothesis of Hay and his colleagues
that proton translocation by M2 plays an important part
in viral pathogenesis (6, 7). Our study thus adds to a
wealth of convergent evidence to support an ion chan¬
nel function for M2 and, in particular, its putative trans¬
membrane domain. For example, while amantadine at¬
tenuates or prevents influenza infection {22), it is inef¬
fective against mutant viruses with substitutions in the
transmembrane domain of M2 (12), and the Na+/H+
exchanger monensin inhibits its action (11). Also, while
the manuscript was in preparation, Pinto et al. (L. H.
Pinto, L. J. Holsinger, and R. A. Lamb, Biophys. J. 61,
1992, abstr. A11) reported that the expression of M2
RNA in Xenopus oocytes conferred amantadine-sensi-
tive (whole-cell) currents. Amantadine may also inter¬
act with other channels, for example to inhibit K-
currents in insulin-secreting cells (23).
The NB protein of influenza B (24), the SH protein of
paramyxovirus SV5 (25) and the vpu protein of HIV-1
(26) are analogous to M2 and may have related func¬
tions. In conclusion, we anticipate that proton-con-
ducting channels reconstituted from M2 peptides
modelled on amantadine-resistant mutants will be un¬
affected by the drug, although the channel character¬
istics of whole M2 protein (when available in sufficient
amounts for reconstitution) may differ significantly from
those of the isolated transmembrane domain.
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